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OUTLINE OF STUDY
This study was instigated after the diagnosis of 
post-traumatic hypopituitarism in a young female under 
our care, who had sustained a closed head injury in a 
motor cycle accident (Case 1, see below). A review of
the world literature revealed only 47 reported cases of
post-traumatic hypopituitarism, with the majority 
occurring in the last 20 years (Edwards and Clark, 
1986). Surprisingly, we were able to collect a further
5 cases over a relatively short period of time, 
suggesting that it might be a more frequent
complication than is currently recognised. It is of 
interest that the low prevalence of clinical 
hypopituitarism is in contrast to the frequent finding 
of damage to the hypothalamus and pituitary by
pathologists after fatal head injury (Daniel, Prichard
6 Treip, 195 9; Ceballos, 1966; Kornblum and Fisher, 
1969; Treip, 1970; Crompton, 1971; Harper et al, 1986) .
As little endocrine information was available a 
large prospective study was undertaken to investigate 
abnormalities in endocrine function after head injury.
10
PROJECT OBJECTIVES
To determine
1. The endocrine response to major head injury.
2. The incidence of early hypothalamic and pituitary 
dysfunction following major head injury.
3. Whether secondary hypoadrenalism occurs and 
possibly contributes to early morbidity and 
mortality.
4. Whether results of early pituitary function tests 
correlate with the extent of brain injury and have 
an immediate prognostic significance.
5. The incidence of late neuroendocrine sequelae 
after severe head injury, in particular post- 
traumatic hypopituitarism.
6. The histopathological findings in the hypothalamus 
and pituitary in fatal cases, which together with 
the results from the pre-mortem endocrine tests 
should allow a detailed correlation to be made 
between structure and function.
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DESCRIPTION OF WORK PERFORMED
Sixty patients who had sustained a major head 
injury were entered into the study. On admission to the 
Neurosurgical Unit a full clinical examination of each 
patient was performed. The cause of the accident, the 
direction of the injuring force, the results of in­
patient investigations (including specialised
neurosurgical radiology) and all medication were 
recorded. The severity of the injury was determined 
from the Glasgow Coma Scale and the duration of post- 
traumatic amnesia.
Within 24 hours of admission a venous blood sample 
for basal hormone concentrations and a dynamic test of 
anterior pituitary function, which consisted of the 
intravenous administration of 4 hypothalamic releasing 
factors (CRH, GRH, TRH and GnRH) with appropriate 
hormone samples collected during the ensuing 2 hours, 
were performed. A second set of endocrine tests were 
performed 1 week later and a final set during 
convalescence after 3-6 months.
As hypogonadism was frequently detected by these 
investigations, a further study examining the pulsatile 
release of LH was performed in 5 male subjects within 1 
week of injury, with blood samples taken at 5 minute 
intervals for 6 hours. A further study to investigate 
central abnormalities of the gonadal axis, which 
involved intravenous infusion of naloxone, was stopped 
because of the naloxone's stimulant effect on these 
sedated patients.
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Twelve of the 60 subjects died as a result of 
their injuries and a histopathological study of their 
pituitary glands and hypothalami was performed. The
pre-mortem endocrine tests in these subjects were 
compared to the histological findings, to determine 
indicators of a bad prognosis.
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C H A P T E R  1
REVIEW OF THE LITERATURE
Post-traumatic Hypopituitarism, with 6 Case Reports 
Endocrine Response to Injury 
Endocrine Studies performed after Head Injury 
Investigation of Hypothalamo-Pituitary Hypofunction 
Assessing Brain Damage after Head Injury
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POST-TRAUMATIC HYPOPITUITARISM
This is defined as dysfunction of the anterior 
pituitary gland after injury, usually to the head. The 
first case was reported by a German physician, Cyran, 
in 1918 and involved a railway worker who had sustained 
a skull fracture when his head was trapped between a 
reversing wagon and buffers. Surprisingly, he survived 
the initial injury and subsequently developed loss of 
secondary sexual characteristics and hypothyroidism, 
presumed to be of pituitary origin (Cyran, 1918).
Cases were reported sporadically until an apparent 
recent upsurge, which may be due to several factors, 
including the increasing incidence of road traffic 
accidents, prolonged survival with improved intensive 
care and an increased awareness of the condition. The 6 
cases collected in conjunction with my supervisor, Dr 
OM Edwards, make a total of 53 in the world literature 
(Table 1).
Case reports of the six local cases 
Case 1:
This 16 year old girl was a pillion passenger on a 
motor cycle which collided with a car. The patient was 
wearing a crash helmet and did not sustain a skull 
fracture but she had fractures of the femoral neck, 
tibia and the arch of the first cervical vertebra. She 
remained unconscious for 3 weeks but the tendon
15
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reflexes were symmetrical with flexor plantar
responses.
On admission cranial CT scan showed no
displacement of midline structures but 3 weeks later, 
following the development of papilloedema, the repeat 
scan showed symmetrical dilatation of the lateral 
ventricles indicating active hydrocephalus. Bilateral 
ventriculo-atrial shunts were inserted. She gradually 
regained consciousness and after 3 months was
transferred to the rehabilitation ward.
Shortly after transfer she developed galactorrhoea 
and was noted to have had no menstrual periods since 
the accident. Menarche had been at 12 years of age and 
her menses had been regular until the accident. She was 
not on an oral contraceptive or taking drugs known to 
cause lactation, and a pregnancy test was negative. She 
was found to be hypotensive with a plasma sodium 
concentration of 120 mmol/L and a low plasma cortisol 
at 0900 hours. She was given hydrocortisone replacement 
therapy, the plasma sodium concentration rose to normal 
and she became normotensive. The basal thyroxine level 
was low while the initial thyrotropin (TSH) level was 
elevated and the response to thyrotrophin releasing 
hormone (TRH) delayed (Table 2) . The prolactin level 
was elevated and there was failure of luteinising 
hormone (LH) and follicle stimulating hormone (FSH) 
response to gonadotrophin releasing hormone (LHRH, 
GnRH). Five months after admission she developed 
polyuria and nocturia and the urine osmolality, after
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water deprivation for 12 hours overnight, was 422 
mOsm/kg, whilst the serum osmolality was 301 mOsm/kg. A 
diagnosis of partial cranial diabetes insipidus was 
made and she was commenced on intranasal desmopressin 
(DDAVP) with relief of her symptoms.
Four years after her injury she remains 
amenorrhoeic, has absent pubic and axillary hair and 
galactorrhoea. The prolactin levels remain elevated and 
there is complete failure of FSH and LH response to 
GnRH. She remains on desmopressin, thyroxine 0.15 mg 
daily, hydrocortisone 10 mg twice daily and more 
recently the combined oral contraceptive.
Case 2;
This 35 year old man was the driver of a van which 
was involved in a head-on collision in which he 
suffered a major closed head injury, associated with a 
depressed fracture of the left frontal bone and a 
fracture dislocation of the left acetabulum.
On admission he was unconscious and a cranial CT 
scan showed a contusion of the left temporal lobe and a 
left frontal haematoma. His condition deteriorated and 
the left frontal fracture was explored, the left 
frontal haematoma aspirated and a cranioplasty 
performed. He remained unconscious for 1 month, with 8 
months of post-traumatic amnesia.
Immediately after admission the patient developed 
diabetes insipidus with a urine output of about 5 L/24 
hr which responded to intramuscular desmopressin. Two
17
months after admission the desmopressin was stopped but 
the urine output rose in excess of 5 L/24 hr with a 
urine osmolality of 159 mOsm/kg and a plasma osmolality 
of 300 mOsm/kg. Two weeks after admission the 0900 
hours plasma cortisol concentration was low, the level 
of thyroxine subnormal and the TSH response to TRH 
delayed (Table 2) . The plasma testosterone level was 
also low, the LH and FSH response to LHRH absent and 
the prolactin level elevated.
Currently he remains on intranasal desmopressin, 
hydrocortisone 10 mg twice daily, thyroxine 0.15 mg 
daily and testosterone 100 mg every 3 weeks.
Case 3 :
This 19 year old man, the driver of a motor car, 
was involved in a head-on collision during which he 
sustained a fronto-vertical fracture and was admitted 
unconscious. He developed decerebrate signs the 
following day and bifrontal and right temporal burr 
holes were made with the insertion of a left fronto- 
ventricular catheter and a right frontal subdural 
catheter. Contusion only was noted at operation. He 
remained unconscious for 1 month and on recovery of 
consciousness became over-talkative, euphoric and was 
noted to be perseverating. He was found to be totally 
blind due to bilateral optic nerve damage.
Over subsequent months he became hyperphagic, 
rapidly gaining 17 kg in weight. He was referred for 
endocrine assessment and was found to be obese (35%
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above ideal body weight) with no clinical evidence of 
hypothyroidism or hypoadrenalism and his secondary 
sexual characteristics were normal. His fluid balance 
was normal with no nocturia and a water deprivation 
test showed normal rise of urine osmolality. There was 
no postural fall in blood pressure and the patient*s 
temperature measured 4 hourly over 1 week showed normal 
circadian variation. An insulin stress test revealed a 
normal cortisol response but absent growth hormone 
response (Table 2). The thyroxine level was low with an 
absent TSH response to TRH, while the basal prolactin 
level was elevated. The testosterone level was low with 
no LH or FSH response to LHRH.
He remains on thyroxine and an intramuscular 
injection of testosterone every 3 weeks. He continues 
to be hyperphagic.
Case 4 ;
This 48 year old man was admitted unconscious and 
hypotensive with a flaccid quadriplegia and extensor 
plantar responses following a road traffic accident, in 
which he was involved in a head-on collision with a 
motor car. Blood stained cerebrospinal fluid was 
exuding from the nose and ears. Radiological 
examination revealed a basilar fracture through the 
sella turcica and rib and pelvic fractures.
He remained unconscious for 24 hours and in post- 
traumatic amnesia for 3 weeks. He was anosmic with 4th 
and 6th cranial nerve palsies. One week after admission
19
he became hypotensive and as he failed to respond to 
fluid replacement he was given an intravenous injection 
of hydrocortisone with rapid improvement. He was 
continued on dexamethasone until his endocrine 
assessment a month later.
An intramuscular injection of 80 units of ACTH was 
given daily for 4 days and the plasma cortisol rose to 
932 umol/L on the last day. An insulin stress test 
showed a subnormal cortisol response (Table 2) . His 
serum thyroxine was subnormal and his 24 hour urinary 
gonadotrophin excretion was less than 5mg 
equivalents/24 hours (normal range 5-10mg
equivalents/24 hours). A water deprivation test was 
performed with a normal rise in urine osmolality.
He remains on hydrocortisone 30 mg daily in 
divided doses, thyroxine 0.2 mg daily and testosterone 
250 mg every 3 weeks.
Case 5 ;
This 21 year old man was admitted following a road 
traffic accident when he was thrown off his motor 
cycle. On admission he was conscious but disorientated 
and no history of previous loss of consciousness was 
obtained. There were no focal neurological signs but a 
skull radiograph revealed a linear fracture of the 
right squamous temporal and frontal bones with a fluid 
level in the sphenoid sinus. He was discharged 4 days 
after admission and was well when reviewed 6 weeks 
later. Three years later he was referred with the
20
recent onset of tiredness, increasing cold intolerance, 
dizziness on standing and weight loss of 7 kg.
Pubertal development had been normal and until the 
accident he had shaved daily. Following the accident he 
shaved on alternate days and lost his pubic and 
axillary hair. He denied any impotency or diminution in 
libido but had noticed a failure of ejaculation.
On examination he was a pale young man with absent 
pubic and axillary hair and a sparse beard. The left 
testis was of normal size, while the right was absent. 
The blood pressure on standing fell from 110/70 mm Hg 
to 90/50 mm Hg. He had a sinus bradycardia and the 
reflexes were depressed.
An insulin stress test performed with the 
simultaneous administration of TRH and LHRH resulted in 
a subnormal cortisol and absent growth hormone response 
(Table 2) . The thyroxine level was low, and there was 
an absent TSH response to TRH. The basal prolactin 
level was high and there was an absent FSH and LH 
response to LHRH. A skull xray showed the pituitary 
fossa to be of normal size.
He made an excellent recovery on replacement 
therapy of hydrocortisone 20 mg daily, thyroxine 0.2 mg 
daily and testosterone given by intramuscular 
injection.
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Case 6 :
This woman, born in 1925, started to menstruate 
when 11 years of age and continued to menstruate 
regularly until 14 when she was struck by shrapnel in 
the face and chest.
Immediately following injury she developed 
polyuria, polydipsia, hypersomnia and amenorrhoea. A 
skull radiograph showed a metal fragment lodged above 
the left side of the pituitary fossa. After a month in 
hospital she improved and was discharged but was 
readmitted 8 months later for investigation of mental 
retardation and continued amenorrhoea. She was found to 
have a right upper quadrantic homonymous hemianopia, 
the basal metabolic rate was subnormal and the blood 
pressure 100/70 mm Hg.
No active treatment was undertaken. She remained 
amenorrhoeic and at 27 years of. age developed hot 
flushes. When aged 49 years she complained of cold 
intolerance, mental and physical retardation and marked 
weight gain? a clinical diagnosis was made of myxoedema 
which was confirmed by finding a low Iodine uptake. 
She was started on thyroxine replacement with relief of 
her symptoms and a weight loss of 38 kg.
When 58 years old she felt tired, mentally and 
physically lethargic, cold intolerant with anorexia and 
weight loss. She was found to have a normochromic 
normocytic anaemia, leukopaenia and thrombocytopaenia. 
A bone marrow biopsy showed slight loss of cellularity, 
normal megakaryocytes and diminished granulopoiesis.
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She had noted a gradual loss of pubic and axillary hair 
for many years.
On examination she had a pale facies with absent 
pubic and axillary hair, there was no postural 
hypotension or abnormal neurological signs.
An insulin stress test revealed a poor cortisol 
and growth hormone response, while the basal FSH and LH 
levels and their response to LHRH were less than 
expected in a post-menopausal woman (Table 2). The 
basal prolactin level was elevated. She was commenced 
on hydrocortisone 30 mg in divided doses in addition to 
her thyroxine 0.2 mg daily. The anaemia, leukopaenia 
and thrombocytopaenia resolved on this therapy.
Skull X-ray revealed a shrapnel fragment above and 
to the left of the pituitary fossa (Fig 1) . A CT scan 
demonstrated that much of the pituitary gland and the 
left side of the hypothalamus had been destroyed, 
resulting in a small increase in size of the left 
lateral ventricle.
23
Figure 1 Skull X-ray demonstrating shrapnel fragment 
above pituitary fossa
A
«j
shrapnel fragment
POST-TRAUMATIC HYPOPITUITARISM - A REVIEW
Cause of Injury
Examination of the 47 cases in the literature
together with our additional 6 cases revealed that 
post-traumatic hypopituitarism occurred mainly in young 
males, reflecting the high prevelance of death due to 
trauma in this age group. The most frequent cause of 
head injury was road traffic accidents, which were 
responsible for 27 of the 53 cases (Table 1) . 
Occasional cases were reported after falls 
(Schereschewsky, 1927; Gross, 1940; Pere et al, 1980;
Bistritzer et al, 1981;), work accidents (Cyran, 1918; 
Kanayama et al, 1972; Pere, 1980) , direct bullet and
shrapnel injury to the pituitary region (Lerman and 
Means, 1945; Werner, 1960; Linquette et al, 1968;
Durand et al, 1969; Salti et al 1979 and our case 6) , 
blunt trauma (Witter and Tascher, 1957; Pittman et al, 
1971; Notman et al, 1980), bomb and blast injuries
(Pascheff, 1922; Lerman and Means, 1945) and child 
abuse (Miller et al, 1980) . The injury is usually to 
the head, the only exception being a patient who landed 
feet first on soft earth, after her parachute failed to 
open (Soules and Sheldon, 1979).
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Skull fractures and direction of injuring force
Skull fractures were common, reflecting the 
seriousness of the impact (Table 1) and in the 47 cases 
reported, excluding the 6 with penetrating bullet or 
shrapnel wounds, 15 had fractures of the base of the 
skull, often involving the sella turcica, 9 had 
fractures of the frontal and temporal bones including 1 
with associated basilar fractures and 2 had multiple 
skull fractures with associated basilar fractures. Only 
3 patients had fractures of the facial skeleton or 
parietal and occipital bones. The fracture site was not 
specified in 4 cases and 11 cases did not have skull 
fractures (including our first case). In the remaining 
reports no information was given on the presence of a 
skull fracture.
Witter and Tascher (1957) considered that blows 
from behind and downwards commonly initiated pituitary 
damage and were often associated with fractures of the 
base or vertex of the skull, whereas Cebalos (19 6 6), in 
a pathological study, demonstrated that in frontal 
injuries when the brain travelled backwards, the 
pituitary was constrained within the sella turcica, 
causing either disruption of the stalk or thrombus 
formation in the long portal vessels.
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Neurological complications
Associated neurological abnormalities were common, 
the most frequent being blindness, either unilateral or 
bilateral with various field defects ranging from 
scotomata to homonymous hemianopia (Pascheff, 1922; 
Escamilla and Lisser, 1942; Porter and Miller, 1948; 
Werner, 1960; Altman and Pruzanski, 19 61; Klachko et 
al, 1968; Linquette et al, 1968; Durand et al, 1969; 
Weiss et al, 1977; Kanade et al, 1978; Landua et al, 
1978; Prosperi et al, 1978; Salti et al, 1979; 
Bistritzer et al, 1981; Jambert et al, 1981; Valenta 
and De Feo, 1982; and our cases 1 and 3). The next most 
common lesions were 5 th, 6 th and 7th cranial nerve 
palsies (Cyran, 1918; Reverchon and Worms, 1921; 
Escamilla and Lisser, 1942; McCullagh and Schaffenburg, 
1953; Altman and Pruzanski, 1961; Weiss et al, 1977; 
Landua et al, 1978; Prosperi et al, 1978; Salti et al, 
1979; Notman et al, 1980; Pere et al, 1980; Valenta and 
De Feo, 1980 and our case 4). Hemiparesis and 
hemianesthesia were less frequent (Witter and Tascher, 
1957; Klachko et al, 1968; Miller et al, 1980; 
Bistritzer et al, 1981 and our case 4) , with anosmia 
(Pascheff, 1922; Gross, 1940; Witter and Tascher, 1957; 
Salti et al 1979 and our case 4) and damage to other 
cranial nerves (Pascheff, 1922; Linquette et al, 1968; 
Paxson and Brown, 1976; Kanade et al, 1978; Notman et 
al, 1980 and our case 4) occurring in only a few cases. 
In many cases there were no neurological but only 
endocrine sequelae to head injury. In our six patients
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there was a high incidence of associated neurological 
abnormalities ranging from complete blindness to 
spastic quadriplegia.
Patients were often unconscious for days or weeks 
but prolonged coma should not be regarded as a 
necessary accompaniment to traumatic hypopituitarism as 
several patients have either had no loss of
consciousness or were unconscious for very short times 
(Witter and Tascher, 1957; Goldman and Jacobs, 1960; 
Altman and Pruzanski, 1961; Durand et al, 1969; Pittman 
et al, 1971; Prosperi et al, 1978; Notman et al, 1980 
and our case 5) .
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Endocrine Findings in Post-Traumatic Hypopituitarism
There was adequate endocrine data on 26 patients 
(Tables 2 and 3) . In most of these patients the basal 
levels of anterior pituitary hormones and their 
response to insulin-induced neuroglycopenia, TRH and 
GnRH were measured. Since most cases were diagnosed 
many months after the trauma, the time of onset of the 
hypopituitarism was not well-defined. The longest delay 
between injury and clinical presentation was 35 years 
(Klachko et al, 1968). However, studies of anterior 
pituitary function on patients developing diabetes 
insipidus shortly after head injury have revealed 
hypopituitarism to be present at 3 weeks (Barreca et 
al, 1980).
Gonadal function
Hypogonadism was a common presenting symptom of 
traumatic hypopituitarism and was clinically evident at 
the time of diagnosis, with amenorrhoea, impotence, 
loss of libido and loss of secondary sexual 
characteristics. The levels of the gonadal hormones and 
the basal gonadotrophins were low, and there was no 
response to a bolus injection of GnRH. One of our 
patients did have a response to GnRH, but less than 
would be expected in a post menopausal woman (Case 6).
However, the GnRH test cannot be used to 
distinguish between hypothalamic and pituitary causes 
of hypogonadotrophic hypogonadism (Mortimer et al,
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1973), since in hypothalamic disorders repeated 
stimulation is often needed to ensure a normal LH and 
FSH response (Hashimoto et al, 1975).
Thyroidal function
Most of the patients were clinically and 
biochemically hypothyroid, with low thyroidal hormones, 
normal basal TSH levels and an absent TSH response to 
TRH. However, a few cases exhibited the phenomenon of 
hypothalamic hypothyroidism with low thyroidal hormones 
but a delayed, prolonged TSH response to TRH, as 
described by Faglia et al (1979) . The TSH, in these 
cases, has recently been shown to have reduced 
biological activity due to impaired receptor binding 
(Beck-Peccoz, 1985).
Adrenal Function
Clinically, this is the most important axis 
because of the potentially fatal consequences of 
glucocorticoid deficiency. The cortisol response to 
stimulation was frequently subnormal, occasionally in 
subjects with no clinical evidence of hypoadrenalism 
(Barreca et al, 198 0). Glucocorticoid replacement 
therapy was required in 23 of the 26 patients. The site 
of damage cannot be ascertained from the results of the 
insulin stress test as low basal levels of cortisol 
with a subnormal response to stimulation occur with 
damage to the hypothalamus and pituitary. However, the
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hypothalamic releasing hormone, corticotrophin 
releasing factor (CRF), which acts directly on the 
pituitary corticotrophes (Grossman et al, 1982) may be 
of use in localising the damage since it has been shown 
to produce an exaggerated ACTH response in hypothalamic 
hypopituitarism and a subnormal ACTH response in 
pituitary-dependent hypopituitarism (Tsukada et al,
1984).
Growth Hormone
In all patients studied there was no growth
hormone response to stimulation. In three children 
physical battering led to sub-dural haematomas in early 
infancy and decreased growth rates. Although short
stature is well-recognised following child abuse, in 
particular the syndrome of psycho-social deprivation, 
the children described by Miller et al (1980) lacked 
the behavioural characteristics of psycho-social 
deprivation, and short stature occurred while in a 
caring environment. Endocrine tests revealed anterior 
hypopituitarism and the patients responded to growth 
hormone treatment. Two of the children had a delayed
rise in TSH release following stimulation with TRH, 
which the authors interpreted as suggestive of a 
hypothalamic cause of the hypopituitarism. Thus all 
children with a serious head injury, regardless of
cause, require long term observation for signs of 
impaired growth. The hypothalamic releasing hormone,
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growth hormone releasing factor, may now be used to 
localise the site of damage in children.
Prolactin
This was elevated in the majority of cases and was 
associated with galactorrhoea in 4 of the 12 female 
patients (Woolf and Schalch, 1973; Dzur and Winternitz, 
1976; Soules and Sheldon, 1979 and our case 1). It was 
thought to rise due to hypothalamic or stalk damage 
with release of lactotrophes from the prolactin- 
inhibiting factor, dopamine. Since the lactotrophes are 
located in the periphery of the gland, anterior 
pituitary necrosis could occur with destruction of 
other pituicytes leaving prolactin secretion unaltered 
(Soules and Sheldon, 1979). In a few patients the basal 
prolactin level was low, with an absent response to 
TRH, indicating extensive anterior pituitary necrosis.
Posterior pituitary function
Diabetes insipidus, either temporary of permanent, 
was a common finding and when present resulted in an 
earlier diagnosis of anterior pituitary failure. It 
occurred in 23 of the 53 cases, being temporary in 9. 
Its frequent association with anterior pituitary 
failure may stem from the fact that hypothalamic or 
upper stalk damage can produce both deficiencies. 
Temporary diabetes insipidus may either be due to 
inflammatory oedema in the hypothalamus or posterior
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pituitary with resolution as the swelling settles or 
permanent damage to the posterior pituitary with 
persisting symptoms until antidiuretic hormone is 
directly released by neurons originating from the 
supra-optic and paraventricular nuclei (Lipsett et al, 
1956).
Site of Endocrine Dysfunction
The pattern of endocrine abnormalities should vary 
according to whether the hypothalamus or pituitary is 
damaged. Injury predominantly involving the 
hypothalamus would produce low basal growth hormone and 
cortisol (ACTH) levels with no response to the stress 
of insulin hypoglycemia, low basal gonadotrophin levels 
with no response to a single bolus stimulation by GnRH, 
hypothyroxinemia with a variable TSH response to its 
releasing factor, hyperprolactinemia and temporary or 
permanent diabetes insipidus.
Predominantly pituitary damage would be expected 
to cause low basal levels of all six anterior pituitary 
hormones with no response to stimulation, since the 
hormone producing cells are destroyed, and occasionally 
diabetes insipidus depending on the level of stalk 
injury.
However, only a few cases had all the features of 
typically hypothalamic (Dzur and Winternitz, 1976; 
Prosperi et al, 1978 and our cases 1 and 2) or 
pituitary (Gomez-Saez et al, 1982) dysfunction. 
Presumably, in most cases injury is sufficient to
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damage both structures producing a mixed endocrine 
picture.
Pathological Findings in the Hypothalamus and Pituitary 
after fatal head injury
Pathological changes in the hypothalamus and
pituitary are commonly found in patients dying of head 
injury. Massive infarction of the anterior pituitary 
following head injury was first described by Daniel et 
al (1959 b) , who reported 6 cases. They suggested that 
this occurred due to interruption of the blood supply 
to the anterior pituitary and warned that pituitary 
infarction should be borne in mind in patients who 
remain in prolonged coma.
Pituitary findings
Daniel and his co-workers had previously
demonstrated the unique blood supply to the anterior 
pituitary gland, which renders it susceptible to 
hypotension and trauma (FIG 2). Using injection
techniques (Xuereb, Prichard and Daniel, 1954) showed 
that the anterior lobe has no arterial blood supply but 
that it is supplied with blood only through the 
hypophyseal portal blood vessels. Thus all the blood 
reaching the anterior lobe has already passed through a 
primary capillary bed lying in the median eminence and 
pituitary stalk. There are two types of portal vessel 
supplying blood to the anterior lobe, the long and
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Figure 2 Blood supply of pituitary gland and stalk
PRIMARY PLEXUS
MEDIAN EMINENCE
SUPERIOR V _
HYPOPHYSEAL ARTERY
STALK
LONG HYPOPHYSEAL- 
PORTAL VEINS
INFERIOR HYPOPHYSEAL ARTERY
SECONDARY PLEXUS
short portal vessels. They are both derived from the 
primary capillary bed but the short portal vessels 
emerge from the lower part of the pituitary stalk below 
the level of the diaphragma sellae. The long portal 
vessels supply upto 90 % of the anterior lobe and the 
short portal vessels supply a variable layer of 
anterior lobe cells adjacent to the posterior lobe. The 
inferior hypophyseal arteries supply the posterior 
lobe.
There have been 4 studies of the pathological 
changes in the pituitary following fatal head injury 
(Daniel and Treip, 1961; Ceballos, 19 66; Kornblum and 
Fisher, 1969; Harper et al, 1986) , since the initial 
observations by Daniel et al in 1959. Differences exist 
between the classification system used in the various 
studies but most divided anterior pituitary necrosis 
into small and large infarctions (large defined as 
affecting 80% or more of the cross sectional area of 
the anterior lobe). In addition two studies examined 
the histological changes in the hypothalamus (Treip, 
1970; Crompton, 1971).
Large anterior pituitary infarcts had a similar 
distribution in all studies, residual parenchyma being 
restricted to a narrow subcapsular band and a broader 
wedge adjacent to the posterior lobe. Small infarcts 
occurred in any part of the lobe and were occasionally 
multiple. Haemorrhage within the anterior lobe was 
uncommon and occurred more frequently in the posterior 
lobe. Infarcts in the posterior lobe were infreqent and
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when present were associated with large anterior lobe 
infarcts. Table 4 summarises the findings with respect 
to the pituitary gland in these 5 studies.
Various mechanisms have been suggested to explain 
the typical central distribution of the large anterior 
pituitary infarct. Daniel et al (1959 a) observed that 
when the pituitary stalk is cut at the operation of 
stalk section and the pituitary gland is examined 
within a few days of operation most of the anterior 
lobe is infarcted. Adams et al (19 63) measured the 
infarct size in one such case and found it to be 90 % 
of the volume of the anterior lobe. The only surviving 
tissue is a thin layer of cells (only a few cells 
thick) extending like a capsule round the gland and a 
layer of variable thickness adjacent to the posterior 
lobe. The large central infarct is due to interruption 
of the long portal vessels. As the stalk is cut above 
the diaphragma the blood supply to the posterior lobe 
(inferior hypophyseal arteries) is not interfered with 
but the posterior lobe is denervated. These arteries 
also supply the short portal vessels thereby explaining 
the presence of surviving tissue next to the posterior 
lobe. The small capsular arteries are thought to 
explain the thin layer of viable cells surrounding the 
gland. The striking similarity in surviving tissue and 
infarct distribution led Daniel et al (1959 b) to 
suggest that stalk section produced by head injury was 
the mechanism responsible for the observed massive 
pituitary necrosis.
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However later studies involving larger numbers of 
cases noted that stalk section was found much less 
frequently than anterior pituitary necrosis and 
concluded that it could not be responsible for the 
necrosis in the majority of cases. Kornblum and Fisher 
(196 9) suggested that confinement of the pituitary 
gland in the sella turcica by the diaphragma sella 
makes the stalk especially vulnerable to shearing 
strain. Subsequent swelling of the gland is limited by 
the diaphragma sella, which has only a small circular 
opening serving as a passage for the pituitary stalk. 
As it swells the fragile long hypophyseal vessels are 
compressed between the stalk and the free edge of the 
diaphragma sella resulting in anterior pituitary 
infarction. The short hypophyseal vessels arising below 
the diaphragma are not affected. Harper et al (1986) 
agreed with Kornblum and Fisher, stating that the blood 
flow through the hypophyseal portal vessels may be 
interrupted without actual transection of the stalk. In 
his study all cases with a large or medium sized 
infarct had raised intracranial pressure and many also 
had significant mid-line shift. This combination of 
factors may be sufficient to impair the portal blood 
supply on the stalk.
Several authors have reported an association 
between basal skull fractures and anterior pituitary 
necrosis, particularly if the fracture affects the 
pituitary fossa (Daniel and Treip, 19 61; Harper et al, 
1986). In these cases the injuring force is transmitted
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through the base of the skull to the region of the 
pituitary, resulting in pituitary damage. The direction 
of force most likely to result in pituitary injury is 
undecided; some studies (Crompton, 1971) suggest that 
lateral impact in the tempero-parietal region is more 
likely to produce pituitary damage, whereas others 
(Ceballos, 1966) suggest that maximum stretching and 
jarring of the pituitary occurs with fronto-occipital 
impact.
Hypothalamic lesions
Hypothalamic injury was relatively common and in 
Crompton*s study (1971) of 106 cases of fatal head 
injury he found lesions in 45 cases? microhaemorrhages 
in 31 and ischaemic necrosis in 26. The 
microhaemorrhages were mainly found in the supraoptic 
and paraventricular nuclei, the median forebrain bundle 
and the median basal eminence, while ischaemic lesions 
had a haphazard distribution. Treip (19 70) confirmed 
this predilection for the supraoptic and 
paraventricular nuclei and postulated that it was due 
to the tethering of the optic nerve to the optic 
foramen by a dural sheath while caudally it forms an 
angle with the lamina terminalis within which the 
supraoptic nucleus lies. Thus, as one side of the angle 
is fixed, sudden movement of the brain such as occurs 
with head injury could readily lead to shearing of the 
rich supply of thin walled vessels to this nucleus with 
consequent haemorrhage. Infarction was common in the
median eminence and the upper stalk, leading to pooling 
of neurosecretory material due to disruption of the 
supraoptico-hypophyseal tract (Treip, 1970). The 
vulnerability of this area could be explained by the 
traction exerted on it and its blood supply by the 
pituitary stalk which is tethered below to the 
diaphragma sella.
The majority of the studies draw attention to the 
disparity between the relatively high incidence of 
hypothalamo-pituitary damage in the pathological 
literature compared to the paucity of clinical reports 
of post-traumatic hypopituitarism. In the most recent 
study Harper et al (19 86) concluded that hypothalamo- 
pituitary damage is common in patients with head injury 
and although many patients with large pituitary 
infarcts may die as a result of the effects of 
increased intracranial pressure and distortion of the 
brain, clinicians should be more aware of this 
treatable endocrine complication of head injury.
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THE ENDOCRINE RESPONSE TO INJURY
Physiology
The neuroendocrine response to injury may begin 
before the injury itself, with awareness of approaching 
danger activating the hypothalamus. This results in the 
secretion of several pituitary hormones including ACTH, 
GH, PRL and vasopressin, activation of the sympathetic 
nervous system and, as a consequence of the ACTH 
release, increased cortisol secretion. Once the injury 
has occurred this stress response is reinforced by 
stimuli from nociceptive afferents in damaged tissue 
(Stoner, 1976). Conscious perception of pain is not 
necessary, as the neuroendocrine response occurs in 
surgical patients under anaesthesia. It is not clear 
how the impulses reach the hypothalamus, although the 
spinoreticular or spinomesencephalic tracts may be 
involved (Willis, 1984). Hypovolaemia also contributes 
to the response with decreased inhibitory neural input 
from the low pressure baroreceptors in the right atrium 
and, if the blood pressure falls, from high pressure 
ones in the carotid arteries. The stimuli reach the 
hypothalamus via the tractus solitarius and the 
medullary reticular formation (Gann and Lilly, 1984).
This early phase after injury is characterised by 
rapid mobilisation of glycogen and lipid stores, 
although the metabolic rate is not raised to the extent 
expected from the degree of fuel availability (Little,
1985). In 1942 Cuthbertson termed this phase of
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mobilisation of fuel stores, together with apparent 
restraint on their utilisation, as the ebb phase. This 
lasts typically around 12-24 hours depending on the 
severity of the injury and the treatment given. It 
merges into a more prolonged period characterised by an 
increase in metabolic rate and a breakdown of body 
tissues, the catabolic or Cuthbertson*s flow phase of 
the response to injury. The duration and intensity of 
this phase varies according to the severity of the 
injury (Wilmore, 1977) but in orthopaedic patients with 
long bone fractures it merges into the anabolic or 
convalescent phase over the next 2-4 weeks (Frayn,
1986).
The neuroendocrine control of metabolism is most 
obvious in the ebb phase when there is a large 
sympathetic discharge, reinforced by pituitary 
stimulation of cortisol secretion. This phase is 
characterised by fuel mobilisation and many of the 
hormones secreted have potential roles in promoting 
glycogenolysis and lipolysis. Adrenaline appears to 
have the major role in liver glycogen breakdown as the 
resultant hyperglycaemia is correlated to the plasma 
adrenaline concentration (Frayn et al, 19 85). 
Similarly, the elevated plasma lactate concentration in 
injured patients, thought to arise from muscle 
glycogenolysis (Daniel et al, 1978) , bears a weak but 
significant relationship to plasma adrenaline 
concentration (Frayn et al, 1985). In addition 
adrenaline, cortisol and glucagon act synergistically
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to promote and sustain hepatic gluconeogenesis (Shamoon 
et al, 1981). Lipolysis is also stimulated by 
catecholamines and may be potentiated by cortisol 
(Fain, 198 0) and the high GH levels reached soon after 
injury (Frayn et al, 1984 b) . As cortisol levels are 
variable shortly after injury, often being lower in the 
more severely injured (Barton, 1987), and because the 
actions of cortisol are mediated through enzyme 
induction it seems probable that the role of cortisol 
is concerned more with maintenance than with initiation 
of this response. Thus, when the glucocorticoid 
response to injury is blocked in animals the 
hyperglycaemic response is transient rather than 
sustained (Frayn, 1986) .
The flow phase of the response to injury is 
characterised by an increased metabolic rate, an 
elevated core temperature and pulse rate, and increased 
urinary excretion of nitrogen together with other 
markers suggestive of net muscle protein breakdown 
(Cuthbertson, 1930 and 19 80). The hypermetabolism is 
initially due primarily to an increased rate of fat 
oxidation (Frayn et al, 1984 a). This response may have 
evolved to encourage wound healing as the wound's 
requirement for glucose necessitates protein breakdown 
to provide amino acids as a gluconeogenic substrate and 
the gluconeogenesis requires energy derived from fat 
metabolism (Frayn, 1986). As the counter-regulatory 
hormones, adrenaline, cortisol, glucagon and GH,
together produce a generally catabolic state, with
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stimulation of lipolysis, glycogenolysis and 
gluconeogenesis, much attention has focused on their 
potential role in producing this metabolic pattern. 
However the time course of their responses do not fit 
with the characteristic time sequence of the flow phase 
metabolic changes. The concentration of these hormones 
is high during the ebb phase but there is a fairly 
rapid return towards normality, such that at the time 
of the peak catabolic response 7-10 days after injury, 
there may still be a moderate elevation of plasma 
cortisol, depending on severity (Frayn et al, 1983), 
but the concentrations of GH, glucagon and 
catecholamines are likely to be back into the normal 
range (Frayn, 198 6). Furthermore infusion of 
catecholamines, cortisol and glucagon in combination to 
simulate the response to injury have produced metabolic 
changes of only modest degree (< 10% elevation of
metabolic rate, 4 g/day rise in urinary nitrogen 
excretion) (Gelfland et al, 1984; Bessey et al, 1984). 
Thus although the counter-regulatory hormones 
contribute to the flow phase metabolic picture other, 
as yet unknown, mechanisms must have a significant 
role.
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THE ENDOCRINE RESPONSE TO INJURY
ADRENAL AXIS
Central control
Since 1948, when Harris demonstrated that the 
neural control of the pituitary-adrenal axis was 
mediated by chemical substances released from nerve 
terminals in the median eminence into hypophyseal 
portal vessels, researchers have been attempting to 
isolate a single hypothalamic corticotrophin releasing 
factor. However it is now apparent that ACTH secretion 
is controlled by several neuropeptides.
In 1981 Vale et al identified a 41 amino acid 
peptide, called CRF-41, which is now accepted as the 
major releasing factor for ACTH. CRF-41 is produced by 
neurons which originate in the paraventricular nucleus 
and terminate in the vessels of the primary plexus in 
the median eminence (Buckingham, 1985). Thus like the 
other releasing factors, it is secreted directly into 
the hypothalamo-hypophyseal portal vessels. Deficits in 
stress-induced ACTH release caused by hypothalamic cuts 
have been correlated with CRF-41 immunoreactivity in 
the median eminence (Tilders et al, 1982). However when 
CRF-41 antisera is administered the ACTH response to 
stress is not completely inhibited, indicating that 
there must be other corticotrophin releasing factors.
There is considerable evidence that vasopressin is 
an important factor in the control of ACTH secretion
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(Gillies and Lowry, 1979) and immunocytochemical 
studies indicate that CRF-41 and vasopressin are 
contained within the same neurons in the 
paraventricular nucleus (Roth et al, 19 82). However 
immunoneutralisation of both peptides (Berkenbosch et 
al, 1984) still fails to completely abolish the stress 
induced release of ACTH. Other factors which may 
modulate ACTH release include oxytocin, angiotensin 2 
and adrenaline (Rivier and Vale, 19 83; Gaillard and Al- 
Damluji, 1987) . It has been suggested that the 
different ACTH secretagogues activate the hypothalamo- 
pituitary-adrenal axis in response to different forms 
of stress (Gaillard and Al-Damluji, 19 87). They can 
also act together synergistically as the ACTH response
to crude hypothalamic extracts is greater than the ACTH
response to any of the secretagogues given individually
(Gillies et al, 1982).
The activity of the CRF-41 secreting neurons is 
controlled primarily by excitatory and inhibitory 
neural pathways originating from other parts of the 
CNS. Studies in laboratory animals involving electrical 
stimulation or lesions of specific brain areas have 
illustrated the roles of the amygdala, hippocampus, 
thalamus, basal septal area and rostral midbrain 
reticular formation in the neural pathways (Knigge, 
1961; Buckingham, 1985). Cholinergic, catecholaminergic 
and 5-hydroxytrytaminergic neurons (5-HT) appear to 
stimulate CRF-41 secretion in man (Buckingham, 19 85). 
GABA-ergic neurons exert a tonic inhibitory influence
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over the hypothalamic secretion of CRF and similarly
opioid peptides inhibit the release of ACTH and related 
peptides (Buckingham, 1985) (Fig 3).
ACTH and cortisol responses to injury
Shortly after it was discovered in 1936 (Coller et 
al, 1936) that there was an impairment in sodium 
excretion after surgery, Weil and Browne (19 39) showed 
that urinary corticoid excretion was simultaneously 
increased. These observations after surgery were
confirmed (Venning et al, 19 44; Bennett and Moore, 
1951) and Bliss et al (1953) demonstrated that the 
increase in urinary steroid excretion was associated 
with increased plasma concentrations of 17
hydroxycorticoids. Subsequently similar changes were
recorded in subjects following injury (Hume et al,
1956; Moore, 1957) .
More recent studies have investigated plasma ACTH 
and cortisol responses to injury. Acute trauma 
stimulates the secretion of ACTH (Buckingham, 1985) and 
within a few hours of accidental injury some patients
have elevated ACTH concentrations sufficient to produce
maximal stimulation of the adrenal cortex (Barton, 
1987; Barton et al, 1987) . However there was great 
variety in the ACTH levels, which correlated poorly 
with plasma cortisol and some of the most seriously 
injured patients had ACTH levels within normal limits 
(Barton et al, 1987). Variable ACTH levels have also 
been reported after burns, with a lack of association
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between ACTH levels and increasing severity of burn 
(Dolecek et al, 1979; Vaughan et al, 1982; Brizio- 
Molteni et al, 1982) . It is of interest that these 3 
studies have reported relatively low values of ACTH in 
some patients with extensive thermal injuries. It has 
been suggested that in this group of patients there may 
be an increase in the sensitivity of the adrenal cortex 
to ACTH or that factors other than immunoreactive ACTH 
may be stimulating cortisol secretion (Barton, 1987). 
During surgery plasma ACTH levels have been found to 
increase to a maximum 0.5-4 hours after the start of 
operation, returning to preoperative levels after 24 
hours (Cooper and Nelson, 1962; Newsome and Rose, 1971; 
Oyama et al, 1979) . In contrast to accidental and 
thermal injury Newsome and Rose (1971) demonstrated 
that cortisol and ACTH levels were correlated and Ney 
et al (1963) showed that the relationship between them 
was similar to normal subjects given ACTH at different 
rates.
Plasma cortisol increases following trauma of any 
kind, including surgery (Johnston, 1964; Gill et al, 
1975), long bone fracture (Frayn et al, 1983) , multiple 
injury (Carey et al, 1971), myocardial infarction 
(Frayn, 1986) , burns (Vaughan et al, 1982) and head 
injury (King et al, 1970; Steinbok and Thompson, 1979). 
The level rises within the first few hours after trauma 
(Johnston, 1964; Gill et al, 1975; Stoner et al, 1977; 
Stoner at al, 1979) and the diurnal pattern of cortisol 
secretion is lost, with elevated values occurring
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throughout the 24 hour cycle (Thomasson, 1959; Wise et 
al, 1972 b; Molteni et al, 1979; Steinbok and Thompson, 
1979; McIntosh et al, 1981). The duration of the
elevated cortisol level depends on the severity of the 
injury. After moderate injury the level starts to fall 
within the first few days but does not reach normal 
levels for over a week (Barton and Passingham, 1981; 
Frayn et al, 1983; Frayn et al, 19 84 a). The elevation 
may extend to weeks if the injury is sufficiently 
severe (Batsone et al, 1976) or the patients are 
elderly (Frayn et al, 1983). Following burns cortisol 
levels are often elevated for longer than 2 weeks (Wise 
et al, 1972 a; Batsone et al, 1976; Vaughan et al,
1982), whereas after surgery normal concentrations are 
usually regained by 4 days (Moore, 1957; Thomasson, 
1959) . Some workers have demonstrated that the extent 
of the rise also depends on the severity of the injury 
(King et al, 1970; Steinbok and Thompson, 1979; Vaughan 
et al, 1982). However other workers have shown that 
although there is a positive relationship between
plasma cortisol levels within 8 hours of injury and
moderate injuries, if the injury is severe the cortisol 
level is frequently lower and a negative relationship 
is present (Stoner et al, 1979; Barton et al, 1987). It 
has been suggested that in severely injured patients 
diminished adrenal blood flow may be responsible for 
the lower cortisol levels (Barton et al, 1984).
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Alteration in feedback mechanisms
It has been suggested that the immediate effect of 
trauma is to increase the set point of the
corticosteroid feedback centre (Yates et al, 1961). 
Thus the pituitary gland is provided with a signal 
similar to a decrease in the blood cortisol
concentration and ACTH secretion continues until the 
new set point in the plasma cortisol concentration is 
reached. Three studies in head injured patients have
suggested that the centre monitoring corticosteroid 
feedback is altered by injury. McCarthy et al (19 64) 
observed that 4 of 11 patients had no increase in 
urinary steroid excretion after receiving metyrapone
and 3 failed to suppress urinary steroid excretion with 
dexamethasone. Steinbok and Thompson (19 79) studied one 
patient whose plasma cortisol levels were initially 
suppressed by 40 mg of dexamethasone daily but as the 
dose of dexamethasone was reduced the plasma cortisol 
level rose again, reaching abnormally high levels while 
dexamethasone was being administered in a dose which 
would normally maintain suppressed levels. This could 
indicate that the feedback control centre for 
glucocorticoids was set at a higher level than normal. 
Feibel et al (1983) confirmed that cortisol was 
resistent to suppression with dexamethasone after head 
injury, particularly if intracranial pressure was 
raised.
Other workers performing experiments involving the 
acute administration of corticosteroids to rats suggest
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that the hypothalamo-pituitary-adrenal response to 
trauma is independent of the plasma corticosteroid 
concentration at the time of the stimulus. Inhibition 
of ACTH release occurred only some time after the blood 
corticosterone concentration had returned to the 
resting level, indicating that a delayed feedback 
mechanism modulates the pituitary-adrenal response to 
stress (Smelik, 1963). A rapid feedback mechanism has 
also been implicated in the control of trauma induced 
hypothalamo-pituitary-adrenal activity and Dallman and 
Yates (1969) demonstrated an immediate but short (less 
than 5 min) period of inhibition of the pituitary- 
adrenal response to trauma in rats during infusion of 
corticosterone.
Mechanism of adrenal axis activation
Many factors associated with injury can activate 
the adrenal axis; hypovolaemia via the carotid and 
aortic baroreceptors activates neural pathways to the 
CNS, and emotional stimuli (such as fear and anxiety) 
acts centrally, but probably the most important 
stimulus involves neural impulses from damaged tissues. 
Hume et al (1962) showed in dogs that the increased 
cortisol secretion rate was dependent on an intact 
nerve supply to the injured area and Eisentein et al 
(1962) showed that injury to the lower limbs of 
paraplegics did not result in elevated cortisol levels. 
However the response to surgery performed under spinal 
anaesthesia is reduced but not abolished (Lush et al,
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1972; Gordon et al, 1973). Enquist et al (1977) have 
demonstrated that autonomic afferent fibres are the 
primary mediators of the cortisol response during 
pelvic surgery, whereas both autonomic and somatic 
nerves are involved in the hours following surgery 
(Christensen et al, 1982).
How the various stimuli regulate trauma-induced 
CRF secretion is unknown although it has been suggested 
that a reduction in opioidergic tone or stimulation by 
5-HT neurons may be partially responsible for the rise 
in plasma cortisol concentration (Buckingham, 1985).
Summary
Both ACTH and cortisol levels increase in response 
to any form of injury, with loss of diurnal rhythm. The 
duration of the increased cortisol level is related to 
the severity of injury and can remain elevated for more 
than a week. A subgroup of patients with severe 
injuries have lower cortisol levels than expected, 
possibly related to diminished adrenal perfusion. There 
are many factors after injury which may activate the 
adrenal axis and some may be operating by resetting the 
glucocorticoid negative feedback centre.
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GROWTH HORMONE
Control of GH secretion
GH is secreted episodically with most of the 
release occurring during sleep. Hypoglycaemia and 
exercise are strong stimuli to GH release and the sites 
at which glucose deprivation operates were shown to be 
in the lateral hypothalamus (Himsworth et al, 1972). 
Glucose administration and free fatty acids suppress GH 
secretion whereas several amino acids stimulate GH 
secretion (Knoff et al, 1965). The hypothalamic 
regulation of GH appears to be predominantly under the 
control of GHRH, with the inhibitor somatostatin 
possibly acting as a paracrine agent (Belchetz, 1984) , 
(Fig 4) . Pharmacological experiments also suggest that 
several neuropeptides influence the release of GH, with 
opioids, VIP and bombesin stimulating release, whereas 
substance P inhibits release (Jansson et al, 1985). 
Hypothalamic neurotransmitters may also alter GH 
secretion, by affecting the release of GHRH or 
somatostatin in the hypothalamus. Possible roles have 
been suggested for noradrenaline, dopamine, serotonin, 
GABA and acetyl choline (Delitala et al, 1987) .
GH secretion after injury
GH levels increase shortly after injury and fall 
rapidly towards normal over 24 hours, even in patients 
with serious injuries (Carey et al, 19 71; Frayn et al,
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1984 b) . Induction of anaesthesia does not appear to 
have an effect on GH levels (Noel et al, 1972) but a 
significant elevation occurs shortly after the 
commencement of surgery (Ross et al, 1966; Charters et 
al, 1969; Newsome and Rose, 1971; Noel et al, 1972; 
Wright and Johnston, 1975; Hagan et al, 1980; Traynor 
and Hall, 1981; Sowers et al, 19 83; Lacoumenta et al, 
198 7). The levels begin to fall during surgery
(Charters et al, 1969; Lacoumenta et al, 1987) and are
often normal on the first post-operative day (Charters 
et al, 1969; Noel et al, 1972) . The GH elevation was 
not correlated to the severity of operation, the 
anaesthetic agents or the age or sex of the patients 
(Charters et al, 19 69) . In patients with burns GH was 
usually within the normal range (Batsone et al, 1976; 
Popp et al, 1977; Dolecek et al, 1979; Balogh et al, 
1984) , although no samples were taken within 2 days of 
injury. One study reported raised values several weeks 
after burn injury (Wilmore et al, 1975).
There have been two studies examining the GH 
response after head injury. Rudman et al (1977) found 
no elevation in GH levels and no relationship with 
severity of injury. However as his subjects (7 in
total) were not studied until day 6 a rise in GH may 
well have been missed. King et al (1981) studying a 
much larger group of subjects (29) investigated GH
levels 3-5 days after injury for 1 month. He confirmed 
Rudmanfs findings demonstrating that GH levels were not 
significantly different from controls during the period
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of his study and there was no relationship to the 
severity of injury. However he did demonstrate a 
significant elevation in GH in 3 of 6 subjects studied 
immediately after admission. Furthermore during the 
first 2 weeks after injury there was a paradoxical GH 
rise in response to intravenous glucose, which was more 
pronounced with increasing severity of injury, and 
which the authors suggested might be due to transient 
hypothalamic dysfunction.
Role of GH after injury
Growth hormone, like adrenaline, cortisol and 
glucagon is one of the counter-regulatory hormones, 
which respond to hypoglycaemia and play a role in 
maintaining euglycaemia. They are all elevated after 
injury and it has been suggested that they are 
responsible for the general catabolic state with 
stimulation of lipolysis, glycogenolysis and 
gluconeogenesis. However the increased levels in 
injured patients are dissociated from the catabolic 
changes by several days (Frayn et al, 1984 b) and 
although adipose tissue lipolysis may be stimulated by 
GH in vitro (Fain, 19 80) and the high GH levels after 
injury may be sufficient to stimulate lipolysis, it has 
been shown that the early metabolic responses are very 
similar in man and rat (Heath, 1985) , the latter being 
a species in which GH secretion is suppressed by stress 
and injury (Barton, 1977).
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As most of the metabolic effects of GH are 
mediated by the somatomedins, which are a group of 
peptides synthesised by the liver in response to GH, 
they have been studied after injury (Frayn et al, 1984 
b). Somatomedins are generally anabolic with effects on 
muscle protein metabolism (Salmon and Duvall, 1970; 
Uthne et al, 1974) and on whole body growth (Van Buul- 
Offers et al, 1979) and are involved in cartilage 
proliferation (Sevitt, 1980). Therefore the relative 
catabolic response after injury could be due to a 
depression of the somatomedin levels. Levels were found 
to be low 2-3 days after injury and in patients with 
burn injuries the duration of the depression was 
strongly correlated with the size of the b u m  (Coates 
et al, 1981). However in trauma patients the low levels 
bore no relationship to the catabolic response to 
injury, which was maximal at about one week (Frayn et 
al, 1984) . Somatomedin activity was strongly correlated 
with plasma insulin, suggesting that this was a more 
important influence than GH after trauma (Frayn et al, 
1984) .
Summary
GH levels rise during surgery but rapidly return 
to normal. Two studies following head injury did not 
examine GH levels in the early phase after injury in 
sufficient numbers to determine if this also happens 
after head injury. One of these studies did demonstrate 
a central defect in GH control at a later stage after
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injury. A role for GH in the general catabolic state 
after injury is uncertain.
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PROLACTIN
Control of prolactin secretion
Prolactin is under tonic inhibitory control by the 
hypothalamus and the major prolactin inhibitory factor 
is dopamine (MacLeod, 1976). Direct evidence to support 
this has been produced in primates by Neill et al 
(1981) who showed that intravenous infusion of 
dopamine, to reproduce stalk blood levels, caused 
significant inhibition of prolactin secretion in both 
intact and stalk-transectioned animals. Endogenous 
opiates may modulate prolactin secretion as 
administration of exogenous opiates stimulates 
prolactin release (Grossman et al, 1981). Although the 
opiate receptor antagonist naloxone had no effect on 
resting prolactin levels (Grossman et al, 1981) it did 
reduce the rise in prolactin following surgery 
(Pontiroli et al, 1982) suggesting that opiates may be 
involved in the control of the prolactin response to 
stress. There is physiological and anatomical evidence 
to suggest that opiates affect prolactin by acting upon 
hypothalamic dopaminergic neurons (Fuxe et al, 1981) . 
TRH stimulates prolactin release when administered 
exogenously but the physiological role of endogenous 
TRH in the secretion of prolactin remains uncertain 
(Franks, 1979). Various neurotransmitters such as VIP, 
CCK, serotonin and GABA may modulate prolactin 
secretion but their role appears minor in relation to 
dopaminergic control. In addition prolactin appears to
be able to regulate its own secretion through a short 
loop feedback, whereby prolactin has a direct action on 
hypothalamic dopamine turnover increasing the amount of 
dopamine available to the pituitary (Scanlon et al,
1981).
Prolactin secretion after injury
Prolactin levels have been found to increase 
following physical or emotional stress (Reichlin, 1981) 
but the exact stimuli and pathways controlling release 
of prolactin after these stresses are unknown. It has 
been suggested that stress either reduces the release 
of hypothalamic dopamine or increase the availability 
of factors that stimulate prolactin release, but as yet 
the mechanism is unknown (Gann and Lilly, 19 84) .
Operations performed under general anaesthesia 
produce an increase in prolactin which begins after 
induction but before skin incision, with the peak 
values occurring during the operation (Noel et al, 
1972; Sowers et al, 1977? Hagan et al, 1980; MacFarlane 
and Rosin, 1980? Pontiroli et al, 1982). Female 
subjects have a greater rise in prolactin than male 
subjects (Noel et al, 1972). The rise in prolactin was 
blocked in patients having epidural analgesia 
suggesting that neurogenic stimuli are important in 
stimulating prolactin release (Hagan et al, 1980) . Noel 
et al (1972) demonstrated that less invasive procedures 
such as gastroscopy and proctoscopy produced smaller 
increases in prolactin. Chest wall injury and surgical
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procedures to the chest wall also produce elevations in 
prolactin level and can be associated with 
galactorrhoea (Morley et al, 1977; McFarlane and Rosin, 
198 0). The raised prolactin levels appear relatively 
short-lived and within 4 8 hours of thoracotomy the mean 
levels were not significantly elevated from the pre­
operative levels (McFarlane and Rosin, 19 80). The one 
study which examined prolactin levels after head injury 
found that 3 out of 6 patients had elevated values 
during the 72 hours of the investigation (King et al,
1981) . One recent study reported that burn injuries 
produce a marked elevation in prolactin which is
related to the severity of the injury and can be
sustained for at least 4 weeks (Brizio-Molteni et al,
1984) , but other studies have observed normal (Balogh 
et al, 1985) or reduced (Popp et al, 1977) prolactin 
concentrations after burns.
Role of prolactin after injury
Although prolactin is considered to be a stress 
hormone (Buckingham, 1985) its role in the body's
response to trauma has yet to be defined. As yet the
only function ascribed to this hormone in man is its 
contribution to lactation (Belchetz, 1984).
Summary
Prolactin levels are increased after all forms of 
injury and are greater in female subjects. Levels begin
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to rise during induction of anaesthesia and reach there 
peak intra-operatively, with a rapid return to normal. 
A small study in head-injured subjects found elevated 
levels within 72 hours of injury in 3 of 6 subjects. 
The role of prolactin in the stress response is 
unknown.
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THE THYROIDAL AXIS
The control of TSH secretion
The hypothalamic control of TSH secretion is 
dependent on two neuropeptides, TRH and somatostatin. 
TRH is secreted by the hypothalamic neurons into the 
hypophyseal portal system and stimulates TSH release. 
Animal experiments in which TRH antiserum and TRH 
antibodies were administered have shown that thyroid 
function declines, confirming that TRH is important for 
the maintenance of normal thyroid function (Fraser and 
McNeilly, 1982) . Somatostatin may be a physiological 
inhibitor of TSH release as somatostatin infusion 
lowers the elevated basal TSH level in patients with 
primary thyroid failure (Lucke et al, 1975), suppresses 
the TSH response to TRH (Siler et al, 1974) and 
abolishes the nocturnal elevation in basal TSH values 
(Weeke et al, 1975) (Fig 5) . Dopamine also has an
inhibitory role in the control of TSH secretion in man 
(Scanlon et al, 1980) and in rats there is a striking 
similarity between the inhibition of TSH and prolactin 
by dopamine (Foord et al, 19 83). The neurotransmitter 
modulation of TRH is poorly documented but it appears 
that serotonin (Smythe et al, 1982) and noradrenaline 
may be stimulatory (Belchetz, 1984). Our finding that 
TSH is secreted in a pulsatile fashion (Clark et al,
1986 and 1987) , which was subsequently confirmed by
others (Greenspan et al, 1986) suggests that, as for
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GnRH, there may be a hypothalamic pulse generator 
controlled by neuronal input from higher centres.
Thyroid hormones have a negative feedback action 
on the thyrotroph and it appears to be nuclear T3 which 
has the most important effect on pituitary TSH
secretion (Larsen, 1982; Belchetz, 1984), such that
nuclear binding of T3 and pituitary TSH secretion show
a direct inverse relationship (Silva and Larsen, 1977) .
As the pituitary has a greatly enhanced ability,
compared with the liver or kidney, to yield T3 from 
circulating T4, the thyroid status as viewed by the
thyrotroph is more influenced by circulating T4, 
although TSH secretion is directly regulated by 
intranuclear T3 (Belchetz, 1984).
The thyroidal axis and injury
There have been many studies of thyroid function 
after injury or serious non-thyroidal illness and the 
pattern of abnormalities has been termed the sick
euthyroid syndrome (Wartofsky and Burman, 19 82). The 
typical alterations in the thyroidal hormones T4 and T3 
are well established but there has been considerable 
change in the interpretation of the TSH response to 
critical illness in the last 1-2 years, with the
development of TSH assays with improved sensitivity and 
lower limits of detection.
A low T3 is commonly found in intensive care 
patients (Zaloga and Chernow, 19 85) and is seen in a 
variety of clinical conditions including liver disease,
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sepsis, neoplastic disorders, renal disease, burns, 
surgery, myocardial infarction and starvation (Kirby et 
al, 1973; Portnay et al, 1974; Brandt et al, 1976; Popp 
et al, 1977; Adami et al, 1978; Becker et al, 1980; 
Smeds et al, 1981; Wiersinga et al, 1981; Wartofsky and 
Burman, 1982; Balogh et al, 1984; Zaloga and Chernow, 
1985; Semple, 1986). T3 begins to fall immediately 
after injury and remains depressed for a few days after 
surgery, a few weeks after major injury and even longer 
after severe burns.
This occurs because the majority of T3 is derived 
from the peripheral conversion of T4, a process which 
is reduced in ill patients (Carter et al, 1976) . There 
is an associated increase in the metabolically inactive 
reverse T3 as a result of decreased rT3 degradation 
rather than increased production (Chopra, 1976). There 
is in vitro evidence suggesting that the same 5'~ 
deiodinase enzyme system may convert T4 to T3 and rT3 
to its metabolites (Chopra et al, 1978). Therefore 
inhibition of this enzyme could account for the 
observed changes.
In more severely ill patients both T4 and T3 
concentrations are low and it has been shown that after 
acute trauma (Philips et al, 1984) and during critical 
illness (Slag et al, 1981) low T4 is associated with a 
poor prognosis. One of the explanations for the low T4 
is that it is displaced from TBG by binding inhibitors, 
which have been identified in the serum of critically 
ill patients (Oppenheimer, 1982) , but there is also
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decreased T4 secretion from the thyroid gland (Kaptein 
et al, 1982) and an accelerated T4 disposal resulting 
in a reduced half-life (Gregerman and Solomon, 19 67; 
Kaptein et al, 19 82). It has been suggested that the 
binding inhibitors may leak out of extrathyroidal 
tissue into the circulation when the integrity of the 
tissue is compromised during severe illness (Chopra et 
al, 1979; Chopra et al, 1982).
The binding inhibitors can interfere with many of 
the kit methods available for measuring the free 
hormones (Chopra et al, 19 80). Wehmann et al recently 
reported reduced levels of free T4 measured by 
equilibrium dialysis (1985), although previous reports 
have found the free T4 to be normal or high and free T3 
concentrations normal or low (Chopra et al, 19 74; 
Chopra et al, 19 80) .
Infrequently a high total T4 occurs in critically 
ill patients and is due to an increase in TBG. There 
may be an associated increase in T3 but free T4 is 
usually normal (free T3 is reduced due to a reduction 
in the peripheral conversion of T4 to T3) (Zaloga and 
Chernow, 1985) .
The tissue levels of thyroid hormones have been 
examined in a few studies. Tissue uptake may be 
impaired by binding inhibitors (Oppenheimer et al, 
1982) , although intracellular red blood cell levels of 
T4 were normal in a few patients with a reduced serum 
T4 (Mendel and Cavalieri, 19 84). A low tissue 
concentration of T3, with a normal tissue concentration
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of T4, was found, in patients dying of severe chronic 
illness (Reichlin et al, 1973). However one study in 
which tri-iodothyronine was administered to severely 
ill burned patients who had low concentratons of 
thyroidal hormones revealed no effect on survival 
(Becker et al, 1982).
Until 1985 most reports and review articles had 
stated that the serum TSH level was normal in critical 
illness and the TSH response to TRH was also normal 
(Gann and Lilly, 1984). However with the development of 
a more sensitive TSH assay Wehmann et al (1985) 
reported that in patients who became seriously ill 
after marrow transplantation for haematologic 
malignancy a fall in TSH to subnormal levels usually 
preceded the decrease in T4. When recovery occurred TSH 
and T4 increased concomitantly. In a further study 
Hamblin et al (1986) noted that in patients with 
hypothyroxinaemia due to critical illness there was a 
close and consistent temporal relationship between TSH 
and T4 during the recovery phase, suggesting that TSH 
may have an essential role in the return of T4 to 
normal during recovery. Thus it has been suggested that 
severe illness can inhibit TSH secretion and along with 
the accelerated disposal of T4, contributes to the fall 
in T4 concentration (Wehmann et al,. 19 85). Additional 
evidence for hypothalamo-pituitary dysfunction in this 
group has been demonstrated by an impaired TSH response 
to TRH in hypothyroxinaemic critically ill patients 
(Vierhapper et al, 1982). Furthermore after
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demonstrating that TSH was released in a pulsatile 
fashion in healthy individuals (Clark et al, 1986) we 
have demonstrated that in patients with renal failure 
pulsatile release is abnormal and there is loss of the 
normal evening rise in TSH (Wheatley et al, 19 87).
The role of the thyroidal axis after injury
As TSH levels do not rise above normal during the 
low T3 and T4 states of critical illness it has been 
concluded that an overall euthyroid status is present 
(Oppenheimer, 1983) , thereby implying that the
thyroidal axis is not involved in the response to 
injury. However the recently demonstrated reduced 
pituitary TSH secretion in critical illness (Wehmann et 
al, 1985; Hamblin et al, 1986) and the impaired 
pituitary responsiveness to TRH (Vierhapper et al,
1982) indicate that secondary or tertiary 
hypothyroidism is occurring in response to severe 
injury.
Summary
Following injury thyroidal hormone concentrations 
fall, with T3 frequently subnormal. Low T4 levels occur 
during severe injury or illness and are associated with 
a poor prognosis. Recently workers have demonstrated 
that TSH levels are also subnormal, implying that 
secondary or tertiary hypothyroidism is present. 
However a study in which tri-iodothyronine was given to
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severely burned subjects demonstrated no effect on 
survival.
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THE GONADAL AXIS
Control of gonadotrophin secretion
Gonadotrophin secretion is controlled by the 
hypothalamic secretion of GnRH and the negative 
feedback effects of the gonadal steroids. Oestrogens 
can also elicit pre-ovulatory LH and FSH surges. Both 
FSH and LH are secreted in a pulsatile fashion from the 
anterior pituitary and in women the frequency and 
amplitude of LH pulses varies with the stage of the 
menstrual cycle (Knobil, 19 80). There is considerable 
evidence that LH pulses are the direct result of GnRH 
pulses secreted from the median eminence into the 
hypophyseal portal blood. Clarke and Cummins (1982) 
sampled GnRH in the portal blood and LH in the 
peripheral blood and demonstrated a one-to-one 
relationship between large GnRH and LH pulses.
Recordings of multi-unit activity in the 
mediobasal hypothalamus have demonstrated that neural 
activity can be correlated with pulsatlie release of LH 
(Thiery and Pelletier, 1981; Kawakami et al, 1982; 
Wilson et al, 1984), indicating that there is a neural 
pacemaker governing the activity of the GnRH neurons. 
Hypothalamic deafferentation experiments suggest that 
the site responsible for generating the rhythmic 
activity lies in the mediobasal hypothalamus in the 
monkey (Krey et al, 1975), possibly within the arcuate 
nucleus (Soper and Weick, 1980).
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Neuroanatomical studies have demonstrated that the 
main sites of GnRH neurons are in the preoptic/septal 
region of the brain and the mediobasal hypothalamus 
(Hoffman, 1983) and both these regions receive 
noradrenergic innervation (Lindvall and Bjorklund, 
1974; Day et al, 1980; Berk and Finkelstein, 1981) . It 
has been shown that alpha 1 adrenergic blocking agents 
inhibit LH pulsatility in monkeys (Bhattacharya et al, 
1972) and, along with dopamine blockers, they inhibit 
the multi-unit activity in the medio-basal 
hypothalamus, which is correlated with LH pulses 
(Kaufman, 1981). The catecholamine influence on GnRH 
pulsatility was further investigated by Clifton and 
Sawyer (1979) who transected the ascending 
noradrenergic pathways in the rat and found that 
cyclicity was minimally effected, although anovulation 
occurred in some animals if noradrenaline synthesis was 
also blocked. They concluded that noradrenergic inputs 
are modulatory rather than mandatory.
Several neuropeptides have been found to influence 
LH pulsatility, with opioid peptides having the 
greatest effect. Treatment with the opioid antagonist 
naloxone leads to increases in LH secretion in men and 
women (Quigley and Yen, 1980; Ellingboe et al, 1982) 
and is associated with an increase in LH pulse 
frequency and in some cases amplitude (Moult et al, 
1981; Ellingboe et al, 1982). The effects of naloxone 
are blocked by GnRH antagonists (Blank and Roberts,
1982) , so it has been postulated that endogenous
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opioids inhibit GnRH release. B endorphin is thought to 
be the most likely candidate and it is located in the 
arcuate nuclues of the hypothalamus (Grossman, 19 83). 
There is evidence supporting an adrenergic or 
noradrenergic link with the opioid peptides and it 
seems that opioid inputs can modulate the catecholamine 
inputs to the GnRH system either at the level of the 
GnRH cell bodies or the GnRH terminals in the median 
eminence (Kalra, 1986). The neuropeptides substance P, 
neuropeptide Y and vasoactive intestinal peptide have 
also been found to affect gonadotrophin secretion 
(Clarke and Cummins, 1987) , although their precise 
roles have not yet been defined.
Testosterone secretion after injury
In the past 20 years it has become apparent that 
gonadal hormone concentrations fall to subnormal levels 
after severe stress. Subjects have been found to have 
reduced levels after various major medical insults 
including myocardial infarction (Wang et al, 1978 a; 
Woolf et al, 1985), surgery (Charters et al, 1969; Aona 
et al, 1972; Nakashima et al, 1975; Wang et al, 1978 
b) , burns (Dolecek et al, 1979; Vogel et al, 1985) , 
respiratory insufficiency (Semple et al, 1981; Goussis 
et al, 1983) , acute renal disease (Handelsman, 1985), 
CVA (Woolf et al, 1985) and head injury (Rudman et al, 
1977; Woolf et al, 1985; Woolf et al, 1986). The 
mechanisms responsible for this reduction have not yet 
been elucidated. In order to determine whether
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abnormalities in the central control of the gonadal 
axis could be responsible many studies have also
examined the gonadotrophin levels, and in a few cases 
the LH and FSH response to stimulation with GnRH
(Rudman et al, 1977; Woolf et al, 1985). There is
general agreement that testosterone decreases by 40-70 
% within 24 hours of these traumatic events (Goussis et 
al, 1983; Woolf et al, 1985). Recovery back to normal 
levels differs between the illnesses, with myocardial 
infarction and surgery having shorter recovery times, 
usually within 1 week (Aono et al, 19 72; Aono et al, 
1976; Wang et al, 1978 a; Wang et al, 1978 b; Woolf et 
al, 1985) . The severity of the injury appears to be
related to the extent of the fall in testosterone.
Nakashima et al (1975) demonstrated that major surgical 
procedures produced a greater reduction in testosterone 
than minor surgical procedures and Woolf et al (19 86) 
demonstrated that after head injury there was a smaller 
fall in testosterone in patients with less severe 
injuries.
The effect of injury on gonadotrophin secretion in men
As gonadal hormones are primarily under the
control of the hypothalamus and pituitary, many studies 
have investigated gonadotrophin levels but with
conflicting results. An increase in LH secretion has
been reported shortly after commencing operation by 
some authors (Aono et al, 1972; Nakashima et al, 1975; 
Aono et al, 1976), whereas other authors have reported
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no perioperative changes in LH concentration (Charters 
et al, 1969; Oyama et al, 1979). During the first and
second post-operative days the LH level has fallen in
some reports (Chaters et al, 1969; Aono et al, 1972; 
Hagen et al, 1980) , although in one study it was not 
significantly different from control values (Aono et 
al, 1976). FSH levels have been reported to fall after 
surgery (Woolf et al, 1985). An early increase in
gonadotrophin levels with a subsequent significant 
decrease has also been reported after burn injury
(Brizio-Molteni et al, 1984) , although Dolecek et al 
(1979) reported that LH levels are elevated in 25 % of 
cases, normal in 31 % and low in 44 %. No changes were 
observed in LH and FSH after acute myocardial
infarction in one study (Woolf et al, 19 85) , whereas
Wang et al (1978 a) observed a significant increase in 
LH on day 4. Following head injury an initial elevation
in FSH and LH (King et al, 1981; Woolf et al, 1986) has
been observed. Subsequently the FSH and LH levels 
decreased significantly (Woolf et al, 1985; Woolf et 
al, 1986) with one study reporting subnormal levels 
(Rudman et al, 1977). Woolf et al (1985) also observed 
that the decrease in LH and FSH occurred after the 
decline in testosterone. Rudman et al (1977) and Woolf 
et al (1985) performed GnRH tests on a total of 9 head- 
injured patients who had been treated with 
dexamethasone and found the gonadotrophin responses to 
be normal. In patients with burns the response to GnRH 
was also reported to be normal (Dolecek et al, 1979;
71
Balogh et al, 1984). Interpretation of these studies 
would suggest that acute stress leads to a brief
temporary increase in LH and possibly FSH secretion, 
with a subsequent reduction over the ensuing days, 
occasionally to subnormal levels.
Injury and gonadal axis dysfunction in women
There have been few studies on the effect of 
trauma on gonadotrophin and gonadal hormone
concentrations in women and no systematic studies in 
different phases of the menstrual cycle have been 
performed. Woolf et al (19 85) demonstrated that 
oestradiol levels began to fall within 24 hours of 
injury (either an intracranial vascular accident or a
head injury) in women of reproductive age and continued 
to fall into the postmenopausal range. These changes 
were independent of the phase of the menstrual cycle
and were accompanied by falling gonadotrophin levels. 
Postmenopausal women had a similar response to trauma 
but with a greater fall in gonadotrophin levels. The 
abnormalities persisted for 7 days in women of 
reproductive age and were not associated with any 
changes in sex hormone binding capacity. No other 
studies have reported oestradiol levels although two 
studies have reported a transient fall in LH levels 5-6 
hours (Aono et al, 1976) and 9 hours (Hagan et al, 
1980) after surgery, which had returned to normal by 24 
hours (Hagan et al, 1980). Hagan also reported a 
transient fall in FSH which was also normal within 24
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hours, although Aono reported no change. Abnormalities 
also occur after thermal injury, with severely burned 
women failing to ovulate for several months after 
injury (Diem et al, 1979). In postmenopausal women a 
hypothalamo-pituitary defect is suggested by the fall 
in gonadotrophin concentration during severe illness 
(Warren et al, 1977) , surgery (Aono et al, 19 76) and 
head injury (Woolf et al, 19 85) .
Mechanisms responsible for gonadal axis dysfunction
It has been suggested that the fall in 
testosterone may be due to changes in SHBG and albumin 
following trauma and that the free or biologically 
active testosterone is normal or increased. Goussis et 
al (1983) investigated 10 critically ill patients and 
found that sex hormone binding globulin (SHBG) 
increased by 35 % and albumin decreased by 24 %. Unlike 
the thyroidal axis, where inhibition of thyroid hormone 
binding to TBG occurs, an increase in serum binding of 
testosterone by SHBG was observed. The free 
(dialyzable) testosterone fraction was not 
significantly changed, indicating that these patients 
are truly hypogonadal. The authors suggested that the 
low testosterone concentration appears to reflect
decreased testosterone secretion, as the changes in 
binding proteins would, if anything, decrease
testosterone clearance. A second study (Gray et al, 
1978) in male rats exposed to chronic stress
demonstrated that normal male rats had a reduction in
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testosterone, whereas levels did not fall in castrated 
testosterone-treated animals. This confirmed that the 
suppression must result from a reduction in 
testosterone secretion.
Most studies agree that the gonadotrophin 
concentrations are inappropriately low for the level of 
gonadal hormone indicating that there is disruption of 
the normal feedback mechanism. However as it has been 
shown that the changes in gonadotrophin concentration 
occur after the fall in gonadal steroids (Woolf et al,
1985) and in other cases, such as myocardial 
infarction, there was no fall in gonadotrophin 
concentration (Woolf et al, 19 85), it is apparent that 
the hypogonadism is not secondary to the absolute level 
of gonadotrophins. This does not exclude a central 
cause for the hypogonadism as possible abnormalities in 
pulsatile secretion of the gonadotrophins or 
alterations in the ratio of bioactive to immunoactive 
LH have not been investigated.
Other mechanisms have been suggested which may 
operate at either the hypothalamo-pituitary or gonadal 
level. As cortisol is elevated in these subjects it has 
been proposed as a possible mediator of the gonadal 
axis abnormalities. Although most studies on normal 
volunteers have shown a suppression in testosterone 
after administration of ACTH or exogenous 
glucocorticoids there is disagreement as to whether 
this is a central or direct gonadal effect (Sakakura et 
al, 1975; Doerr and Pirke, 1976; Cumming et al, 1983) .
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However some studies have reported no effect (Smals et 
al, 1974) or a stimulatory effect (Kirschner et al, 
1965) on gonadal hormones. Furthermore head-injured 
patients treated with dexamethasone had results 
comparable to those who did not receive any 
glucocorticoids (Woolf et al, 1985) and similar 
observations have been reported in surgical patients 
(Nakashima et al, 1975). Gray et al (1978) demonstrated 
that stressed adrenalectomised rats had a fall in 
testosterone, whereas unstressed adrenalectomised rats 
had no fall, which they took to indicate that the 
pituitary-adrenal axis did not mediate the changes in 
the gonadal axis.
The sympathetic nervous system is activated by 
severe injury and particularly by traumatic brain 
injury (Clifton et al, 1981) and it is known that 
infusion of adrenaline decreases both testosterone 
production and concentration (Levin et al, 1967) , 
whereas dopamine suppresses levels of gonadotrophins 
but not testosterone (Huseman et al, 1980? Travaglini 
et al, 1981; Nakagawa et al, 1982; Sowers et al, 1983). 
Therefore Woolf et al (1986) examined the possibility 
of catecholamine mediation of the changes in gonadal 
hormone concentration. A highly significant inverse 
correlation was found between admission noradrenaline, 
adrenaline and the day 4 testosterone concentration. As 
mildly injured patients with small elevations of 
catecholamines were found to have no change in 
testosterone, despite a significant fall in LH, the
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authors suggested that any catecholamine effect was 
probably on testicular secretion of testosterone.
Another central mechanism which could produce the 
observed changes is dependent on the opioidergic 
system. Opioids are an important modulator of the 
hypothalamic pulse generator (Moult et al, 19 81; 
Ellingboe et al, 1982) and increased opioidergic tone 
which occurs after stress could result in loss or 
decrease of gonadotrophin pulsatility.
Summary
Following injury there is a fall in testosterone 
levels in male subjects and oestradiol levels in female 
subjects. The extent of the fall in testosterone is 
related to the severity of the injury. Changes in 
gonadotrophin levels after injury have differed between 
studies. However it appears that there may be a 
transient increase in their concentrations shortly 
after injury, followed by a reduction, occasionally to 
subnormal levels.
The mechanism responsible for the fall in gonadal 
steroid concentration is unknown. Different groups have 
suggested that, after injury, increased levels of 
glucocorticoids, catecholamines or opioids, may produce 
either peripheral or central gonadal dysfunction.
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ENDOCRINE STUDIES PERFORMED AFTER HEAD INJURY
There have been few studies of endocrine function 
following head injury and most workers have 
investigated only a small number of subjects. Hormones 
have been measured at a variable time after injury with 
dynamic tests performed infrequently. All the studies 
have concentrated on the hormonal changes on admission 
and shortly afterwards with no long term follow up.
In 1977 Rudman et al reported both hypothyroidism 
and hypogonadism in 7 male patients following major 
head injury. Thyroidal dysfunction (decreased levels of 
T4, T3, fT4 & TSH) and gonadal dysfunction (decreased 
levels of testosterone, FSH & LH) developed after 6-7 
days coma and resolved after regaining consciousness. 
The GH, PRL and cortisol concentrations did not differ 
from normal, although cortisol levels did became 
elevated when therapy with dexamethasone was stopped. 
As the TRH and GnRH tests were normal but the the basal 
TSH and gonadotrophin concentrations were reduced the 
abnormality was considered to be at the hypothalamic 
level. Clinicians were advised to monitor head injury 
patients for myxoedema coma.
A small study of hypothalamo-pituitary function 
was reported by King et al in 19 81 in which the diurnal 
variation in GH, PRL, TSH, FSH and LH were investigated 
in 6 patients by analysing samples taken from admission 
to the third day at four hourly intervals. In addition 
the GH response to intravenous glucose was determined.
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During the four hourly sampling GH, PRL, LH and FSH 
were elevated in 3 of the 6 patients studied. However 
the hormone elevations were not in the same 3 patients. 
In contrast to Rudman's study the only consistent 
finding was a normal TSH concentration in all 6 
patients. There was no predictable hormone pattern and 
no relation to the degree of injury or time after 
injury. Further evidence of hypothalamo-pituitary 
dysfunction was demonstrated by a paradoxical increase 
in GH during an intravenous glucose load, in severely 
injured patients.
Considerably more information is known about the 
cortisol response in head injury. King et al (1970) 
studied 13 patients, again taking four hourly samples 
from admission to 3 6 hours. The cortisol level was
found to be elevated and significantly greater than a 
control group of patients who had samples taken after 
operations (laminectomy). Loss of circadiam rhythm 
persisted in patients with prolonged coma, even when
cortisol levels had returned to within normal limits.
In a larger study of 49 patients Steinbock and 
Thompson (1979) confirmed the post-injury elevation in 
cortisol with loss of circadian rhythm. In addition he 
reported a correlation with the severity of the head 
injury (as determined by the duration of coma) and
there was a trend suggesting that middle fossa basal 
skull fractures predisposed to cortisol abnormalities. 
In 6 patients hypercortisolaemia persisted for greater 
than 1 week. In a further 6 patients dexamethasone was
found to partially supress the elevated levels, 
suggesting that hypercortisolaemia after head injury is 
related to an alteration rather than an abolition of 
the normal feedback mechanism.
Two recent papers by Woolf et al (1985 and 1986) 
have presented further data on the gonadal axis, 
confirming the hypogonadism observed by Rudman. The 
first study was designed to examine the effect of head 
injury, myocardial infarction, surgery and intracranial 
vascular accidents on the gonadal axis. The 17 men and 
5 women with traumatic head injury were found to have 
the largest fall in testosterone and oestradiol 
respectively, when compared to the other 3 groups. 
Although significant decreases in LH and FSH were found 
these occurred after the decline in gonadal steroids. 
The gonadotrophin responses to GnRH in the 4 patients 
tested (3 were receiving dexamethasone) and the SHBG 
concentrations were within normal limits. The authors 
concluded that as LH and FSH were inappropriately low 
for the level of testosterone and oestradiol, their 
patients had developed secondary pituitary 
insufficiency and because the pituitary gonadotropes 
response to GnRH had been normal in the 4 patients 
tested, they concluded the abnormality must be at the 
hypothalamic level.
In his second paper Woolf (1986) observed that the 
magnitude of the hormonal dysfunction was dependent 
upon the severity of the neurological insult, with a 53 
% fall in testosterone between admission and day 4 in
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severely injured patients, compared to a 25 % fall in 
the less severely injured.The testosterone precursors, 
17 OH progesterone and DHEA sulphate, were also reduced 
by day 4. Although the LH and FSH concentrations were 
significantly reduced from elevated admission levels, 
only the less severely injured had subnormal LH levels. 
In all patients the noradrenaline and adrenaline 
concentrations were elevated on admission and a highly 
significant negative correlation was found between
admission noradrenaline and adrenaline levels and the 
day 4 testosterone. Thus the authors concluded that the 
sympathetic nervous system might be mediating the
gonadal axis dysfunction.
Summary
Hypercortisolaemia is a freqent finding after head 
injury with disruption of the normal circadian rhythm. 
Transient hypogonadotrophic hypogonadism, possibly of 
hypothalamic origin, is also well recognised. Findings 
in the thyroidal axis are more varied with one author 
reporting hypothalamic hypothyroidism with subnormal 
TSH values in 7 patients, while another reported
completely normal TSH values in 6 patients. Prolactin 
and growth hormone have only been examined in one small 
study of 6 patients, in which 3 cases were found to 
have elevated values.
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INVESTIGATION OF HYPOTHALAMO-PITUITARY HYPOFUNCTION
During the last 2 decades considerable advances 
have been made in diagnostic endocrinology with the 
development of radioimmunoassays for pituitary 
hormones. These assays are cheap, rapid and reliable, 
but many of them are less sensitive at low hormone 
concentrations and unable to detect subnormal values. 
Thus clinical hypopituitarism can occur with basal 
hormone levels still within the normal range of the 
assay and paradoxically, as some pituitary hormones (eg 
GH) are secreted episodically, normal individuals may 
have undetectable levels at certain times during the 
day. To overcome these difficulties dynamic tests 
capable of quantifying pituitary hormone reserve were 
developed. The isolation and synthesis of the 
hypothalamic releasing factors thyrotrophin releasing 
hormone (TRH, a tripeptide) in 1969 (Boler et al, 1969) 
and luteinising hormone releasing hormone (GnRH, a 
decapeptide) in 1971 (Matsuo et al, 19 71) provided 
specific tools to investigate their respective 
pituitary axes. Since their synthesis and commercial 
availability they have been used in combination with 
insulin as a complete test of hypothalamo-pituitary 
reserve (Harsoulis et al, 1973).
Insulin combined test
This test is performed over 2 hours and consists 
of the intravenous administration of insulin (0.05-0.15
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U/kg), TRH (200 ug) and GnRH (100 ug). Assuming 
adequate hypoglycaemia is achieved (blood glucose < 2.1 
mmol/L) both GH and ACTH release will be stimulated 
from the anterior pituitary. Since the cortisol 
response parallels the ACTH response and its assay is 
more reliable and cheaper, cortisol is usually measured 
in place of ACTH.
It was hoped that the hypothalamic releasing 
factors in the combined test (triple bolus test) might 
be able to distinguish between hypothalamic and 
pituitary disease but this has not been the case. An 
initial report by Faglia et al in 1973 suggested that 
hypothalamic hypothyroidism was characterised by a 
delayed, prolonged and exaggerated TSH response to TRH, 
whereas pituitary dependent hypothyroidism led to a 
subnormal or absent TSH response to TRH. However 
subsequent workers (Tunbridge et al, 1973) have shown 
that while a flat TSH response indicates pituitary 
disease with a high degree of probability, normal or 
exaggerated TSH responses can occur in both pituitary 
and hypothalamic disease. The newer TSH assays are 
capable of defining a lower limit of the normal range 
and are gradually replacing the TRH test, which has 
rarely been complicated by pituitary apoplexy (Lever et 
al, 1986).
GnRH is also unable to distinguish between 
hypothalamic and pituitary disease since disorders of 
either centre produces a flat gonadotrophin response to 
stimulation. The loss of endogenous GnRH pulsatility in
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hypothalamic disorders results in decreased synthesis 
of LH and FSH, so that even with an intact pituitary a 
subnormal response occurs. It has been possible to 
overcome this problem by pre-treating the patients with 
timed pulses of GnRH, so that despite hypothalamic 
disease pituitary synthesis of gonadotrophins is re­
established, resulting in a detectable response to 
stimulation.
The standard method for assessing the hypothalamo- 
pituitary axis has been the insulin tolerance test but 
it cannot be used in certain circumstances; firstly in 
patients aged more than 50 years because of the 
increased risks of myocardial ischaemia and secondly in 
epileptic patients. Particular care must be taken if 
the test is carried out in patients with frank 
hypopituitarism since severe hypoglycaemia, coma and 
death can ensue. Medical supervision is required 
throughout the test because of the risk of 
unconsciousness and a supervised meal is necessary on 
completion of the test. Occassionally patients report 
that the test was unpleasant because of drowsiness, 
sweating, palpitations and hunger. However if all the 
precautions are strictly observed the test can be 
performed routinely on an out-patient basis with 
minimal risk.
Corticotropin and growth hormone releasing factors
The next significant advance occurred in 19 81 when 
Vale et al (1981) characterised a 41 amino-acid
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peptide, corticotropin releasing factor (CRF), which is 
considered to be one of the principal releasing factors 
for ACTH in man. Orth et al (1983) observed that the 
rise in ACTH following CRF administration is less than 
that after insulin induced hypoglycaemia, and suggested 
that other substances, such as vasopressin, must also 
contribute to ACTH release. Nonetheless CRF is 
considered very useful in the evaluation of patients 
with suspected ACTH deficiency. It has been reported 
that pituitary disease typically results in an absent 
or subnormal ACTH response to stimulation, whereas 
hypothalamic disease produces an exaggerated ACTH 
response to CRF (Tsukada et al, 19 84) . This augmented 
response has been ascribed to the low plasma 
concentration of glucocorticoid which is known to
suppress the pituitary responsiveness to CRF. The
authors concluded that the CRF test is a useful tool 
for evaluation of pituitary ACTH reserve and has 
diagnostic value in adrenocortical insufficiency due to 
hypothalamic and pituitary disorders.
In the CRF test 50-100 ug of CRF is administered 
as an intravenous bolus with ACTH and/or cortisol 
measured over the subsequent 2 hours, with the peak
cortisol response occurring within 60 minutes.
In 1982 Guillemin et al (1982) and Rivier et al 
(1982) isolated 44 and 40 amino-acid residues of growth 
hormone releasing hormone (GHRH) from 2 pancreatic
tumours in patients presenting with acromegaly. 
Subsequently it was found that only the first 29 amino-
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acids are required for full agonist activity (Grossman 
et al, 19 84). The GHRH test consists of the intravenous 
administration of 50-100 ug of the 29, 40 or 44 amino- 
acid residue with GH measured over the ensuing 2 hours. 
In healthy individuals the GH response is extremely 
variable, with a wide normal range (Grossman et al, 
1984) , and peak values are less than those after 
insulin-induced hypoglycaemia (Wakabayashi et al, 
1986). In growth retarded children and adults attempts 
have been made to separate hypothalamic from pituitary 
causes, with an absent GH response typically occurring 
in pituitary disease (Grossman et al, 1984). 
Coincidental with the withdrawal of human growth 
hormone in 1985 GHRH was used therapeutically in a few 
centres in growth retarded children with a degree of 
success (Ross et al, 1986).
Combined releasing factor test
As all the pituitary axes could now be tested by 
the 4 releasing factors workers have recently reported 
on the anterior pituitary hormone responses to 
combinations of these factors in animals, healthy 
volunteers and patients with various pituitary 
disorders.
The first releasing factor combination study was 
carried out in rats (Wehrenburg et al, 1984) and it 
indicated that there was no direct interaction between 
the 4 releasing factors at the pituitary level. The 
authors concluded that any single or multiple impaired
85
hormone response would be due to single or multiple 
pituitary abnormalities, rather than due to interaction 
between the administered secretagogues.
The first study in humans (Sheldon et al, 19 85) 
confirmed that there was no significant interaction and 
reported that the hormone response to the 4 factor 
combination was not statistically different from the 
hormone response achieved when the releasing factors 
were administered alone.
The second study (Holl et al, 19 85) reported the 
hormonal increments to the releasing factor combination 
in 10 normal men and women and considered the test a 
valuable, physiological assessment of hypothalamo- 
pituitary function. The authors observed an increased 
and prolonged TSH rise and suspected augmentation of 
the TSH response to TRH by GHRH.
The next study (Looij et al, 1986) confirmed a 
significant potentiation of the TSH response to TRH by 
GHRH. However because there was no inhibition of 
hormone release it was thought that the releasing 
factor combination was a valuable test of anterior 
pituitary function.
A further study (Sandler et al, 19 86) compared the 
hormonal responses to the 4 releasing factor 
combination plus arginine vasopressin with a 
conventional combined test using insulin together with 
TRH and GnRH. Both normal volunteers and patients with 
pituitary disorders were studied. No difference between 
the 2 tests was observed in the LH, FSH, TSH and PRL
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responses to stimulation. Both the cortisol and GH 
responses to the releasing factor combination with 
vasopressin were significantly greater than those seen 
with insulin induced hypoglycaemia or the combined 
releasing factor test without vasopressin. Patients 
with pituitary hypofunction were distinguished by both 
tests. As most peak hormone responses occurred within 
60 minutes of administration of the releasing factors 
it was suggested that the test could be achieved using
only basal, 30 and 60 minute samples. The authors
concluded that the combined releasing factor test
appeared to be a safe, rapid and useful test of 
anterior pituitary function.
In the 4 studies the dosage of TRH and GnRH was 
consistent (200 and 100 ug respectively). However in
Sheldon's study (19 85) CRF and GHRH were both 
administered at a concentration of 1 ug/kg, whereas in 
the other 3 studies 100 ug of each were used. The 
releasing factors were administered as successive 20 
second intravenous infusions or at 2 and 3 minute 
intervals. Clinical effects of the releasing factor 
test included transient nausea, flushing, a feeling of 
warmth over the face and upper trunk, dysgeusia and 
urinary urgency. No symptoms persisted for more than 10 
minutes and there was no effect on blood pressure or 
pulse rate. None of these side-effects were more severe 
or prolonged than what has already been reported for 
CRF (Orth et al, 1983), GHRH (Thorner et al, 1983) or 
TRH (Anderson et al, 1971).
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As most of the patients in our study were 
critically ill at the time of initial investigations 
pituitary function had to be assessed using a test 
which was simple and practicable, had no deleterious 
effect on conscious level and no significant side- 
effects. The insulin combined test is contraindicated 
because hypoglycaemia could further impair 
consciousness, whereas the combined releasing factor 
test has no effect on conscious level, no serious side- 
effects and only requires 3 blood samples after 
administration of the releasing factors. The latter 
test was therefore used in this study. The disadvantage 
in using a multiple releasing factor stimulus is that 
it can only test the pituitary gland, whereas the 
insulin component, in the insulin combined test, 
assesses both the hypothalamus and pituitary. This 
differance in site of action may be important as 
dissociation between the two kinds of tests has been 
noted, not only in patients with primary hypothalamic 
disorders but also in those with large pituitary 
tumours with suprasellar extensions, which cause 
disturbance of the portal vascular link (Lytras et al, 
1984). However in patients with hypothalamic 
hypoadrenalism it is likely that the pituitary-adrenal 
response to CRF would be subnormal, the basal cortisol 
low and other endocrine deficits would be present.
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ASSESSING BRAIN DAMAGE AFTER HEAD INJURY
Many factors affect the outcome after a major head 
injury including the patient's age and psychosocial 
status but the most important determinant is the degree 
of brain damage. As many British hospitals admit upto 
1000 cases of head injury each year and upto 1 million 
cases present to Accident and Emergency Departments in 
the United Kingdom it is important to have a quick, 
reliable means of estimating the severity of brain 
injury (Jennett, 1979). Furthermore this must be 
assessed at an early stage after injury, so that 
patients who appear to be relatively mildly injured, 
but are at risk of developing early complications, or 
who appear severely injured but have the potential for 
recovery, can be identified quickly and appropriate 
therapeutic measures taken.
GLASGOW COMA SCALE
Since 1974 the most widely adopted method for 
estimating the severity of brain damage has been the 
Glasgow Coma Scale (Teasdale and Jennett, 1974). This 
scale defines the level of responsiveness in 3 
modalities - eye opening, motor response and verbal 
response and by assigning numerical values to each 
parameter the score can be analysed statistically 
(Jennett et al, 1976). High numbers are used for normal 
responses and low for abnormal responses. Patients 
scoring 7 or less are in coma, those with 9 or more are
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out of coma and about half of those with scores of 8 
are in coma. Thus the coma scale is an index of the
depth of coma and it has a continuous relationship with 
outcome (Fig 6) . When comparisons were made between
studies it was found necessary to standardise the time 
at which assessment was carried out and the best value 
within 24 hours was used (Jennett, 1979).
DURATION OF COMA AND POST-TRAUMATIC AMNESIA
Further indices of the severity of brain injury
(and thus outcome) include the duration of coma and
post-traumatic amnesia (PTA) (Jennett et al, 1976). In 
view of the practical difficulties involved in defining 
accurately the time at which a person has come out of 
coma it was decided not to attempt to record the 
duration of coma in this study. Furthermore it has been 
demonstrated that this parameter is less accurate at 
predicting outcome than PTA (Russell and Smith, 1961) .
By assessing patient outcome after 6 months 
Jennett et al (1981) have shown that the length of PTA 
correlates well with the degree of eventual disability. 
Almost all patients with severe disability had a PTA of 
greater than 4 weeks and over 80 % of patients with a 
PTA of less than 2 weeks made a good recovery.
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PATIENTS AND CLINICAL DETAILS
Sixty consecutive adult patients admitted with a 
major head injury were included in the study. A major 
head injury was defined as resulting in a period of 
unconsciousness followed by post-traumatic amnesia of 
greater than 24 hours duration (Russell and Smith, 
1961).
Exclusion Criteria
1 No patients under the age of 16 were included in 
the study.
2 Patients who received treatment with 
methylprednisolone or dexamethasone (usually 
administered by a referring hospital) were not 
studied.
3. It was planned that patients with a history of 
endocrine disease should not be studied. Although 
no patients were excluded from entering the study 
for this reason, one male patient was subsequently 
found to have undiagnosed primary hypothyroidism 
and two male survivors had undiagnosed primary 
gonadal disease.
Procedure after patients were admitted with a head 
injury
I performed a full examination of all patients 
shortly after they were admitted and a record was taken 
of the therapy given and the results of investigations
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that were available. If the patient had none of the 
exclusion criteria they were considered for recruitment 
into the study. At this stage informed consent was
sought by myself from the patients' relatives. 
Endocrine tests were then performed using the releasing 
factor combination. Tests were carried out within 24 
hours of the head injury when possible but as some 
patients were initially admitted to other hospitals in 
the region before referral to Addenbrookes their first 
endocrine tests were performed after a greater delay. 
All endocrine tests were performed by myself.
In-patient course
During their admission neurological status was 
determined by nursing staff using the Glasgow Coma 
Scale (Teasdale and Jennett, 1974) . The best value 
obtained within 24 hours of admission was used during 
subsequent analysis (Jennett, 1979). In addition the 
duration of post-traumatic amnesia was recorded. In 
most cases this was determined by myself, but when
patients still in PTA were transferred to another 
region it was determined from their case notes.
The neurological status was the main factor used 
by the neurosurgeons and neuroanaesthetists to 
determine whether patients required to be paralysed and 
ventilated. Those on assisted ventilation for greater
than 1 week and those unable to maintain a sufficient
oral intake after coming off the ventilator were 
commenced on parenteral nutrition, supervised by the
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nutrition team. It was the neurosurgeon's policy to 
restrict fluid input to 1 L/24 hours, to attempt to
reduce cerebral oedema. This occasionally led to mild 
hypernatraemia and elevation of the serum urea. If 
urine output was inappropriately increased urine and 
plasma osmolalities were measured in order to detect 
diabetes insipidus.
ROUTINE IN-PATIENT INVESTIGATIONS (performed by 
neurosurgeons)
Blood Tests
Electrolytes and urea were measured daily until 
satisfactory oral intake was re-established. A full 
blood count was taken and repeated later in those 
patients with multiple injuries who required a blood 
transfusion. Arterial blood gases were measured several 
times daily in ventilated patients, who usually had an 
arterial line in situ.
X Ray Investigations
All patients in the study had a skull X ray 
performed (AP and lateral). A computerised tomogram 
brain scan (CT scan) was performed at least once in 40 
patients. X rays of other injuries (including facial, 
pelvic, rib, long bone and vertebral fractures) were 
performed as necessary.
Other Investigations
Intracranial pressure and central venous pressure 
were not routinely monitored. Infection screens were 
carried out where appropriate.
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IN-PATIENT THERAPY (Table 5)
Induction of anaesthesia
If artificial ventilation was required thiopentone 
or midazolam were used to induce anaesthesia. In 
addition those patients requiring surgery received 
halothane or nitrous oxide.
Paralysing agents
Pancuronium and alcuronium were used in 
Addenbrookes. Suxamethonium and d-tubocurarine were 
occasionally used by the referring hospital.
Analgesia/Sedation
While being artificially ventilated opiate agents 
were routinely prescribed. The opiate most frequently 
prescribed was phenoperidine, with fentanyl, morphine 
and omnopon used less often. During recovery, or if 
the injury was less severe, aspirin, paracetamol and 
codeine phosphate were used.
Antibiotics
Ampicillin, flucloxacillin and metronidazole were 
prescribed in the presence of a skull fracture. Other 
antibiotics were used infrequently.
Anti-epileptics
Patients with focal or generalised seizures were 
treated with phenytoin.
Mannitol
29 of the 60 patients required mannitol at some 
stage after injury to reduce cerebral oedema.
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Table 5
DRUGS ADMINISTERED DURING IN-PATIENT ADMISSION
Number of 
Subjects
A During ventilatory support
Thiopentone 17
Induction agents
Midazolam 6
Neuromuscular blocking agents
Pancuronium/
alcuronium 40
Suxamethonium 18
d-Tubocurarine 2
Analgesics/Sedatives
Phenoperidine 35
Fentanyl 13
Morphine 1
Omnopon 1
General Anaesthetic
Nitrous oxide 24
Halothane 24
B Antibiotics 50
C Analgesics - non-ventilated subjects Codeine 15
- following ventilation [ Codeine 22
[Paracetamol 13
[ Aspirin 26
D Anti-epileptic Phenytoin 15
E Sedative Benzodiazepine 8
Phenothiaz ine 19
F H2 receptor antagonist Ranitidine 22
G To reduce cerebral oedema Mannitol 29
Dexamethasone 2
H For diabetes insipidus DDAVP (desmopressin) 4
Blood transfusion
15 patients received a transfusion because of 
blood loss due to long bone/pelvic fractures.
Ranitidine
This was prescribed in 22 patients as prophylaxis 
against stress induced gastric erosions.
PATIENT DETAILS
Age and Sex
There were 36 male survivors, 12 female survivors 
and 12 fatalities (1 female) , producing a male to 
female ratio of 3:1 in the survivors and 11:1 in the 
fatalities. The sex distribution of our study group 
reflects the greater number of head injuries that occur 
in males. The age distribution of each group is shown 
in Table 6. The male survivors had 2 peak age ranges 
for head injuries, between 20-29 years and 40-4 9 years. 
The female survivors had 1 peak between 20-29 years and 
the fatalities had an even distribution between the 
various age groups. The first peak in the male 
survivors was largely due to road traffic accidents, 
whereas the later peak was due to road traffic 
accidents and falls. The mean age in the male survivors 
was 36.1 ± 2.7 years (37.8 in those admitted within 24 
hours of injury and 34.5 in those studied after 1-3 
days - no significant difference). The female survivors 
had a mean age of 3 0.0 ± 3.5 years and the fatalities
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Table 6 AGE OF SUBJECTS (YEARS)
16-19
20-29
30-39
40-49
50-59
>60
Male
Survivors
5
11
3 
10
4 
3
Female
Survivors
2
6
1
2
1
0
Fatalities
3
2
2
3
0
2
Total
10
19
6
15
5
5
3 6.2 ± 5.4 years. There was no significant age
difference between any of the groups.
Cause of Injury
The cause of the injury is demonstrated in Table 
7. Traffic accidents were responsible for 49 of the 60 
injuries. In the 47 male subjects car accidents were 
the most frequent cause of head injury (13 cases), 
although motorcycle accidents were also common (12 
cases). As there are far fewer motorcycles than cars 
this confirms that motorcyclists have a much greater 
risk of accident and injury. There were no motorcycle 
injuries in the females. Despite the large proportion 
of bicycles in Cambridge (and East Anglia) only 5 of 
the 60 subjects had been injured when cycling. A 
greater proportion of the fatalities were cyclists or 
pedestrians when compared to the survivors (50 % v 25 
%). This may reflect the lack of protection from injury 
in pedestrians and cyclists.
Delay in performing test
The shortest delay between injury and the first 
releasing factor test occurred in the group of male 
survivors examined within 24 hours of injury, although 
it was not significantly shorter than the delay in the 
group of fatalities (p < 0.06) (Table 8). The longest 
delays occurred in the second group of males and the
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Table 7 CAUSE OF INJURY
Survivors Fatalities Total
Male
Car accident 11
Motorcycle
accident 9
Bicycle hit
by vehicle 3
Pedestrian knocked
down by vehicle 5
Fall 6
Work Injury 1
Shotgun Injury 0
Assault 1
Female
7 2 20
0 3 12
0 2 5
3 4 12
2 0 8
0 0 1
0 1 1
0 0 1
Table 8 DELAY IN HOURS BETWEEN INJURY AND FIRST 
RELEASING FACTOR TEST
Fatalities Female Male
Survivors Survivors
21.8 ±4.9 47.1 ± 8.9 Group 1 n=17 14.5 ± 1.3
Group 2 n=19 41.6 ± 3.8
female subjects, both of which were significantly 
longer than the other 2 groups (p < 0.01).
Severity of Injury
The severity of the brain injury was determined by 
the best value for the Glasgow Coma Scale within 24 
hours of injury. A score of less than 8 indicates that 
the patient is still in a coma (Jennett, 197 9) . From 
Table 9A it can be seen that none of the fatalities 
came out of a coma during the first 24 hours after 
injury, whereas 27 of the 48 survivors did. The mean 
value in the male survivors was 9.5 ± 0.6 (9.9± 0.8 in
those studied within 24 hours and 9.1 ± 0.8 in those 
studied after 1-3 days). There was a similar mean value 
in the females (9.0 ±0.9), which was not significantly 
different from the males. The fatalities had a 
significantly lower value than both the male and female 
surviors (4.0 ±0.5, p < 0.001).
The second index of the severity of injury was the 
duration of post-traumatic amnesia. A major head injury 
is defined by PTA of greater than 24 hours duration 
(Russell and Smith, 1961) . As 40 of the 48 survivors 
had PTA lasting more than 1 week many of the patients 
studied had sustained very severe head injuries (Table 
9B) .
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Table 9A GLASGOW COMA SCALE (BEST VALUE WITHIN 24 
HOURS)
Male Female Fatalities
Survivors Survivors
(n=3 6) (n=12) (n=12)
3-5 6 2 10
6-8 9 4 2
9-12 13 3 0
13-15 8 3 0
Table 9B DURATION OF PTA
Male Female
Survivors Survivors
n=36 n=12
24hrs - 1 week 5 3
1 week - 1 month 13 3
1 month - 3 months 11 5
>3 months 7 1
Assisted ventilation
Assisted ventilation was required in 24 of the 36 
males, 6 of the 12 females and all of the fatalities. 
During their ventilatory support and subsequent
management many drugs were administered and they are 
shown in Table 5.
Fractures
Skull fractures occurred in 32 of the 60 subjects 
(Table 10) . Multiple fractures (involving more than 2 
bones) and fractures of the parietal bone were the most 
common fractures (9 cases each). Temporal fractures 
were also common, whereas frontal, occipital and basal 
fractures were less frequent. Fracture lines were 
thought to involve the pituitary fossa in 5 subjects. 
Only 3 of the 12 fatalities had no fracture compared to 
25 of the 48 survivors, reflecting the greater severity 
of the injury in the fatalities.
Fractures in other bones were common, occurring in 
24 of the 48 survivors and 9 of the 12 fatalities. The 
most frequently fractured bones were the long bones, 
closely followed by the ribs (including the clavicles) 
and the facial bones (Table 11) . Other injuries were 
uncommon with 1 patient requiring repair of an aortic 
tear and another requiring an operation for a compound 
eye injury. During the first week after injury 24 
operations were performed (Table 12) . Evacuation of an 
extradural or subdural haematoma was the most frequent
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Table 10 FREQUENCY AND SITE OF SKULL FRACTURES
Survivors Fatalities Total
Frontal
Male
1
Female
2 0 3
Fronto­
parietal 0 0 1 1
Parietal 4 0 1 5
Temporal 0 3 2 5
Tempero-
Parietal 2 1 0 3
Basal
(Pit Fossa) 2(1) 0 1 3(1)
Multiple
(Pit Fossa) 4(1) 1 4(3) 9(4)
Occipital 3 0 0 3
No Boney Injury 20 5 3 28
Total 36 12 12 60
Table 11 FRACTURES OTHER THAN SKULL FRACTURES
Survivors Fatalities Total
Male Female
Long Bone 
Wrist/Ankle/
8 1 4 13
Patella 3 3 1 7
Ribs/Clavicle 6 2 3 11
Facial 4 4 2 10
Vertebral 2 0 2 4
Table 12 OPERATIONS PERFORMED DURING FIRST WEEK AFTER
INJURY
Survivors Fatalities
Male Female
Evacuation of: 
subdural haematoma 
extradural haematoma 
Elevation of depressed 
skull fracture 
Orthopaedic operation 
Eye operation 
Aortic Repair 
Facial operation
Total
1 2 1
2 3(1) 0
1 1 0
4(2) 3(3) 1(1)
1 0 0
1(1) 0 0
0 3(3) 0
10 12 2
Operations performed between the first and second 
releasing factor test are in brackets.
operation (9 operations), with orthopaedic operations
required in 8 cases. Thirteen of the operations were 
performed before the first releasing factor test, with
11 operations occurring betwen the first and second
test.
Neurological complications
Neurological complications were frequent (Table 
13) . Hemiparesis and cranial nerve palsies were the 
most common, both occurring in 9 survivors. Post- 
traumatic seizures developed in 7 subjects. Impairment 
of intellectual function was reported to some extent by 
every survivor. All noticed a deterioration in 
concentration and short-term memory.
METHODS
COMBINED RELEASING FACTOR TEST
As soon as possible after admission to the 
Neurotrauma Unit patients received intravenous 
infusions of 4 hypothalamic releasing hormones; human 
corticotropin-releasing hormone (hCRH 100 ug) , human 
growth hormone-releasing hormone (hGRH 100 ug) , 
thyrotropin releasing hormone (TRH 200 ug) and 
gonadotropin releasing hormone (GnRH 100 ug) . The 
combination was administered through an intravenous 
cannula in the antecubital fossa, as sequential 30 sec
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Table 13 NEUROLOGICAL COMPLICATIONS
Male Female
Survivors Survivors
Paraparesis 1 0
Hemiparesis 5 4
Quadriparesis 4 1
Cranial Nerve Palsy
CNl 0 1
CN3 2 1
CN6 1 1
CN7 3 0
Seizures 5 2
boluses in the order listed. Blood samples for hormone 
assay were taken at 0, 3 0, 60 and 120 min from the
opposite arm through another indwelling intravenous
cannula, which was flushed with heparinised saline to 
keep the line open.
The releasing factor combination was administered 
within 24 hours of admission, or as soon as possible 
thereafter if the patient had been transferred from 
another hospital. During the infusion and blood testing 
patients had continuous blood pressure and 
electrocardiographic monitoring. The protocol was 
approved by the Addenbrooke's Hospital Ethical 
Committee.
Follow-up tests
All surviving patients had a repeat releasing 
factor test performed 7 days after the initial test (7- 
10 days after injury). A further review and releasing 
factor test was performed 3-6 months after injury in 
those patients residing or still hospitalised in East 
Anglia. Patients (and where appropriate close relatives 
or medical staff) were questioned about the development 
of endocrine symptoms since the injury (including 
diabetes insipidus). The patients therapy was noted and 
a full examination performed with all neurological and 
endocrine abnormalities recorded. Any patients found to 
have a reduced cortisol response during the releasing 
factor test had an insulin stress test performed.
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Releasing factors
Synthetic hCRH and hGRH (1-29 amide), purchased 
from Bachem UK Ltd, were dissolved in acidified saline 
(0.02% HC1 in 0.9% saline), as previously described 
(Grossman et al, 1982). GnRH (Ayerst Laboratories) and 
TRH (Roche Pharmaceuticals) were purchased and prepared 
according to the manufacturers’ instructions.
HORMONE ASSAYS
All assays were performed by laboratory staff of 
the Department of Biochemistry, Addenbrooke's Hospital 
except for free testosterone assays which were carried 
out by myself. The interassay coefficients of
variation for each method are included in brackets.
T4 Double antibody radioimunnoassay using ANS to 
displace T4 from TBG (in house method, cv 4.4% at 96 
nmol/L).
T3 Double antibody PEG assisted radioimmunoassay 
(in house method, cv 6.3% at 3.2 nmol/L).
Total Testosterone Solvent extraction followed by 
125 I-labelled radioimmunoassay (in house method, cv 
8.6% at 17.1 nmol/L).
Free Testosterone DPC Free Testosterone Kit
(solid-phase 125 I-labelled radioimmunoassay, cv 8.0% 
at 70 pmol/L).
Oestradiol Steranti Oestradiol Kit (125 I-
labelled radioimmunoassay, cv 8.2% at 497 pmol/L).
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GH Double antibody radioimmunoassay using
national reagents from Edinburgh SAS laboratory. 
Standard: 1st IRP 66/217. (cv 7.4% at 4.7 mU/L).
Cortisol 125 I-labelled radioimmunoassay using
Amersham 'Amerlex' reagents, (cv 6.4% at 478 nmol/L).
FSH Double antibody radioimmunoassay using
national reagents from Chelsea Hospital for Women.
Standard: NIBSC 69/104. (cv 7.6% at 4.9 IU/L).
LH Double antibody radioimmunoassay using
national reagents from Chelsea Hospital for Women.
Standard: NIBSC 68/40. (cv 7.9% at 4.4 IU/L).
Prolactin Double antibody radioimmunoassay using
a secondary standard calibrated against NIBSC 75/504.
(cv 9.0% at 493 mU/L).
TSH In the initial half of the study this was
determined using an immunoradiometric assay using
monoclonal antibodies and a 'sandwich1 technique.
Standard: 2nd IRP 80/558. In the latter half it was
determined by a sensitive enzyme amplified immunoassay,
using alkaline phosphatase as the label (IQ Bio Ltd,
Cambridge, cv 7.4% at 8.5 mU/L).
All assays participate in the National Quality
Control Schemes.
HISTOPATHOLOGICAL STUDY
Twelve of the patients (11 male and 1 female) 
subsequently died and their clinical details are 
presented in Table 14. In 8 cases both the hypothalamus
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Table 14 CLINICAL DETAILS OF FATALITIES
Age Sex Time 
of Test 
(hrs after 
injury)
Survival GCS Skull
Fracture
DI
32 M 13 1 day 3 Multiple No
41 M 2 4 hours 3 Multiple
(fossa)
No
27 M. 10 5 days 5 Occipital No
20 M 14 8 days 4 No Yes
46 M 36 9 days 6 Multiple
(Basal)
Yes
19 M 23 4 days 3 No Yes
64 M 23 2 days 3 Multiple 
(fossa)
No
73 M 23 3 days 3 Parietal No
17 M 23 3 days 8 Basal No
16 M 19 2 days 3 No Yes
29 M 22 2 days 3 Parietal No
43 F 25 3 days 3 Multiple Yes
and pituitary were available for study. In a further 2
cases the pituitary only was available and in another 2 
cases the hypothalamus only was available.
The aims of this study were to determine the site, 
extent and frequency of damage to the hypothalamus and 
pituitary and to compare these findings with the 
premortem endocrine function tests. It was also hoped 
that prognostic indicators might be determined.
Single blocks of the pituitary and hypothalamus 
were taken and, after paraffin wax embedding, step 
sections were cut (0.25 mm intervals) to include the 
principal nuclear masses and tracts. Staining was 
performed with haemotoxylin and eosin. Line diagrams 
were drawn of 2 representative pituitary sections from 
each patient and the mean percentage cross-sectional 
area of infarction was calculated for each patient 
using the Reichert-Jung MOP-3 system. Anterior 
pituitary infarction was defined as large if greater 
than 75% of the cross-sectional area was necrotic, 
medium-sized between 25-75% and small if less than 25%.
Immunocytochemical staining was then performed 
using antisera to ACTH, FSH, LH, TSH, GH and PRL and 
the extent of staining for each hormone was determined.
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STATISTICAL ANALYSIS
The data was transformed logarithmically to 
produce a normal distribution and the mean values 
reported are the back-transformations (antilog) of the 
mean of the log values.
Repeated measures analysis of variance, using a 
computer program (BMDP Statistical Software, Los 
Angeles), was performed on the transformed data from 
the releasing factor tests on admission, 1 week later 
and after 3-6 months. The admission test results were 
also subdivided into those obtained from patients 
within 24 hours of injury and those after 1-3 days. 
Although changes are reported as significant if p < 
0.05, as multiple comparisons are made only 
relationships where p < 0.01 should be accepted with
confidence.
Spearmans rank correlation coefficients were 
calculated for the duration of PTA and various 
endocrine parameters and for the best value for the 
Glasgow Coma Scale within 24 hours of injury and the 
same endocrine parameters.
The number of subjects analysed during the first 
test was 60 (12 females, 12 fatalities and 36 males, 17 
of the males being seen within 24 hours). The second 
test, one week later, was performed on 4 8 subjects (3 6 
males, and 12 females) and the convalescent test was 
performed on 10 females and 23 males.
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C H A P T E R  3
RESULTS
Cortisol 
Growth Hormone 
Prolactin 
Thyroidal Axis 
Gonadal Axis
Basal Hormone Concentration and Size of Increment 
Injury Severity and Hormone Concentration 
Histological Findings 
Endocrine-Histological Comparisons 
Diabetes Insipidus
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CORTISOL
Male Survivors (Tables 15A and B)
Basal Values
The mean basal value was elevated outside the 
normal range on admission and was significantly greater 
than the values after 7-10 days and 3-6 months (both p 
< 0.001). There was no significant difference between 
the mean values of those patients whose admission test 
was performed within 24 hours of injury and those in 
whom the initial test was performed 1-3 days after 
injury. By 7-10 days although the mean value had fallen 
into the normal range it remained significantly greater 
than the 3-6 month value (p < 0.001), which was in the 
middle of the normal range.
Response to CRH
There was an increment in response to CRH during 
each of the 3 tests, ranging from a mean of 172 nmol/L 
on admission to 242 nmol/L after 7-10 days. Although 
the smallest increment occurred on admission it 
produced the highest peak level because of the elevated 
basal level. There was no difference between the peak 
values obtained within 24 hours or 1-3 days. 
Occasionally the basal cortisol level was so high 
within 24 hours and 1-3 days of injury that a further 
increase was not observed.
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Table 15
MEAN BASAL CORTISOL LEVELS (nmol/L) + RESPONSE TO CRH
A Male Survivors (mean - SEM, mean + SEM)
Basal 30' 60' 120'
Admission 807 976 979 904
n = 36 (760,856) (920,1035) (922,1038) (852,959)
Day 7-10 594 836 712 556
n = 36 (560,629) (788,886) (627,754) (525,590)
3-6 months 370 583 569 407
n = 23 (344,398) (542,627) (529,612) (379,438)
B Male Survivors - Admission Test. Subdivided
Basal 30' 60' 120’
Within 813 994 947 889
24 hours (731,904) (894,1106) (852,1054) (799,989)
n = 17
After 801 959 1007 907
1-3 days (725,885) (868,1060) (911,1113) (821,1002)
n = 19
On admission the values 30 and 60 min after 
stimulation were similar and this pattern recurred 
during the subsequent 2 tests, with the 60 min level
greater on admission but the 30 min level greater after 
7-10 days and 3-6 months. The peak values were higher 
the shorter the time that had elapsed since injury, 
such that the 30 and 60 min values on admission were 
significantly greater than the 30 and 60 min values 
after 7-10 days (p < 0.05 and p < 0.001 respectively) 
and after 3-6 months (both p < 0.001). Similarly the 30 
and 60 min values after 7-10 days were significantly 
greater than those after 3-6 months (p < 0.001 and p < 
0.01 respectively).
"Subnormal" Basal Levels and Responses to CRH
Within 3 days of injury all but 4 patients had 
cortisol levels greater than 500 nmol/L. One patient 
studied within 24 hours and three studied within 1-3 
days had values of 140, 230, 320 and 430 nmol/L 
respectively. Three of these cases had a peak cortisol 
value of greater than 700 nmol/L in response to CRH, 
indicating normal function of the pituitary-adrenal 
axis. The remaining case (with a basal value of 23 0 
nmol/L) had no response. During subsequent follow-up 
all 4 patients had normal basal levels, with a normal 
response to stimulation with CRH. It was considered 
probable that the subject with no cortisol reponse to 
CRH had received dexamethasone in the referring
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hospital, although there was no record of its 
administration.
Two patients who initially had levels of greater 
than 1000 nmol/L were found to have considerably lower 
levels on retesting 7-10 days later (220 + 390 nmol/L). 
However their response to CRH was intact (both had a 
peak cortisol greater than 80 0 nmol/L) and subsequent 
tests remained normal. At this timepoint all but one 
patient with basal levels less than 50 0 nmol/L had an 
increment of at least 150 nmol/L. This patient had a 
normal test at 3-6 months.
Convalescent basal levels 3-6 months later were 
less than 250 nmol/L in four patients. Three of these 
patients had peak levels greater than 700 nmol/L, while 
the remaining patient's cortisol level only rose from 
170 to 330 nmol/L. This patient subsequently had an 
insulin stress test performed which demonstrated an 
adequate cortisol response to hypoglycaemia.
Female Survivors (Table 15C)
Basal values
The highest mean value occurred on admission but 
although it was above the upper limit of the normal 
range it was not significantly greater than the value 1 
week later. The 3-6 month value was back in the middle 
of the normal range and was significantly less than the 
admission and 7-10 day values (p < 0.005 and p < 0.025 
respectively). The three basal values were similar to
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the equivalent basal values in the male survivors, with 
no significant difference observed.
Response to CRH
As noted in the male survivors there was an 
increment in response to CRH in each of the 3 tests. 
However the largest increment occurred on admission 
(256 nmol/L) and the smallest after 7-10 days (76 
nmol/L) . During the admission test the 30 and 60 min 
values were identical, whereas in the subsequent two 
tests the peak level occurred solely after 30 mins. The 
30 and 60 min values on admission were significantly 
greater than the 30 and 60 min values after 7-10 days 
(p <0.05 and p < 0.005 respectively) and 3-6 months (p
< 0.01 and p < 0.005 respectively). In contrast to the 
male survivors there was no difference between the 
response to CRH after 7-10 days and 3-6 months. 
Although the values achieved after CRH in the female 
group at 7-10 days were less than those in the male 
group, only the 60 min value was significantly lower (p
< 0.05). There was no difference between the male and 
female groups on admission or after 3-6 months.
"Subnormal" Basal Levels and Responses to CRH
Within three days of injury 3 patients were found 
to have levels less than 500 nmol/L but each had a good 
response to CRH (peak greater than 70 0 nmol/L). One of 
these patients was noted to have a small increment when
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retested after 1 week, which had persisted after 3-6 
months. However an insulin stress test demonstrated a 
normal cortisol response.
Fatalities (Table 15D)
There were 12 patients who died shortly after 
injury, 11 men and 1 woman. Two of the men survived for 
more than one week and therefore had a second releasing 
factor test performed.
The basal value lay between the values in the male 
and female survivors and was not significantly 
different from either value. However, in contrast to 
both groups of survivors, there was no increment in 
response to CRH stimulation, with the values after CRH 
actually less than the basal value, although not 
significantly.
There was a large variation in the basal cortisol 
levels, with six patients having levels greater than 
1000 nmol/L on admission, whereas four patients had 
levels of 400 nmol/L or less. Three of the patients 
with low levels (399, 90 + 250 nmol/L) had no increment 
in response to CRH and were considered to be 
glucocorticoid deficient. The remaining patient had a 
subnormal response (400 to 4 80 nmol/L) and may have had 
partial glucocorticoid deficiency. Most of the patients 
with levels greater than 10 00 nmol/L had no increment 
after stimulation and it was considered likely that 
their cortisol production rate was already maximally 
stimulated.
Ill
Table 15 (cont)
MEAN BASAL CORTISOL LEVELS (nmol/L) + RESPONSE TO CRH
C Female Survivors
Basal 30' 60' 120'
Admission 728 984 984 804
n = 12 (642,825) (868,1115) (868,1115) 709,911)
Day 7-10 635 711 587 499
n = 12 (554,724) (620,817) (512,674) (435,573)
3-6 months 406 624 579 424
n = 10 (354,466) (544,716) (505,664) (369,486)
D Fatalities (n = 12)
Basal 30’ 60' 120'
735 659 595 631
(619,873) (555,782) (501,707) (531,749)
Both patients who had two tests performed 
initially had levels greater than 1000 nmol/L. One was 
subsequently treated with high dosages of dexamethasone
for 3 days and when retested after 7 days his cortisol 
was still suppressed (70 nmol/L), with no response to 
stimulation (this subject was the only one in the study 
to have definitely received steroids and his results 
are included as his first test was performed prior to 
steroid administration). The second patient*s level had 
fallen to 370 nmol/L with a good response to 
stimulation (peak of 75 0 nmol/L).
Age and Cortisol Level
No relationship was found between the age of the 
patient and the basal cortisol level on admission or 1 
week later.
Summary
The mean basal cortisol concentrations obtained 
within the first 3 days after head injury were elevated 
in the male and female survivors and the fatalities.The 
highest level occurred in the male survivors but it was 
not significantly greater than the levels in the other 
two groups. On retesting the survivors after 7-10 days 
and 3-6 months there was a stepwise fall of the basal 
cortisol level into the normal range.
Following stimulation with CRH there was an 
increment in the cortisol concentration in the
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survivors during each of the 3 tests but not in the 
fatalities (Fig 7). As for the basal values, there was 
a stepwise decline from the peak values on admission to
the peak values obtained after 3-6 months.
It was assumed that a poor response to CRH was 
only clinically relevant if the basal cortisol value 
was less than 500 nmol/L, as significant dysfunction of 
the pituitary is unlikely with a basal level of this 
magnitude. A poor response to CRH in patients with a 
basal level lower than 500 nmol/L was arbitrarily 
defined as an increment of less than 150 nmol/L, as 
this cut off point gave a clear division between the 
various response patterns. Glucocorticoid deficiency 
was present in 5 of the fatalities, who had low basal 
cortisol levels and a subnormal or absent response to 
stimulation with CRH. Two survivors (1 male and 1 
female) with basal levels less than 500 nmol/L had 
subnormal increments when retested after 3-6 months, 
but their cortisol responses during an insulin stress 
test were normal. .
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GROWTH HORMONE
Male Survivors (Tables 16A and B)
Basal Values
The mean basal value was highest on admission and 
fell gradually to the 3-6 month value. The admission 
value was significantly greater than both the 7-10 day 
and 3-6 month values (p < 0.05 and p < 0.005
respectively) . Subdividing the admission values 
demonstrated a higher value within 24 hours of injury 
but it was not significantly greater than the 1-3 day 
value. The mean basal value was within the normal range 
( <10 mU/L) during all the tests.
Response to GRH
There was an increment in response to GRH during 
each of the 3 tests. The peak level occurred after 3 0 
mins during each of the tests and it was lowest on 
admission and highest after 3-6 months. The admission 
peak value was significantly less than the 7-10 day and 
3-6 month values (both p < 0.001). There was no
significant difference between the 7-10 day and 3-6 
month values. Subdividing the admission test results 
demonstrated no difference in the peak values obtained 
within 24 hours and after 1-3 days, which were both 
substantially less than the subsequent results.
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Table 16
MEAN BASAL GH LEVELS (mU/L) AND RESPONSE TO GRH 
A Male Survivors (Mean - SEM, Mean + SEM)
Basal 301 ’ 6JV_ 120*
Admission 3.6 6.7 4.9 3.3
n = 33 (3.1,4.2) (5.7,7.9) (4.2,5.7) (2.8,3.8)
Day 7-10 2.4 21.6 10.8 3.7
n = 33 (2.1,2.8) (18.5,25.1) (9.3,12.6) (3.2,4.3)
3-6 months 1.7 28.1 15.1 4.4
n = 21 (1.4,2.1) (23.0,34.3) (12.4,18.5) (3.6,5.4)
B Male Survivors - Admission Test Subdivided
Basal 301 60' 1201
Within 4.7 8.1 5.4 3.8
2 4hrs (3.7,5.9) (6.5,10.2) (4.3,6.8) (3.1,4.8)
n = 15
After 2.8 5.7 4.6 2.9
l-3days (2.3,3.5) (4.6,7.0) (3.7,5.6) (2.3,3.6)
n = 18
Individual Basal Levels and Responses to GRH
A basal level greater than the upper limit of 
normal (10 mU/L) occurred in 5 of 33 patients on 
admission, 2 of 33 subjects one week later and in 1 of 
21 subjects after 3-6 months. Predictably, levels less 
than the lower limit of the assay (1 mU/L) were more 
frequent the longer the time since injury. On admission 
3 of 33 subjects had such levels (all after 1-3 days), 
one week later 3 of 33 subjects and after 3-6 months 6 
of 21 subjects.
On admission the mean peak value was significantly 
reduced and in 20 of the 30 tests performed at this 
stage the peak level was less than 10 mU/L. In contrast 
the 11 tests in which the peak level was greater than 
50 mU/L tended to occur at a longer time after injury, 
with 5 after 1 week and 6 after 3-6 months. Even 
allowing for this general trend (ie the greater the 
length of time since injury the higher the peak level), 
there was substantial variability between individuals 
as demonstrated by the wide range of peak values on
admission (1.2-37 mU/L) and after 3-6 months (4.9-150 
mU/L) . Furthermore in 4 of the 10 patients whose
highest peak level occurred 1 week after injury the 
value was more than 3 0 mU/L greater than the peak after 
3-6 months, suggesting that in addition there is
considerable intra-patient variability, which cannot be
explained by a longer time elapsing since injury.
A basal level less than 1 mU/L was associated with 
a poor response to GRH during the first week after
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injury, with 4 of the 6 cases having peak values less 
than 5 mU/L, whereas after 3-6 months no such 
association was present, with 3 of the 6 cases having
very high peak levels.
Female Survivors (Table 16C)
Basal Values
As for the male survivors there was a stepwise 
fall from the admission level to the value after 3-6 
months, although it did not achieve significance. The 
mean values were within the normal range and were 
similar to the equivalent values in the male survivors.
Response to GRH
The pattern was again similar to the male 
survivors, with the lowest peak occurring on admission 
and the highest after 3-6 months, but as above the 
differences did not achieve significance. The initial 
reduction in the response to GRH was not as substantial 
as in the male survivors, such that the peak level on 
admission in the female group was significantly greater 
than the male group (p < 0.005). The subsequent 2 peak 
levels were similar in both sexes.
Individual Basal Levels and Responses to GRH
The basal level was elevated on 4 occasions (twice 
on admission) . A level less than 1 mU/L occurred during
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9 of the 34 tests, with half the patients having such 
levels after 3-6 months.
In contrast to the male subjects peak levels less
than 10 mU/L were evenly distributed between the 3 
tests, whereas the highest peak levels (> 50 mU/L) did 
tend to occur after 3-6 months (7 of 10 subjects) . As 
noted in the male subjects there was a large 
variability in the response to GRH with a very wide 
range of peak values on admission and after 3-6 months 
(6.8-140 mU/L and 2.4-120 mU/L respectively).
Fatalities (Table 16D)
The mean basal value was similar to the values in 
the 2 groups of survivors. Four of the 12 subjects had 
levels less than 1 mU/L on admission and 1 of the 2 
patients retested after 1 week had developed a value of 
< 1 mU/L. Two subjects had levels greater than 10 mU/L, 
with the highest basal level in the study occurring in 
the female fatality (25 mU/L).
The peak level was similar to the male survivors 
peak on admission but was significantly less than the 
female survivors (p < 0.01). Basal levels less than 1 
mU/L were associated with a poor response to 
stimulation, with all 5 cases having peak levels less 
than 3 mU/L, including 3 who had no increment. The 
fatality who had developed a low basal level when 
retested had no response to stimulation with GRH, 
whereas the other fatality who was retested initially 
had a basal level less than 1 mU/1 with a poor response
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Table 16 (cont)
MEAN BASAL GH LEVELS (mU/L) AND RESPONSE TO GRH
C Female Survivors
Basal 30' 60' 120
Admission 3.6 18.4 15.9 3.9
n = 12 (2.6,4.9) (13.6,24.9) (11.7,21.5) (2.9
Day 7-10 2.8 22.3 12.7 4.3
n = 12 (2.1,3.9) (16.3,30.6) (9.3,17.5) (3.2
3-6 month 2.2 25.8 18.7 7.9
n = 10 (1.6,3.0) (18.5,36.0) (13 .5,26. 1) (5.7 ,
D Fatalities (n = 12)
Basal 30' 60' 120
3.9 7.0 6.3 4.6
(3.0,5.2) (5.3,9.2) (4.8,8.3) (3.5
,5.3)
,6.0)
11.1)
,6.1)
which had increased to a basal level of 5 mU/L with a 
peak of 90 mU/1 on retesting.
Summary
The mean basal GH level was highest on admission 
and fell gradually to the 3-6 month value. The mean 
level was within the normal range during each of the 3 
tests and was similar in the 3 groups of subjects.
The response to GRH was lowest on admission, 
although in the female subjects this did not achieve 
significance. The admission response in the male 
survivors was similar to the fatalities and both were 
significantly less than the admission response in the 
females. There was a large variability in the response 
to GRH between individuals and there also appeared to 
be a large intra-subject variability between tests, 
after allowing for the time elapsed since injury.
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PROLACTIN
Male Survivors (Tables 17A and B)
Basal Values
The mean basal values were elevated during all 3 
tests. The values on admission and after 7-10 days were 
similar and both were significantly greater than the 3- 
6 month value (p < 0.01 and p < 0.005 respectively). 
Although the 3-6 month value (191 mU/L) was greater 
than the current upper limit of our hospital reference 
range (150 mU/L) it has been suggested that a higher 
upper limit (200 mU/L) is required, which would place 
the 3-6 month value within the normal range. The higher 
admission test occurred within 24 hours of injury, 
although it was not significantly greater than the 1-3 
day value.
Response to TRH
In all 3 tests there was an increment in response 
to stimulation with TRH, with the peak level occurring 
after 30 mins. There was no significant difference 
between the response to TRH on admission and the 
response during the subsequent two tests, although the 
lowest values occurred on admission. Similarly, there 
was no significant difference between the responses 
when the admission test was subdivided, although the 
levels within 24 hours of injury were lower. However
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Table 17
MEAN BASAL PROLACTIN LEVELS (mU/L) AND RESPONSE TO TRH 
A Male Survivors (Mean - SEM, Mean + SEM)
Basal 30' '60' 1201
Admission 279 1019 615 380
n = 33 (253,307) (924,1123) (558,678) (345,419)
Day 7-10 305 1219 740 444
n = 33 (276,336) (1106,1344) (672,816) (403,490)
3-6 month 191 1232 702 349
n = 21 (170,215) (1095,1385) (624,790) (310,392)
B Male Survivors - Admission Test Subdivided
Basal 301 60' 120'
Within 309 864 527 331
24hrs (266,354) (744,1003) (454,612) (285,384)
n = 15
After 257 1158 693 424
1-3 days (225,293) (1015,1322) (608,791) (372,484)
n = 18
the peak level within 24 hours was significantly less 
than the 7-10 day and 3-6 month peaks (both p < 0.025).
Individual Prolactin Levels and the Response to TRH
Only one patient had a basal level more than 1000 
mU/L. This occurred after 7-10 days and was probably 
related to a short course of treatment with 
metoclopramide, which was commenced after his first 
test. When reviewed after 3-6 months his basal value 
was less than 300 mU/L. Two patients had levels between 
600-800 mU/L on admission and one week later but were 
then transferred elsewhere so that no convalescent 
samples were available. Two further patients had levels 
greater than 600 mU/L on isolated occasions after 7-10 
days. By 3-6 months only one patient of the 21 tested 
had a value greater than 400 mU/L (410 mu/L) and he was 
asymptomatic.
One patient had a level less than the lower limit 
of the assay (10 0 mU/L) within 24 hours of injury, 
whereas this occurred in 4 of 21 patients tested after 
3-6 months.
No patients were found to have a subnormal 
prolactin response to stimulation (peak less than 40 0 
mU/L). Three patients had peak levels between 400-500 
mU/L during their first test and one of these patients 
continued to have peaks of a similar magnitude during 
subsequent tests. His basal levels were all less than 
the lower limit of the assay (10 0 mU/L). The results of 
his other stimulation tests were normal.
120
An exaggerated response to stimulation (peak 
greater than 2000 mU/L) did not occur in any subjects 
within 24 hours of injury. Within 1-3 days 4 patients 
had an exaggerated response which had persisted in 2 
patients and developed in a further 3 patients 1 week 
later. Only 1 patient continued to have an exaggerated 
response after 3-6 months. An elevated basal level was 
associated with 4 of the 10 exaggerated responses.
Female Survivors (Table 17C)
Basal Values
The mean basal level was highest on admission and 
remained above the upper limit of normal after 1 week. 
By 3-6 months the level was back within the normal 
range and was significantly less than the admission 
value (p < 0.025). The basal levels on admission and 
after 3-6 months were significantly greater than the 
corresponding basal values in the male group (both p < 
0.005), but the value obtained 1 week after admission 
was not significantly different.
Response to TRH
As noted in the male subjects the peak level 
occurred after 30 mins in each group and it was lowest 
during the admission test, although this did not reach 
significance. The female group had a greater response 
to TRH than the male group during each of the 3 tests,
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with peak, 60 and 120 min results all significantly 
higher (p < 0.001, all results).
Individual Prolactin Levels and the Response to TRH
All but 2 patients had basal prolactin levels 
outside the normal range on admission (greater than 300 
mU/L) and during the first week after injury 9 of the 
12 patients had values greater than 700 mU/L. By 3-6 
months only 1 patient continued to have a basal value 
greater than 400 mU/L. One further patient had been 
commenced on a phenothiazine and had a grossly elevated 
level (7700 mU/L). No patients had levels less than the 
lower limit of the assay on admission or after 3-6 
months.
No patients had a subnormal prolactin response to 
stimulation (peak less than 800 mU/L), although 1 
patient had a peak of 84 0 mU/L one week after injury. 
Her basal level was normal and subsequently during the 
3-6 month test her peak level became exaggerated.
An exaggerated prolactin response to stimulation 
occurred in 9 of the 12 patients (peak greater than 
3000 mU/L) at some stage after injury. Apart from the 1 
patient who had received psychotropic medication the 
elevated peak values were between 3 00 0-45 00 mU/L. An 
elevated peak value was noted 4 times on admission, 6 
times one week later and 4 times after 3-6 months. On 
all but one occasion it was associated with an elevated 
basal value.
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Menstrual Disturbances
Three females were amenorrhoeic when reviewed 
after 3-6 months and a further 3 subjects had a 
temporary menstrual upset, missing at least 1 cycle 
after injury. One of the amenorrhoeic subjects was 
taking phenothiazine medication and had a grossly 
elevated PRL level (7600 mU/L). The remaining 2 
amenorrhoeic subjects had virtually normal basal and 
peak levels after 3-6 months but 1 week after injury 
their basal and peak levels had been substantially 
elevated (both basal levels 1500 mU/L, peak levels > 
4000 mU/L) . Two of the 3 subjects with a transient 
menstrual disturbance also had elevated basal and peak 
values after 1 week (basal values 1000 and 800 mU/L), 
with normal values by 3-6 months.
Fatalities (Table 17D)
The mean basal prolactin was similar to that 
observed in the male survivors and was above the upper 
limit of normal. It was significantly less than the 
female group's basal value (p < 0.005). Although the
peak level occurred after 30 min the response was poor, 
with a mean increment of only 146 mU/L, compared to 740 
mU/L in the males and 1869 mU/L in the females. 
Consequently it was significantly less than the male 
and females peak value on admission (both p < 0.001).
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Table 17 (cont)
MEAN BASAL PROLACTIN LEVELS (mU/L) AND RESPONSE TO TRH
C Female Survivors
Basal 3 01 60' 120
Admission 510 2379 1661 918
n = 12 (430,606) (2003,2825) (1398,1972) (773,1091)
Day 7-10 395 2545 1435 768
n = 12 (330,473) (2127,3047) (1199,1718) (642,920)
3-6 month 20 2478 1468 817
n = 10 (230,342) (2032,3023) (1204,1791) (670,996)
D Fatalities (n = 12)
Basal 30' 60' 120
236 382 317 257
(193,289) (311,468) (259,389) (210,315)
Three patients had basal levels less than 
the lower limit of the assay (100 mU/L) and two 
patients had considerably elevated values (800 + 970
mU/L).
Five patients had either no response or a 
subnormal response to stimulation, including the three 
patients with basal levels less than 100 mU/L. No 
fatalities had an exaggerated response to stimulation.
Both patients who had two tests performed 
initially had elevated basal values (420 + 340 mU/L)
with normal responses to stimulation. On repeat testing 
they both had no response to stimulation with one
having a basal level less than 100 mU/L.
Summary
The mean basal prolactin level was elevated on 
admission in all 3 groups of subjects and remained 
elevated in both groups of survivors 1 week later. By 
3-6 months the mean value was back within the normal 
range. During all tests the female survivors had a 
significantly greater basal and peak level than the
male survivors and the fatalities.
The peak response occurred after 30 mins in all 
groups, although the increment was much reduced in the 
fatalities. The peak value was also significantly
reduced in the male survivors within 24 hours of
injury, although none were found to have a subnormal 
response (peak level less than 400 mU/L). In contrast a 
subnormal or absent response to stimulation was
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observed in 5 of the 12 fatalities. An exaggerated 
response to stimulation was a relatively frequent 
finding in the female survivors, occurring in half of 
them one week after injury and still present in 4 after 
3-6 months and it was frequently associated with an 
elevated basal value. No exaggerated responses occurred 
in the fatalities and it was uncommon in the male 
survivors.
Menstrual disorders were common in the female 
survivors, with 3 reporting amenorrhoea and a further 3 
noting at least 1 missed period after injury. Five of 
these subjects had substantially elevated basal and 
peak levels 1 week after injury, but only 1 subject 
(who was taking phenothiazine medication) continued to 
have a significant elevation after 3-6 months.
Relationship between Cortisol, GH and PRL levels
Within 24 hours of injury the basal GH and PRL 
levels were significantly correlated (r=0.399, p < 
0.02), but neither were correlated to cortisol. After 
1-3 days cortisol levels were lower in more severely 
injured subjects (see Injury Severity section) and 
there was a significant negative relationship between 
the cortisol level and both GH (r=-0.565, p < 0.02) and 
PRL (r=-0.493, p < 0.02). By 7-10 days a positive
correlation had become established between cortisol and 
GH (r=0.350, p < 0.025) but not with PRL. No
correlations were present after 3-6 months.
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THYROIDAL AXIS
TSH
The normal range for TSH in the radioimmunoassay 
used in the study was < 1 mU/L to 4 mU/L. Values
reported as less than 1 mU/L were substituted by 1 mU/L 
during statistical analysis. During the last 6 months 
of the study a more sensitive enzyme amplified 
immunoradiometric assay (EAIA) became available with a 
lower detection limit of 0.04 mU/L, which enabled 
values of < 1 mU/L to be used in the statistical
analysis.
Male Survivors (Tables 18A and B)
Basal Values
There was a stepwise increase in mean basal 
values, with the lowest value occurring on admission 
and the highest value after 3-6 months (p < 0.005).
There was no difference between the values obtained 
within 24 hours and 1-3 days.
One patient was found to have a basal level of 24 
mU/L within 24 hours of injury with a peak response of 
124 mU/L. Primary hypothyroidism was diagnosed (thyroid 
antibodies positive) and he was commenced on thyroxine 
therapy.
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Table 18
MEAN BASAL TSH LEVELS (mU/L) AND RESPONSE TO TRH
A Male Survivors (Mean - SEM, Mean + SEM)
Basal 301 60' 120f
Admission 1.0 13.7 9.3 4.8
n = 33 (0.9,1.1) (12.5,15.1) (8.5,10.2) (4.4,5.3)
Day 7-10 1.2 11.3 7.7 4.2
n = 33 (1.1,1.3) (10.3,12.4) (7.0,8.4) (3.8,4.6)
3-6 months 1.5 14.8 10.2 6.2
n = 21 (1.4,1.7) (13.2,16.6) (9.1,11.4) (5.5,6.9)
B Male Survivors - Admission Test Subdivided
Basal 3 0 1 601 1201
Within 1.0 14.6 9.6 5.3
24hrs (0.9,1.2) (12.6,17.0) (8.3,11.2) (4.6,6.2)
n = 15
After 1.0 13.1 9.0 4.5
1-3 days (0.9,1.2) (11.4,14.9) (7.9,10.3) (3.9,5.1)
n = 18
TSH Response to TRH
The mean TSH level rose after stimulation to peak 
at 30 mins during each of the 3 tests. The highest peak 
value occurred after 3-6 months, followed by the peak 
on admission. The 7-10 day peak, 60 and 120 min values 
were significantly less than the 3-6 month values (all 
p < 0.05). There was no difference between the
admission tests within 24 hours and those tested after 
1-3 days.
Basal TSH and the Response to TRH
Within 24 hours of injury 13 of 15 patients had 
levels reported as less than 1 mU/L (the remaining 
patients had levels of 1.1 + 1.2 mU/1) . This high
proportion gradually reduced during subsequent tests 
and within 1-3 days 9 of 18 patients, within 7-10 days 
13 of 33 patients and by 3-6 months 4 of 21 patients 
had levels less than 1 mU/L. No patients had this level 
during all 3 tests.
Only 4 of these patients with levels less than 1 
mU/L had a subnormal TSH response to TRH (peak level < 
7 mU/L). Three of them had levels less than 1 mU/L and 
a subnormal TSH response during both their admission 
test and 1 week later. The remaining patient developed 
a transient reduction in his basal level after 1 week, 
which was associated with a subnormal TSH response. The 
basal TSH concentration was determined by the more 
sensitive enzyme amplified immunoradiometric assay
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during 5 of these 7 abnormal tests. The basal values 
were subnormal on 3 occasions (0.1, 0.2 and 0.2 mU/L
NR 0.4-4 mU/L) and at the lower end of the normal range
in the remaining 2 tests (0.6 and 0.7 mU/L) . None of
the patients tested after 3-6 months had a subnormal 
response.
An exaggerated response to stimulation (peak 
greater than 27 mU/L - excluding the patient with 
primary hypothyroidism) was observed in 2 patients 
within 3 days of injury and persisted in 1 patient on 
retesting 1 week later (peak 30 mU/L) . He was not
retested at 3-6 months but 2 other patients had
developed peaks of 28-30 mU/L at that time. All 4 
patients had normal basal TSH levels at the time of 
their exaggerated response.
Female Survivors (Table 18C)
Basal Values
In contrast to the male survivors the mean basal 
values were similar in the 3 groups, with no 
significant difference noted. All means were within the 
normal range and none were significantly different from 
the corresponding means in the male survivors.
TSH Response to TRH
The peak level occurred after 30 mins and the 
highest peak occurred after 3-6 months, although it was 
similar to the peak value on admission. As noted in the
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male survivors the lowest values in response to TRH 
occurred after 7-10 days, although in the female group 
this did not achieve significance. During each of the 3 
tests the female group had higher values in response to 
TRH than the male group, but not significantly.
Basal TSH and the Response to TRH
On admission basal levels less than 1 mU/L were 
less frequent than in the male survivors, only 
occurring in 4 cases. All 4 patients had a normal TSH 
response to TRH. One week later 3 of these patients and 
2 further patients had levels less than 1 mU/L. At this 
stage one patient, with a basal level of 0.7 mU/L 
(determined by EAIA), had a borderline normal TSH 
response to TRH (peak 7 mU/L). After 3-6 months 3 of 
these patients continued to have levels less than 1 
mU/L but within the normal range (0.9, 0.9 and 0.5
mU/L). The TSH response was just within normal limits 
in the patient with the basal value of 0.5 mU/L (peak 
7.6 mU/L).
An exaggerated response to stimulation occurred in 
only 1 patient and was present during all of her 3 
tests. The peak levels were 43 mU/L on admission, 44 
mU/L after 1 week and 59 mU/L after 3-6 months. The 
basal TSH, total T4 and total T3 were within normal 
limits during the 3 tests and her thyroid antibodies 
were negative. The patient was asymtomatic when 
reviewed at 3-6 months. These findings are consistent
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with central hypothyroidism or subclinical primary 
hypothyroidism.
Fatalities (Table 18D)
The mean basal level was within the normal range 
and was not significantly different from the 2 groups 
of survivors. Although the peak level occurred 30 mins 
after stimulation with TRH the increment was much 
reduced. All values after stimulation were 
significantly less than the values in the survivors 
(peak level: p < 0.0 01 compared to male and female
survivors).
Seven of the twelve patients had basal levels less 
than 1 mU/L. Three of these patients had samples 
analysed by the enzyme amplified assay which gave 
values of 0.96, 0.12 and 0.12 mU/L (NR 0.4-4 mU/L).
Four subjects had no response to stimulation with 
TRH (all had basal levels less than 1 mU/L, including 
the 2 with values of 0.12 mU/L) and three subjects had 
subnormal responses (peak less than 7 mU/L). A further 
patient who initially had a normal response, developed 
a basal level less than 1 mU/L on retesting, with no 
response to stimulation and the second patient who was 
retested had developed a subnormal response. Thus no 
response or a subnormal response to stimulation with 
TRH occurred in 9 of the 12 fatalities.
Two of the remaining 3 patients had an exaggerated 
response to stimulation despite having normal basal 
values (peaks of 29 and 41 mU/L).
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Table 18 (Cont)
MEAN BASAL TSH LEVELS (mU/L) AND RESPONSE TO TRH
C Female Survivors
Basal 30' 60' 120
Admission 1.6 18.3 12.7 6.7
n = 12 (1.3,1.8) (15.5,21.6) (10.7,14.9) (5.7,7.9)
Day 7-10 1.5 15.0 9.2 5.5
n = 12 (1.3,1.8) (12.6,17.8) (7.8,11.0) (4.6,6.5)
3-6 month 1.4 18.4 12.6 7.7
n = 10 (1.2,1.7) (15.4,22.1) (10.5,15.0) (6.4,9.2)
D Fatalities (n = 12)
Basal 30' 60' 120’
0.9 3.3 3.1 2.4
(0.6,1.1) (2.5,4.4) (2.4,4.1) (1.8,3.2)
TOTAL THYROXINE (Tables 19 and 21)
This was lowest on admission but remained within 
the normal range. The fatalities had the lowest mean 
thyroxine level and it was significantly lower than 
both the male and female survivors admission values 
(both p < 0.025). In both groups of survivors the
admission level was significantly less than the 7-10 
day value (p < 0.025 and p < 0.0 5 in males and females 
respectively). Although the 7-10 day value was also 
greater than the 3-6 month value in both groups this 
did not achieve significance. The female group had 
higher levels than the males at each of the 3 tests but 
again these differences were not significant. There was 
no difference produced by subdividing the male 
survivors admission test results.
Subnormal thyroxine levels occurred in 8 survivors 
within 3 days of injury and remained low.in 2 patients 
when retested a week later. One of these cases (who 
remains lost to follow up) had a subnormal TSH response 
to TRH on both occasions. Another patient developed a 
low level 1 week after injury and this was associated 
with a subnormal TSH response to stimulation. When 
retested after 3-6 months his thyroxine and TSH 
response were normal. None of the 3-6 month thyroxine 
levels were subnormal.
A subnormal thyroxine occurred in 5 of the 
fatalities and was associated with a subnormal TSH
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response to TRH in 4 cases and a subnormal basal TSH 
level in 2 cases.
One patient had a transient elevation of his total 
thyroxine 7 days after injury (163 nmol/L). However his 
free thyroxine was normal (18 pmol/L) and subsequently 
his 3-6 month test was also normal.
Total Tri-Iodothyronine (T3) (Tables 20 and 21)
T3 levels reported as less than 0.5 nmol/L (the 
lower limit of the assay) were substituted by 0.5 
nmol/1 during statistical analysis.
All 3 groups had mean levels that were less than 
the lower limit of normal (1 nmol/L) on admission and 
the male survivors continued to have a subnormal mean 
level 1 week later. All subsequent mean values were 
within the normal range. Although the admission T3 was 
lower in the fatalities than the male and female 
survivors, it did not reach significance. In the male 
survivors the highest value occurred after 3-6 months 
and this was significantly greater than the two 
previous values (both p < 0.001). Similarly in the
females the 3-6 month value was significantly greater 
than the admission value (p < 0.0 01) but it just failed 
to achieve significance when compared to the 7-10 day 
value. There was no significant difference between the 
male and female results during any of the 3 tests.
Examination of individual results revealed that 
values less than or equal to 1 nmol/L (the lower limit 
of normal) occurred in 29 of 45 survivors within 3 days
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Table 19
THYROXINE LEVELS (nmol/L) 
n = 33
Males
Admission 84.5
(80.7,88.4) 
Day 7-10 96.6
(92.4,101.1) 
3-6 months 92.5
(87.6,97.7)
Table 2 0
TRI-IODOTHYRONINE LEVELS
(Mean - SEM, Mean + SEM)
Males
Admission 0.8 7
(0.82,0.93) 
Day 7-10 0.97
(0.91,1.03) 
3-6 months 1.54
(1.48,1.72)
(Mean - SEM, Mean + SEM)
Females Fatalities
90.8 70.6
(86.3.95.5) (65.4,76.8) 
104.2
(99.0,109.6)
102.8
(95.3.106.5)
(nmol/L) (n = 33)
Females Fatalities
0.79 0.70
(0.71,0.88) (0.61,0.79)
1.13 
(1.02,1.20)
1.48
(1.31,1.66)
Table 21
ADMISSION T4 and T3 SUBDIVIDED
Thyroxine Tri-iodothyronine
Within 85.8 0.93
24 hrs (n = 15) (79.7,92.3) (0.83,1.03)
Day 1-3 (n = 18) 83.4 0.83
(78.2,89.0) (0.75,0.91)
of injury, 20 of 45 survivors after 1 week and none of 
the 31 survivors tested after 3-6 months. An even
greater proportion of the fatalities had subnormal 
values on admission (9 of 12) and six had values less 
than the lower limit of the assay (0.5 nmol/L). Four of 
the 5 fatalities with a low T4 also had a low T3.
The one survivor with a transiently elevated
thyroxine level was also the only patient to have an
elevated T3 in the study (2.5 nmol/L).
Relationship between basal TSH and T4 and T3
No correlation was present between the basal TSH 
and T4 until 3-6 months after injury, when a
significant positive correlation was present (r=0.408, 
p < 0.03). In contrast a significant correlation was
present with T3 by 7-10 days (r=0.329, p < 0.04), which 
was strengthened after 3-6 months (r=0.420, p < 0.03).
Relationship between T4 and T3
The T4 and T3 were correlated at all times, with 
the higher correlation coefficients shortly after 
injury (admission r=0.694; day 7-10 r=0.539 both p < 
0.001) and the lowest after 3-6 months (r=0.495, p < 
0.01) .
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Summary
On admission there was no difference between the 
mean basal TSH in the 2 groups of survivors and the 
fatalities and in subsequent tests the two groups of 
survivors also had similar results. In male survivors 
the mean basal TSH concentration was lowest on 
admission and gradually rose in stepwise fashion to its 
highest level after 3-6 months, whereas in female 
survivors the basal level was similar during the 3 
tests. A basal TSH less than the lower limit of the 
assay (1 mU/L) was a frequent finding in male survivors 
within 24 hours of injury and in fatalities. In both 
these groups subnormal and low-normal basal TSH 
concentrations measured by EAIA were associated with an 
impaired TSH response to TRH.
The peak level in response to stimulation occurred 
after 3 0 mins in the survivors and fatalities. In 
survivors there was a reduction in the TSH response to 
TRH during the first week after injury, which was 
significant after 7-10 days in the males. The largest 
TSH response to stimulation occurred after 3-6 months.
The lowest response to stimulation occurred in the 
fatalities, 9 of whom had a subnormal or absent 
response to stimulation. Four survivors had a subnormal 
TSH response to stimulation within 10 days of injury, 
although by 3-6 months no patients were found to have 
this pattern.
Minimal elevations of the TSH response to TRH 
above the upper limit of normal were observed in 5
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patients at various times after injury. Two patients (1 
fatality and 1 female survivor) had more substantial 
peaks (41 and 59 mU/L) with normal basal levels. These
findings could be explained by central hypothyroidism 
or subclinical hypothyroidism.
Thyroxine levels were lowest in the fatalities and 
were occasionally associated with a subnormal basal TSH 
level and an impaired TSH response to TRH. In the 
survivors the lowest values occurred on admission and 
were significantly lower than the values 1 week later. 
In both groups of survivors the mean after 1 week was 
greater than the 3-6 month value (not significantly), 
suggesting that there was a rebound increase in 
production of thyroxine after the initial fall.
The T3 levels were also lowest in the fatalities 
but not significantly. In survivors the 3-6 month value 
was significantly greater than the admission value. The 
T4 and T3 were significantly correlated at all times, 
with the greatest correlation coefficients shortly 
after injury. There was no significant difference 
between the T4 levels in the males and females or 
between the T3 levels. The basal TSH was correlated to 
the T3 one week after injury and to both the T4 and T3 
after 3-6 months.
The patient found to have primary hypothyroidism 
had a thyroxine of 48 nmol/L, a T3 of 0.6 nmol/L and a 
basal TSH of 24 mU/L, which rose to 126 mU/1 after 
stimulation with TRH. He was commenced on thyroxine 
replacement therapy.
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GONADAL AXIS
FSH
Male Survivors (Tables 22A and B)
Basal Values
The mean basal values were within normal limits 
during each of the 3 tests. However as the lower limit 
of normal is poorly defined and taken as the lower 
limit of the assay, subnormal levels would not have 
been detected. The lowest mean level occurred after 7- 
10 days and it was significantly less than both the 
admission and 3-6 month values (p < 0.025 and p < 0.005 
respectively). Subdivision of the admission values 
demonstrated that the reduction in basal • FSH occurred 
within 1-3 days of injury, as there was a significant 
fall from the value within 24 hours of injury to the 
value after 1-3 days (p < 0.025). The value within 24 
hours was similar to the 3-6 month value, whereas the 
1-3 day value was similar to the 7-10 day value.
Consequently values reported as less than 1 IU/L 
(lower limit of the assay) occurred in 4 of 15 patients 
(27%) within 24 hours, rising to 8 of 18 (44%) after 1- 
3 days and 15 of 33 (45%) after 7-10 days. By 3 months
only 1 of 21 patients (5%) continued to have a level 
less than 1 IU/L.
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Table 2 2
MEAN BASAL FSH LEVELS (IU/L) AND 
A Male Survivors (Mean - SEM,
RESPONSE TO 
Mean + SEM)
GnRH
Basal 30' 60 1 120*
Admission 1.7 5.6 6.1 5.3
n = 33 (1.5,1.8) (5.1,6.1) (5.5,6.7) (4.8,5.8)
Day 7-10 1.3 2.9 3.0 2.7
n = 33 (1.2,1.4) (2.6,3.2) (2.7,3.3) (2.4,2.9)
3-6 month 2.0 4.7 4.6 4.3
n = 17 (1.8,2.3) (4.2,5.3) (4.0,5.2) (3.8,4.9)
B Male Survivors - Admission Test Subdivided
Basal 3 0 1 60' 120'
Within 2.2 6.6 8.0 6.7
24 hrs (1.9,2.7) (5.6,7.4) (6.7,9.5) (5.6,7.9)
n = 15
After 1.3 4.8 4.9 4.4
1-3 days (1.1,1.5) (4.1,5.7) (4.2,5.7) (3.7,5.1)
n = 18
FSH Response to GnRH
The peak level occurred after 60 mins, apart from 
the convalescent test at 3-6 months when the 30 min 
value was just greater than the 60 min value.
The highest peak level occurred on admission and 
it was significantly greater than the 7-10 day and 3-6 
month values (p < 0.001 and p < 0.05 respectively). In 
keeping with the fall in basal FSH the increment in
response to GnRH was much reduced 7-10 days after
injury and at this stage all values after stimulation 
were significantly less than the values on admission (p 
< 0.001) and after 3-6 months (p < 0.005). Subdividing 
the admission test results demonstrated that the peak 
value within 24 hours of injury was significantly
greater than the value after 1-3 days (p < 0.025).
However the reason for this difference was not the same 
as for basal FSH, as the peak level after 1-3 days was 
not reduced when compared to the 3-6 month value. The 
significant difference had been produced by a relative 
increase in the FSH response within 24 hours of injury.
Individual FSH Levels and the Response to GnRH
Two elderly patients had elevated basal FSH and LH 
values during all 3 tests. They both gave a history of 
loss of libido and impotence prior to their head injury 
and therefore it was considered likely that they had 
primary gonadal failure unrelated to their injury. 
Their results were excluded from statistical analysis.
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One further patient had an elevated value on admission, 
which had returned to normal one week later. Elevated 
values did not occur in any other patient.
Within 24 hours of injury a peak value of greater 
than 10.5 IU/L (the upper limit for the peak in our 
hospital's reference range) in response to GnRH
occurred in 8 of 15 patients (53%) compared to 3 of 18 
between day 1-3 (17%) , 1 of 33 one week later (3%) and 
0 of 17 after 3-6 months (0%) . The two patients with 
presumed primary hypogonadism had exaggerated responses 
during all tests and were not included in these 
results.
There was only one patient who had a peak level 
less than 1.5 IU/L (the lower limit for the peak in our 
hospital's reference range). His peak level was 
subnormal on initial testing (day 1-3) and one week
later but had returned to normal by 3-6 months. During 
the 2 tests with reduced peak levels his basal values 
were less than 1 IU/L, whereas the normal peak after 3- 
6 months was associated with a higher basal value. By 
choosing a threshold of 3 IU/L it was possible to 
demonstrate the much diminished response present after 
7-10 days. During this period 19 of 33 (58%) patients
had a peak less than 3 IU/L compared to 3 of 15 (20%)
within 24 hours, 5 of 17 (28%) within 1-3 days and 2 of
17 (12%) after 3-6 months.
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Female Survivors
Basal FSH (Table 22C)
The mean basal levels were within normal limits in 
all groups. The lowest level occurred after 7-10 days 
but it was not significantly lower than the admission 
value. Both were significantly less than the value 
after 3-6 months (admission: p < 0.05 and 7-10 days: p
< 0.025). The 3-6 month value was also significantly 
greater than the equivalent value in the male group (p
< 0.05), whereas there was no sex difference between 
the previous 2 tests.
FSH Response to GnRH
The peak value occurred after 60 mins in each 
group. The highest value following stimulation with 
GnRH was after 3-6 months but it was not significantly 
greater than the admission or 7-10 day values. The 
female group had a significantly greater peak level 
compared to the male group during each of the 3 tests 
(admission: p < 0.05, 7-10 days: p < 0.001, 3-6 months:
p < 0.001).
Individual Basal FSH Levels and the Response to GnRH
Two patients were post-menopausal and their 
results were excluded from statistical analysis. Both 
had basal values within the normal range on admission 
which had become grossly elevated by 3-6 months. Their
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FSH response to stimulation had also become exaggerated 
by 3-6 months. No pre-menopausal patients had basal 
values greater than the upper limit of normal during
any test. A value less than the lower limit of the 
assay occurred in 2 patients on admission and 3 
patients one week later.
Two patients had a subnormal response to 
stimulation with GnRH (peak less than 3 IU/L) , both on 
admission. Their basal levels were less than the lower 
limit of the assay during these subnormal responses. 
Their subsequent tests were within normal limits.
An exaggerated response occurred in 7 of 10 
subjects on admission, 4 of 9 subjects one week later 
and 3 of 8 subjects after 3-6 months. Two of the three 
patients with a persistently exaggerated response were 
amenorrhoeic and the third patient had missed 2 periods 
before her cycle had recommenced.
Fatalities (Table 22D)
Two of the male fatalities had primary gonadal 
disease and their results were excluded from 
statistical analysis. Both had grossly elevated basal 
gonadotrophin levels and an exaggerated response to 
stimulation. One patient was aged 32 years and had 
small atrophic testes at postmortem and the other was 
aged 73 years. The female fatality was also excluded 
from the analysis.
The mean basal FSH was within normal limits but 
was significantly greater than both the male and female
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Table 22 (cont)
MEAN BASAL FSH LEVELS (IU/L) AND RESPONSE TO GnRH
C Female Survivors
Basal 30' 601 120
Admission 1.6 8.6 8.8 8.0
n = 10 (1.3,2.0) (7.0,10.6) (7.2,10.8) (6.5,9.9)
Day 7-10 1.4 8.5 8.8 7.6
n = 9 (1.2,1.8) (6.8,10.5) (7.1,10.9) (6.1,9.4)
3-6 months 2.8 8.7 9.4 8.4
n = 8 (2.2,3.6) (6.9,11.0) (7.5,11.9) (6.7,10.6)
D Fatalities (n = 9)
Basal 30' 60' 120
4.3 7.7 7.8 7.3
(3.4,5.4) (6.1,9.8) (6.2,9.9) (5.8,9.3)
survivors results (p < 0.001 and p < 0.005
respectively). No fatalities had a basal level less 
than the lower limit of the assay and two had an 
elevated basal level.
The peak level occurred after 60 mins and it was 
within the normal range. It was intermediate between 
the male and female survivors but was not significantly 
different from either group. Four of the nine male 
fatalities (excluding the 2 with primary gonadal 
disease) had an exaggerated response and 1 had a 
subnormal response.
Both fatalities who were retested after 1 week had 
no change in their basal levels although their peak 
levels became lower (subnormal in one) .
Summary
Altough the mean basal FSH concentrations remained 
within normal limits in all groups the fatalities had a 
significantly greater value than the male or female 
survivors on admission. A fall in FSH levels occurred 
in the male survivors within 1-3 days of injury and 
remained low 1 week later. A similar pattern may have 
been present in the females as their admission values 
were lower than the 3-6 month values. However not 
enough females were tested shortly after injury to 
enable the admission test results to be subdivided. The 
only difference in basal values between the 2 groups of 
survivors occurred after 3-6 months when the level was 
significantly greater in the females than the males.
141
The peak value after stimulation occurred after 60 
mins in the fatalities and survivors. The male
survivors had their highest level within 24 hours of
injury, followed by a substantial reduction in the peak 
level achieved after 7-10 days. No such pattern was
apparent in the females, who had similar peak levels 
during each test. Their peak was significantly greater 
than the male survivors during each test. The peak 
value in the fatalities was intermediate between both 
groups of survivors. The 3 survivors (2F, 1M) who had 
temporary subnormal peak responses had subnormal basal 
levels during these tests (<1 IU/L). No patients had a 
subnormal response when retested after 3-6 months. 
Three female patients who had experienced disruption of 
their menstrual cycle continued to have an exaggerated
FSH response to stimulation with GnRH after 3-6 months.
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LH
Male Survivors (Tables 23A and B)
Basal Values
Although there was a stepwise increase in the mean 
basal value from admission to 3-6 months this did not 
reach significance. However subdivision of the 
admission tests demonstrated that the value within 24 
hours of injury was similar to the 3-6 month value, 
whereas the 1-3 day value was lower than all other 
basal values and was significantly reduced (p < 0.025) 
when compared to the 24 hour value. It was the only 
mean value less than the lower limit of normal (3 
IU/L). This pattern, with a reduction after 1-3 days 
maintained for 1 week, is identical to that observed 
for FSH. Consequently the majority of results less than 
the lower limit for the hospital's reference range (3 
IU/L) occurred after 1-3 days (12 of 18, 67%) and 7-10 
days (13 of 33, 39%) when compared to within 24 hours
(4 of 15, 27%) and after 3-6 months (3 of 21, 14%).
Subnormal basal levels, particularly shortly after 
injury, were frequently associated with an exaggerated 
response to stimulation.
LH Response to GnRH
During each of the 3 tests the peak level occurred 
after 30 mins and was exaggerated (greater than 
hospital reference range of 27 IU/L) on admission and
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Table 23
MEAN BASAL LH LEVELS (IU/L) AND RESPONSE TO GnRH 
A Male Survivors (Mean - SEM, Mean + SEM)
Basal 30' 601 120
Admission 3.4 40.5 34.5 26.7
n = 33 (3.1,3.8) (36.7,44.7) (31.3,38.0) (24.3,29.4)
Day 7-10 3.6 27.5 22.0 17.1
n = 33 (3.3,4.0) (24.9,30.4) (19.9,24.3) (15.4,18.8)
3-6 month 4.2 22.6 19.8 15.4
n = 17 (3.7,4.8) 20.0,25.6) (17.5,22.4) (13.6,17.4)
B Male Survivors - Admission Test Subdivided
Basal 30' 60' 120'
Within 4.5 44.7 40.6 30.5
24hrs (3.8,5.4) (32.8,53.0) (34.3,48.1) (25.7,36.1)
n = 15
After 2.7 37.3 30.1 23.8
1-3 days (2.3,3.1) (32.0,43.6) (25.8,35.1) (20.4,27.8)
n = 18
after 7-10 days. The largest response occurred within
24 hours of injury although it was not significantly 
greater than the 1-3 day value. On admission all the
values after stimulation with GnRH were significantly
greater than the 7-10 day values (all p < 0.005) and
the 3-6 month values, (all p <0.001). There was no
significant difference between the 7-10 day and 3-6
month values.
Individual Responses to GnRH (Fig. 8)
The 2 elderly patients with presumed primary 
gonadal disease had elevated basal LH levels and an 
exaggerated response to stimulation during all 3 tests. 
Their results were not included in the statistical 
analysis.
Only 1 patient had an elevated basal level
(greater than 10 IU/L) and this occurred within 24 
hours of injury. His subsequent levels were normal. 
Three patients with a subnormal basal level after 3-6 
months had a normal LH response to stimulation.
' A grossly exaggerated response of more than twice 
the normal peak (greater than 54 IU/L) occurred in 8 of 
15 (53%) patients within 24 hours, falling to 6 of 18 
(33 %) after 1-3 days, 4 of 33 (12%) after 7-10 days 
and in no patients after 3-6 months. Three patients had 
peak levels greater than 100 IU/L within 24 hours of 
injury, with the highest peak recorded at 185 IU/L. In 
the group reviewed after 3-6 months 5 of 17 (29%)
patients continued to have a peak greater than the
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normal limit (27 IU/L). These 5 patients all had an 
exaggerated response during their first test and 3 also 
had an exaggerated response during their second test.
A subnormal response (peak less than 7 IU/L) 
occurred in 2 patients. This was observed after 1-3 
days in one patient and after 7-10 days in the other 
and was associated with subnormal basal levels. Both 
patients had a normal response when retested after 3-6 
months.
Female Survivors
Basal Values (Tables 23C)
The mean basal values had the same pattern as the 
male survivors with the lowest level on admission and 
the highest level after 3-6 months, but as with the 
males there was no significant difference. However the 
values on admission and after 7-10 days were less than 
the lower limit of normal (2.5 IU/L) and were 
significantly less than the corresponding values in the 
male survivors (both p < 0.025).
LH response to GnRH
The peak value occurred after 30 mins during each 
test. The highest value after stimulation was on 
admission and it was significantly greater than the 
values one week and 3-6 months later (both p < 0.05), 
which were similar. The admission peak level was 
greater than the upper limit of normal (35 IU/L),
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whereas the 7-10 day and 3-6 month levels were within 
the normal range. There was no significant difference 
between the male and female responses during any of the
3 tests.
Individual Basal LH Levels and the Response to GnRH
The 2 post-menopausal patients had basal LH values 
within the normal range during the first week after 
injury, which became grossly elevated by 3-6 months. 
Their LH response to stimulation was also greatly 
increased after 3-6 months. Their results were excluded 
from this analysis.
After 3-6 months one patient had a basal LH level 
greater than normal, with an exaggerated LH response, 
but her menstrual cycle had returned to normal.
Subnormal basal LH values were common, occurring 
in 9 of the 10 (90%) pre-menopausal patients on
admission. Seven (70%) continued to have subnormal 
levels one week later. Three of the eight pre­
menopausal patients retested after 3-6 months had 
subnormal levels and two of them were amenorrhoeic. Two 
of the subnormal basal levels were associated with an 
exaggerated LH response to stimulation (1 of the 
amenorrhoeic subjects), with the remaining response 
within normal limits.
Despite the frequent finding of subnormal basal 
levels only one patient had a subnormal LH response to 
stimulation. This occurred after one week and was
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normal again after 3-6 months. On both occasions the 
basal level was subnormal.
An exaggerated response to stimulation occurred in 
7 of the 10 (70%) pre-menopausal patients on admission
and was present in 5 out of 9 (56%) one week later.
After 3-6 months 4 out of 8 patients continued to have 
an exaggerated response, although the maximum value had 
fallen from 272 IU/L on admission to 48 IU/L. On many 
occasions an exaggerated response was associated with a 
subnormal basal level.
Fatalities (Table 23D)
The results from the two fatalities with primary 
gonadal disease were excluded from this analysis. Both 
had elevated basal levels and an exaggerated response 
to stimulation.
The mean basal level was within normal limits, 
although it was significantly greater than both the 
male survivors (p < 0.025) and female survivors (p < 
0.001) basal values. Three of the 9 male fatalities, 
without primary gonadal disease, had an elevated basal 
level, as did the one female fatality. One fatality had 
a subnormal basal level, which was associated with a 
grossly exaggerated response to stimulation (peak 23 0 
IU/L).
The peak level occurred after 30 mins and it was 
significantly less than the peak admission values in 
both groups of survivors (both p < 0.01). Three
patients had no LH response to stimulation, with two
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Table 23 (cont)
MEAN BASAL LH LEVELS.(IU/L) AND RESPONSE TO GnRH 
C Female Survivors
Basal 30' 601 120f
Admission 1.9 49.4 44.7 31.1
n = 10 (1.5,2.4) (38.1,64.1) (34.5,58.0) (24.0,40.3)
Day 7-10 2.0 28.0 22.4 15.9
n = 9 (1.6,2.7) (21.3,29.5) (17.1,29.5) (12.1,20.8)
3-6months 3.3 28.6 22.8 17.1
n = 8 (2.5,4.4) (21.4,38.2) (17.1,30.5) (12.8,23.2)
D Fatalities (n = 9)
Basal 301 60f 120'
6.8 19.5 17.3 12.9
(5.2,8.9) (15.0,25.3) (13.3,22.5) ■ (10.0,16.8)
having normal basal levels and one having an elevated 
value. Four patients had an exaggerated response 
(including the female and excluding the subjects with
primary gonadal disease). Two of these had an elevated 
basal level, one had a normal level and one had a 
subnorma1 leve1.
The two fatalities who were retested after 1 week 
had normal basal levels during both tests. One had a 
normal response to stimulation during both tests, 
whereas the other initially had an exaggerated response 
which had become subnormal on retesting.
Relationship Between Basal FSH and Basal LH
A significant relationship was present at all 
times after injury, with the strongest correlation 
present on admission (r=0.774, p < 0.001) and the
weakest after 7-10 days (r=0.379, p < 0.02).
Summary
The mean basal LH concentration was highest in the 
fatalities and was significantly greater than both the 
male and female survivors on admission. The male 
survivors had a significant fall in level between 24 
hours and 1-3 days of injury, with the level becoming 
subnormal. However, their mean value for the first 3 
days after injury was within the normal range and was 
significantly greater than the value for the female 
survivors, which was subnormal. One week later the
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basal value remained subnormal in the females and was 
still significantly less than the males. After 3-6 
months the value had risen and there was no significant
difference between the sexes.
The peak value after stimulation occurred at 30 
mins in the fatalities and survivors. Both groups of 
survivors had exaggerated peak levels on admission, 
with a stepwise reduction to the 3-6 month values, 
which were within the normal range. The peak value in 
the fatalities was significantly less than the values 
in the 2 groups of survivors. An exaggerated response 
to stimulation shortly after injury was frequently 
associated with a subnormal basal LH concentration. 
However on 3 occasions a subnormal basal level was 
associated with an impaired response to stimulation.
Four of the 8 pre-menopausal females (one of whom 
was amenorrhoeic) and 5 of the 21 males who were 
retested after 3-6 months continued to have an 
exaggerated response to stimulation. No patients had a 
subnormal response at this time.
The basal FSH and basal LH were significantly 
correlated at all times after injury.
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MALE SURVIVORS
Total Testosterone (Tables 24 and 26)
The mean total testosterone was subnormal on 
admission and had decreased further 1 week later, 
although not significantly. By 3-6 months the value was 
back in the middle of the normal range and it was 
significantly greater than the 2 previous values (both 
p < 0.001). Subdividing the admission test results
demonstrated that within 24 hours of injury the 
testosterone concentration had begun to fall and was 
already just below the lower limit of normal. The nadir 
was reached by 1-3 days and this level was 
significantly less than within 24 hours (p < 0.001).
Examination of individual results (Fig 9) revealed 
that 8 of 15 (53%) patients had a value in the normal
range within 24 hours of injury, whereas this had 
fallen to 1 of 18 (6%) by 1-3 days and 5 of 33 (15%) by 
7-10 days. By 3-6 months 16 of 21 (76%) patients had 
values within the normal range. The 5 patients who 
continued to have subnormal values after 3-6 months had 
developed hypogonadal symptoms.
All but two of the thirty-three male survivors (3 
were excluded because of primary hypogonadal or 
thyroidal disease) had a subnormal testosterone level 
during the first week after injury. The two exceptions 
had nadirs of 11 and 12 nmol/L.
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Relationship Between Testosterone and Basal and
Stimulated Gonadotrophin Levels
During the course of the study a testosterone 
level was measured on 87 occasions in the 33 male 
survivors. One third of these levels (29) were within 
the normal range and only four of these were associated 
with a subnormal basal LH level and one with a basal 
FSH less than 1 IU/L. The remaining two thirds (58) of 
testosterone levels were subnormal and could be divided 
into one half (29) with normal basal LH levels and one 
half (29) with subnormal basal LH levels. An FSH level 
less than 1 IU/L (the lower limit of normal) occurred 
in 26 of the 58 cases with a subnormal testosterone and 
in 18 of the 29 cases with a subnormal LH and
testosterone. Thus a normal testosterone level was 
rarely associated with a subnormal basal gonadotrophin 
level, whereas a subnormal testosterone level was 
associated with a subnormal basal LH in half the cases 
and a basal FSH less than 1 IU/L in just under half the 
cases.
An exaggerated peak FSH level occurred 12 times
and was associated with a normal testosterone on 6
occasions and a subnormal testosterone in the remaining 
6 cases. On each occasion an exaggerated peak LH 
response was also present.
An exaggerated peak LH level occurred 47 times and 
was present on 14 of the 29 occasions that the
testosterone level was normal and on 33 of the 58 
occasions when the testosterone was subnormal.
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Fatalities
The mean testosterone was significantly greater in 
the fatalities (p < 0.001). Only one fatality had a
subnormal level on admission (5.4 nmol/L), although 
both patients that were retested had developed low 
levels by the time of the second test (4.4 and 2.4 
nmol/L). At the time of the low testosterone levels all 
three patients had no FSH response to stimulation and 
two had small LH increments (3.0 rising to 5.2 IU/L and 
3.3 rising to 4.5 IU/L).
Patients with Persistent Hypogonadism
There were 5 patients, with no previous history of 
hypogonadism, who continued to have a subnormal
testosterone level after 3-6 months, which was 
associated with the development of hypogonadal 
symptoms. None of them had elevated basal LH or FSH 
levels at any stage. At 3-6 months two had a subnormal 
basal LH level and three had a normal level. Three
continued to have an exaggerated LH response to
stimulation.
Relationship Between Basal LH and Testosterone
Concentrations
There was a strong correlation between the basal 
LH level and the testosterone concentration on 
admission (r=0.614, p < 0.001). The correlation just
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failed to achieve significance 1 week later (r=0.283, p 
< 0.055) and was no longer present after 3-6 months.
Free Testosterone (Table 25 and 26)
In 17 patients free testosterone was measured on 
admission and one week later and in 10 of them it was 
also measured after 3-6 months. The free testosterone 
level is age dependent with a normal range of 60-140 
pmol/L between 20-30 years and 40-100 pmol/L between 
6 0-70 years.
The mean value on admission was subnormal and it 
had fallen further 1 week later. Both of these values 
were significantly less than the 3-6 month value (p < 
0.01 and p < 0.001 respectively), which was back in the 
normal range. Subdivision of the admission value 
demonstrated that there was a significant fall from the 
value within 24 hours, which was probably just
subnormal, to the value after 1-3 days which was the
lowest value recorded (p < 0.0 05).
Very low levels (less than 20 pmol/L) were not 
found in any patients within 24 hours of injury, but 
were present in 3 of 6 patients after 1-3 days, 8 of 17 
patients one week later and in 1 of 10 patients after 
3-6 months.
Three of the five patients who had low total
testosterone values after 3-6 months and hypogonadal 
symptoms also had free testosterone measured. One
result was grossly subnormal (7.5 pmol/L) and the other
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two patients had values at or just below the lower 
limit of normal (50 and 51 pmol/L).
The free and total testosterone values were highly
significantly correlated (r=0.868, p < 0.001).
Female Survivors 
Oestradiol (Table 27)
The oestradiol concentration was within normal 
limits for the follicular phase on admission and after 
3-6 months, with the lower value on admission but not 
significantly. However after one week the level was 
subnormal and significantly less than the 3-6 month 
value (p < 0.05). The one female fatality had a level 
at the lower limit of normal.
Female Survivors With Menstrual Irregularities
One female was post-menopausal and one was peri- 
menopausal with a history of irregular periods prior to 
injury. Eight of the ten pre-menopausal females were 
reviewed after 3-6 months. Two reported no menstrual 
upset, three missed 1-3 periods before their cycle was 
re-estabished and three remained amenorrhoeic.
The oestradiol level was subnormal in the three 
patients with amenorrhoea. Their basal and peak FSH 
levels were normal at 3-6 months, but two continued to 
have subnormal basal LH levels and one also had an 
exaggerated LH response to stimulation (the patient 
with pronounced hyperprolactinaemia).
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Table 24 TOTAL TESTOSTERONE LEVELS (nmol/L)
Males Fatalities (n=12)
Admission n=33 5.4 (4.8,6.2) 15.1 (12.1,18.8)
Day 7-10 n=33 4.1 (3.6,4.7)
3-6 months n=21 15.8 (13.4,18.5)
Table 25 FREE TESTOSTERONE LEVELS (pmol/L)
Males
Admission n=17 36.1 (31.0,42.1)
Day 7-10 n=17 25.0 (21.4,29.1)
3-6 months n=10 69.2 (57.6,83.6)
Table 26 ADMISSION TOTAL AND FREE TESTOSTERONE LEVELS 
SUBDIVIDED
Total Testosterone Free Testosterone
Within 24hrs 9.6 (8.3,11.1) 49.6 (43.1,57.1)
n = 15 n = 11
After 1-3 days 3.4 (3.0,3.?) 20.0 (16.6,24.2)
n = 18 n = 6
Table 2 7 OESTRADIOL LEVELS (pmol/L)
Admission n=10 109 (92,120)
Day 7-10 n=9 77 (65,91)
3-6 months n=8 124 (102,149)
Summary
Gonadal steroid concentration fell after injury in 
both the male and female survivors. The mean oestradiol 
level was subnormal in the female group tested one week 
after injury and the testosterone level was subnormal 
in the male groups tested within 24 hours, after 1-3 
days and one week later. The fatalities had a 
significantly greater testosterone level than the male 
survivors.
The free and total testosterone concentrations 
were strongly correlated after injury and the basal LH 
was significantly correlated to the testosterone 
concentration on admission.
Subnormal testosterone levels were frequently 
associated with a subnormal basal LH and a basal FSH 
less than 1 IU/L, whereas normal testosterone levels 
were rarely accompanied by low basal gonadotrophin 
values. The proportion of times an exaggerated peak 
gonadotrophin concentration occurred was similar 
whether the testosterone level was normal or subnormal 
and appeared to be more dependent on time since injury 
than testosterone level.
Persistent hypogonadism was present in 8 (5 males,
3 females) of the 31 patients retested after 3-6 
months. The 3 females were amenorrhoeic and the 5 males 
reported impotence and loss of libido. All 8 had low 
gonadal steroid concentrations, 5 had subnormal basal
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LH concentrations and 4 had an exaggerated LH response 
to stimulation.
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RELATIONSHIP BETWEEN BASAL HORMONE LEVEL AND THE SIZE
OF THE INCREMENT IN RESPONSE TO STIMULATION WITH ITS 
RELEASING FACTOR
Cortisol
In the male and female survivors combined the 
basal cortisol levels were negatively correlated to the 
cortisol increment after CRH on admission, (r=-0.705, p 
< 0.001), after 7-10 days (r=-0.265, p < 0.04) and
after 3-6 months (r=-0.699, p < 0.001).
GH
In male survivors there was a close positive 
correlation on admission and 1 week later between the 
basal GH level and the GH increment (r=0.491, p < 0.004 
and r=0.552, p < 0.001 respectively), which was
maintained if the female survivors were also included 
(r=0.298, p < 0.04 and r=0.476, p < 0.001
respectively). No relationship was present after 3-6 
months.
PRL
There was no relationship observed on admission or 
after 1 week in either group of survivors. However by 
3-6 months both groups had established a significant 
positive correlation (males r=0.481, p < 0.02; females 
r=0.714, p < 0.025).
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TSH
In male survivors many of the results on admission 
were less than 1 mU/L and most had not been measured by 
the EAIA, so no correlation was attempted at this time. 
However a positive correlation was observed on 
admission in the female survivors (r=0.639, p < 0.02). 
One week later a significant correlation was observed 
in both groups (males r=0.334, p < 0.03: females
r=0.779, p < 0.005) and was still present after 3-6
months (males r=0.422, p < 0.03: females r=0.800, p <
0.005).
FSH
A highly significant positive correlation was 
present on admission in both the male and female 
survivors (r=0.630, p < 0.001 and r=0.742, p < 0.003 
respectively). After 1 week only the male survivors 
continued to have a significant correlation (r=0.39 6, p 
< 0.02) and by 3-6 months no relationship was present 
in either group.
LH
The only significant correlation between these 2 
variables occurred on admission in both groups of 
survivors (males r=0.299; females r=0.510 both p < 
0.05). After 1 week and 3-6 months no relationship was 
present.
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Summary
At all stages after injury there was a significant 
negative relationship between the basal cortisol level 
and the size of the increment in response to CRH, 
whereas TSH was positively correlated to its increment 
at all stages. During the first week after injury GH, 
FSH and LH were correlated to their increment but no 
relationship was present after 3-6 months. In contrast 
PRL was only correlated to its increment after 3-6 
months.
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THE RELATIONSHIP BETWEEN INJURY SEVERITY AND HORMONE
CONCENTRATIONS
Cortisol
The injury severity was compared to the basal and 
peak cortisol levels in the 3 groups of subjects. The 
GCS was used to determine injury severity but as high 
scores indicate mild injuries and low scores severe 
injuries, it is inversely related to injury severity. 
As it is the relationship with injury severity that is 
under study all correlation coefficients calculated 
using the GCS have had their sign changed in this and 
subsequent sections.
Initially no correlation appeared to be present on 
admission in male survivors, but subdividing the 
admission tests revealed significant relationships. In 
those admitted within 24 hours of injury there was a 
positive correlation between injury severity and both 
the basal and peak cortisol levels (r=0.578, p < 0.01 
and r=0.544, p < 0.02 respectively). However at 1-3
days a negative correlation was found between the basal 
cortisol and injury severity (r=-0.488, p < 0.03). By 
7-10 days a positive correlation had been re­
established (r=0.369, p < 0.02). No relationship was
observed in the female survivors at any stage, in the 
fatalities or in the male survivors after 3-6 months.
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GH levels
There was a strong correlation in male survivors 
between injury severity and the basal GH level during 
the first week after injury. The highest correlation 
coefficient occurred within 24 hours of injury 
(r=0.719, p < 0.002) and the relationship remained
strong after 1-3 days (r=0.54 8, p < 0.02) and 1 week 
later (r=0.504, p < 0.002). There was no correlation
observed in the female survivors at any stage or in the 
fatalities. Combining the 2 groups of survivors 
resulted in the loss of all significant relationships. 
The only relationship between the peak GH level and 
injury severity was observed on admission in the male 
survivors (r=0.3 98, p < 0.02).
PRL levels
In both male and female survivors the basal PRL 
level was correlated to the injury severity on 
admission (r=0.433, p < 0.01 and r=0.545, p < 0.04
respectively). One week later there was a significant 
correlation in the male survivors only (r=0.337, p < 
0.03) .
The peak PRL value had an even stronger 
relationship with injury severity in the male survivors 
(on admission r=0.472, p < 0.003; after 1 week r=0.596, 
p < 0.001), although no correlation was present in the 
female survivors.
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TSH levels
No correlation was present between the injury 
severity and the basal TSH level in any of the groups 
of subjects at any time (although for the reasons 
stated previously no correlation was attempted for the 
male survivors on admission). However on admission the 
peak TSH was negatively correlated to injury severity 
in all subjects combined (male and female survivors and 
fatalities: r=-0.357, p < 0.004) and all male subjects 
combined (survivors and fatalities: r=-0.318, p <
0.02). No correlation was present in individual groups 
of subjects.
T4 and T3 concentrations
On admission, in the combined group of survivors
and fatalities, a significant negative correlation was 
present between T4 and injury severity (r=-0.331, p < 
0.01) and T3 and injury severity (r=-0.334, p < 0.01). 
This relationship persisted in the survivors 1 week
later (T4: r=-0.337, p < 0.02. T3: r=-0.242, p < 0.05) 
but was lost by 3-6 months.
Gonadotrophin levels
The only relationship between FSH and injury 
severity occurred in the male survivors after 7-10
days, at the time of their FSH nadir. At this stage
there was a significant negative correlation between
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the injury severity and both the basal and peak FSH 
levels (r=-0.343, p < 0.03 and r=-0.368, p < 0.02
respectively). In female survivors after 3-6 months the 
basal FSH level just failed to achieve significance 
(r=-0.582).
There was no relationship between the injury 
severity and basal or peak LH levels in the male 
survivors at any time or in the fatalities. However in 
the female survivors after 3-6 months a significant 
negative correlation was achieved for both the basal 
and peak LH (r=-0.64 0, p < 0.05 and r=-0.788, p < 0.01 
respectively).
Testosterone + Oestradiol Concentrations
On admission there was a significant negative 
correlation (r=-0.315, p < 0.04) between injury
severity and testosterone in the male survivors. No 
relationship was present in the fatalities or during 
later tests in the survivors.
There was no relationship between injury severity 
and the oestradiol concentration at any time.
Summary
There was a significant positive relationship 
between injury severity and the basal cortisol level 
within 24 hours of injury and after 1 week, but a 
negative correlation was present after 1-3 days.
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In addition injury severity was positively 
correlated to the basal GH, basal PRLf peak GH, peak 
PRL and peak cortisol levels on admission and the basal
and peak PRL levels 1 week later.
A negative correlation was present between injury 
severity and T3, T4 f testosterone and peak TSH levels
on admission and with T4, T3, basal and peak FSH levels
1 week later.
No relationship was observed with the LH levels in 
the male survivors or fatalities, although injury 
severity was significantly negatively correlated to 
both the basal and peak LH in female survivors after 3- 
6 months.
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HISTOPATHOLOGICAL STUDY
Large infarcts were present in the anterior 
pituitary glands, of 9 cases (Fig 10), no subjects had a 
medium-sized infarct and a small infarct was present in 
1 .case. Thus all 10 anterior pituitary glands available 
for study had evidence of infarction, (two cases were 
mislaid). The large infarcts were centrally situated, 
with a thin layer of cells surviving under the capsule 
and adjacent to the posterior lobe. Pituitary stalk 
transection occurred in 1 case and it was associated 
with a small pituitary infarct. This subject died 
shortly after injury (5 hours), which may not have 
allowed time for a more substantial pituitary infarct 
to have developed.
The posterior lobe was normal in 9 of the 10 
specimens. In 1 case a small infant was present.
Damage to the hypothalamus was relatively mild, 
with occasional petechial haemorrhages in the 
supraoptic or paraventricular nuclei (6 cases), median 
eminence (3 cases) and the stalk (2 cases). Small areas 
of infarction were also present in the median eminence 
in 2 cases.
Skull Fractures and Pituitary Histology
Skull fractures were present in 9 of the 
fatalities and 6 had multiple fractures involving the 
base of the skull, 3 of which extended into the 
pituitary fossa. Five out of these 6 subjects had large
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Figure ro Large anterior pituitary infarct
Posterior pituitary
'
pituitary infarcts. The one exception had a fracture 
through the pituitary fossa but only a small pituitary 
infarct, although the pituitary stalk was transected.
Large pituitary infarcts were also observed in the 3 
remaining subjects who had single fractures, which 
involved the occipital bone and the parietal bone (2 
subjects). The pituitary gland was available in 1 of 
the 3 subjects who did not have a skull fracture and it 
had a large infarct.
Direction of Injuring Force and Pituitary Histology
In 6 cases the impact was predominantly in the 
antero-posterior plane and in the remaining 6 cases the 
main impact was from the side. Of the 9 pituitary 
glands with large infarcts 4 came from subjects who 
were injured in the antero-posterior direction and 5 
came from subjects injured by a lateral force.
Immunocytochemistry
This study was performed on 7 of the 10 anterior 
pituitary glands from the head-injured fatalities and 3 
control glands from subjects who had died from cardiac 
disease. In glands from the head-injured subjects 
staining for ACTH, TSH, PRL and FSH tended to be 
restricted to the periphery of the gland, in areas of 
surviving tissue. In contrast staining for GH was 
similar to that in the control subjects, with a 
positive reaction throughout the gland. Staining for LH
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was negative in 6 of the 7 head-injured subjects, but 
positive in the control subjects.
No relationship was observed between hormone 
levels and the extent of the staining, although the 
degree of staining was not assessed quantitatively.
Results of Pituitary Stimulation Tests
The endocrine results from the fatalities have 
already been presented separately for each axis, but in 
order to enable comparison with the histology, a 
further brief summary is included (Table 28) . The TSH 
and PRL responses were frequently deficient, whereas 
the gonadotrophin responses were usually preserved. 
Four subjects had an impaired GH response and 5 
patients with cortisol levels less than 400 nmol/L and 
a subnormal response to stimulation with CRH were 
considered to be glucocorticoid deficient.
Analysing individual patient results demonstrated 
that 5 subjects had 4 or more deficient hormone 
responses to stimulation, 4 subjects had 1-3 deficient 
responses and the remaining 3 subjects had no deficient 
responses. The 2 patients, who were retested 1 week 
later, had both undergone marked deterioration in their 
pituitary response to stimulation.
Endocrine-Histological Comparison
Six of the 9 subjects with large anterior 
pituitary infarcts had multiple (2 or more) impaired
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Table 2 8
RESPONSE TO RELEASING FACTOR STIMULATION (FATALITIES) 
n = 12
, No response Subnormal response Total
TSH 6 2 8
PRL 5 1 6
Cort* 4 1 5
GH 3 1 4
FSH 3 0 3
LH 2 1 3
* excluding patients with a basal level greater than 
500 nmol/1
hormone responses to stimulation. Two of the remaining 
3 cases with large infarcts had normal dynamic tests 
and 1 had a deficient TSH response only. The subject 
with the small infarct and pituitary stalk transection 
had disruption of all axes with no hormone response to 
stimulation.
One of the 2 subjects in which only the 
hypothalamus was available had multiple hormone 
deficiencies and an infarct involving the median 
eminence. The other subject had normal dynamic 
endocrine tests and no significant hypothalamic damage.
Multiple deficient hormone responses were present 
in 5 of the 6 subjects with fractures involving the 
base of the skull, 2 of the 3 subjects without a skull 
fracture and in 1 subject with a parietal fracture.
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DIABETES INSIPIDUS
This occurred much more frequently in the 
fatalities than the survivors. Five of the 12 
fatalities developed it after injury, whereas it was 
detected in only 2 of the 48 survivors. The delay 
before its onset was quite variable in the fatalities, 
with 2 developing it within 24 hours of injury and the 
remaining 3 developing it after 3-5 days. In 4 of the 
fatalities the diagnosis was made from the fluid 
balance, plasma electrolytes and urine and plasma 
osmolalities. The DI persisted in all 4 cases and 
required treatment with DDAVP. The fifth fatality had a 
transient increase in urine output on day 4-5 
associated with an increase in plasma sodium 
concentration. Although urine and plasma osmolalities 
were not checked it is likely that this subject had 
temporary DI, which did not require treatment with 
DDAVP.
Both survivors that developed DI were female and 
neither required treatment with DDAVP. In 1 subject it 
occurred 48 hours after injury and had resolved within 
a further 24 hours. The second subject was noted to be 
passing large volumes of dilute urine within 12 hours 
of injury, which returned to normal during the next 12 
hours. Urine and plasma osmolalities were checked in 
both cases to confirm the diagnosis of DI. When 
reviewed after 3-6 months neither case had noted a 
recurrence of their DI.
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Endocrine Findings in Subjects with Diabetes Insipidus
In the 2 survivors with transient DI there were no 
associated anterior pituitary hormone deficiences. As 
observed. in many other survivors who did not develop 
DI, a subnormal T3, an elevated basal PRL level and an 
exaggerated LH response to GnRH were present. In 
contrast deficient anterior pituitary hormone responses 
to stimulation were present in many of the fatalities 
with DI, although similar abnormalities were present in 
fatalities who did not develop DI. Only 1 fatality with 
DI was found to have normal dynamic testing, although 
as DI did not occur until 3 days after the test, he 
might also have developed anterior pituitary 
deficiences by that stage.
Pathological Findings in Fatalities with Diabetes 
Insipidus
Vasopressin is synthesised in the supraoptic and 
paraventricular nuclei of the hypothalamus and is 
transported down the supraoptic-hypophyseal tract to 
the posterior pituitary, where it is stored until 
required. The rapid development of DI in 2 fatalities 
(within 24 hours of injury) suggests that their 
pituitary store may have been damaged as well as the 
hypothalamic sites of synthesis and in 1 of these 
cases, in which the posterior pituitary was available, 
areas of infarction were present in the neurohypophsis.
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In contrast histological examination of the posterior 
pituitary was unremarkable in the subjects in whom the 
onset of DI was delayed for 3-5 days. Hypothalamic 
histology was similar in all the subjects, with small 
petechial haemorrhages involving the supraoptic and 
paraventricular nuclei. In addition 2 subjects had 
small areas of infarction in the median eminence.
Direction of Injuring Force
Definite evidence of skull impact in the antero­
posterior plane was present in 6 of the 7 subjects with 
DI. In 2 of the fatalities, who did not have a skull 
fracture, the only evidence of head injury was facial 
bruising, 3 other subjects had facial fractures and the 
sixth subject had a large occipital fracture and 
haematoma. The final subject did not have a skull 
fracture but the impact appeared to have been from the 
side, involving the tempero-parietal region. It is 
interesting to note that 3 of the 5 fatalities with DI 
did not have a skull fracture.
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C H A P T E R  4
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INVESTIGATION OF THE PULSATILE RELEASE OF LH
Our results demonstrate that the typical hormonal 
pattern in the gonadal axis after head injury is a low 
gonadal steroid concentration, a subnormal or low- 
normal basal gonadotrophin concentration and an 
exaggerated gonadotrophin response to stimulation with 
GnRH. The combination of a low end-organ hormone 
concentration with normal basal pituitary trophic 
hormone levels but an exaggerated pituitary hormone 
response to stimulation is typical of hypothalamic 
dysfunction. The hypothalamus is thought to contain the 
site responsible for GnRH pulse generation, posssibly 
in the arcuate nucleus (Clarke and Cummins, 19 87) and 
therefore hypothalamic dysfunction can result in 
abnormal or absent gonadotrophin pulsatility with 
consequent hypogonadism. In order to further 
investigate the possibility of hypothalamic dysfunction 
being responsible for the observed abnormalities in the 
gonadal axis, the pulsatile release of LH has been 
studied in a group of head-injured patients.
METHODS OF PULSE ANALYSIS
A review of the endocrine literature reveals that 
there is no standard method of pulse analysis. Several 
factors are important in maximising the identification 
of gonadotrophin pulsations including frequency of 
blood sampling, method of pulse analysis and assay 
precision.
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The frequency of sampling has been performed every 
20 mins in some studies (Santen and Bardin, 1973) and 
every 2-3 mins in other studies (Veldhuis et al, 19 86). 
Crowley et al (1985) performed 5 min sampling and then 
analysed his results missing out 3 in every 4 samples 
(to mimic 20 min sampling) , 2 in every 3 samples (15
min sampling) and alternate samples (10 min sampling). 
He clearly demonstrated that many pulses were missed at 
sampling intervals of 15 or 20 mins, with little 
difference between 5 and 10 min intervals. Recently 
Veldhuis et al (1986) has shown that to capture 90 % of 
pulses sampling should be every 2-3 mins for 24 hours, 
although the volume of blood required makes this 
impractible for many subjects. Clayton (1987) reported 
that a suitable compromise is a 10 min sampling 
frequency with as long a duration as possible.
The most commonly used method of pulse analysis is 
that suggested by Santen and Bardin in 1973, which 
employs a fixed threshold criterion. A significant peak 
is present if there is a 20 % or greater increase in 
hormone concentration above a preceding nadir. As 
sampling is now performed more frequently it has been 
suggested that with 5 or 10 min sampling the 2 0 %
increment above the nadir should be present in at least 
2 consecutive timepoints (Crowley et al, 1985). It was 
hoped this method would limit false-positive LH pulses 
to less than 1 %, but Veldhuis et al (19 85) has
demonstrated a sixfold increase in the number of false- 
positive pulses if the intra-assay coefficient of
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variation is 8 % compared to 5 %. Thus he has proposed 
a further refinement of Santen and Bardin's technique 
by defining the pulse detection threshold in terms of
the intra-assay measurement error, which varies with 
the hormone concentration, enabling the threshold to be 
adjusted according to the LH concentration. This method 
reduces both the number of false-positive pulses and 
the number of true-positive pulses which are 
overlooked.
A second approach to the problem of pulse 
identification is to use the sensitive statistical 
technique of time series analysis (Clark et al, 1987). 
This consists of spectral analysis, which tests the 
data for a potentially infinite number of cycles each 
having a different frequency. In practice the spectrum 
usually shows either a featureless form indicating no 
clear periodicity or one or more dominant peaks 
indicating periodicity with the corresponding 
frequency. Thus spectral analysis should give some 
indication of the periodicity of any pulsatility in the 
data. To safeguard against reporting spurious 
periodicities and also to give a fitted model for the 
data it is advisable to perform a periodic regression 
analysis or harmonic analysis (Clark et al, 1987) . This 
technique assumes a regular periodicity and may be less 
sensitive if pulses are irregular. However studies 
using this technique (Murdoch et al, 1985; Bannister et 
al, 1986; Clark et al, 1987) have reported shorter 
periodicities than those obtained by using threshold
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methods, indicating the increased sensitivity of this 
technique.
Recently a different approach to pulse 
identification, developed from the field of 
chromatography, which may be even more sensitive than 
time series analysis, has been reported (Oerter et al,
1986). There is an enormous literature on the detection 
of peaks in chromatography and resolution of 
overlapping peaks is a frequent problem, but this vast 
experience in peak detection has not previously been 
adapted for use in endocrinology. Computer programs for 
chromatographic peak detection will often work 
remarkably well when applied to a series of hormone 
measurements. However their performance can be
dramatically improved by incorporating several
characteristics of the endocrine data into the program, 
such as drifting baseline, circadian rhythm, sharp 
upstroke and trailing exponential downstroke. The
program devised by Oerter et al (19 86), called 
"Detect", is based on 2 programs they developed for 
identification of chromatographic peaks. It contains 
sections dealing with estimation of measurement error, 
setting tolerances for derivatives and peak detection, 
which identifies significant upstrokes and downstrokes 
taking into account the standard error of observations 
and of the first and second derivatives. It also has 
the facility to estimate peak shape, half-life of the 
peaks decay and the instantaneous secretion rate. This 
method avoids using artificial or arbitrary criteria,
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which are present in all other methods of pulse 
analysis and every threshold or decision is derived in 
more than one manner, so that this technique should
produce less false positive peaks while being very 
sensitive.
Assay precision is the final factor which 
influences pulse identification. As the basic problem 
of pulse analysis is one of recognising a small signal 
against a noisy background any factor which reduces 
this noise (increased assay precision and reduced 
crossreactivity) will improve pulse detection.
PATIENTS AND METHODS
Informed consent was obtained from relatives 
before inclusion in the study. The protocol was 
approved by the Addenbrooke's Hospital Ethical 
Committee.
Patients
The study was performed on 5 male patients 
admitted to the Head Injury Unit with a major head 
injury. Details of the patients age, duration of PTA, 
Glasgow Coma Scale scores, site of skull fracture, 
neurological status at the time of the pulsatility 
study and neurological complications are shown in Table 
29.
Four of the 5 patients required assisted ventilation 
and they received pancuronium and phenoperidine.
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In all patients antibiotic cover was provided by 
flucloxacillin, ampicillin and metronidazole and once 
patients were breathing spontaneously analgesia was
achieved with codeine phosphate. No patients received 
mannitol or glucocorticoids.
The control group consisted of 6 healthy age- 
matched males.
Hormone Assays
LH was measured by an immunoradiometric assay 
(MAIACLONE, Serono Diagnostics, Woking) standardised 
against WHO 68/40 and with an interbatch coefficient of 
variation of 5.9% at 7 IU/L and of 5.5% at 46 IU/L. The 
normal range of this assay for male subjects is 1.8 - 
10 IU/L.
Testosterone was measured by ether extraction 
followed by radioimmunoassay using reagents from St 
Thomas*s Hospital, London.
Experimental Protocol
Samples were taken for testosterone and LH within 
24 hours of injury (Day 1) in all but 1 patient who was 
transferred from another hospital, in whom the first 
sample was taken 40 hours after injury. Daily samples 
were then obtained for the next 4 days (Day 2 to Day 
5), with further samples between Day 10-14 and after 3- 
6 months.
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Combined releasing factor tests were performed as
in the main study (on admission, after 1 week and 3-6 
months).
The pulsatility study was performed between Day 6- 
10, with sampling commencing between 6-7 AM. Blood was 
taken without stasis via an indwelling venous cannula 
at intervals of 5 minutes for 4 hours after which 
sampling was at 15 minute intervals for a further 2 
hours.
Pulse analysis was performed using a fixed 
threshold technique, time series analysis and the 
"detect" program. For the threshold method an LH pulse 
was defined as an increment in LH concentration from 
nadir to peak of greater than 20•% in two or more 
consecutive samples and the pulse amplitude was 
calculated as the difference between the peak and the 
preceding nadir.
All blood sampling, LH hormone assays and pulse 
analysis using the threshold method and the "detect" 
program were performed by myself.
Results
(1) Testosterone and time since injury (Fig 11)
As noted in the main study there was a significant 
fall in testosterone to subnormal levels after injury. 
The mean value was back within the normal range by 3-6 
months. The levels on day 2, 3 and 10-14 were all
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Figure 11 Testosterone and time since injury
24-1
20-
Controls
16-
Patients
Testosterone
(nmol/L)
12-
Lower limit 
of normal range
4 -
NSP<0.01P<0.01NS P<0.01
Significance compared to control group
t Day 14 3 MonthsDay 3Day 2Day 1
Time since injury
significantly less than the day 1 and 3-6 month values 
(all p < 0.01) and the mean control value (p < 0.01).
(2) LH and time- since injury (Fig 12)
The basal LH was highest on day 1 and was
significantly greater than all subsequent patient 
values (p < 0.01), except the 3-6 month value. It just 
failed to reach a significantly greater level than the 
mean control value (p < 0.06). The patient's mean value 
then progressively fell to a nadir on day 4, followed 
by a gradual rise to the 3-6 month value. The values 
from day 2 to day 10-14 were all significantly less
than the control mean (all p < 0.01). The 3-6 month
value was similar to the control mean.
(3) Peak LH During Releasing Factor Stimulation Test 
. (Table 30)
The pattern observed in the main study was
repeated in these patients with the highest peak 
occurring on admission. Although the peak value was 
outside the normal range in 4 patients on admission the 
mean value was not significantly greater than the 
values after 1 week or 3-6 months.
(4) Basal LH During Pulsatility Study
Each subject had 55-60 samples taken during the 6 hours 
of the pulsatility study and their mean LH value was 
calculated (Table 31). The mean value was
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Figure 12 LH and time since injury
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Table 3 0 PEAK LH (IU/L) DURING RF TEST
Admission Day 7-10 3-6 months
JF 56 IU/L 33 IU/L 22 IU/L
AW 50 " 30 " 17 "
RM 31 " 25 " 29 "
PW 35 " 12 " 18 "
GM 6 " 19 " 25 "
Mean ± SEM 36 ± 9 24 ± 4 22 ± 2
Table 31 MEAN LH DURING PULSATILITY STUDY
Patients
JF
AW
RM
PW
GM
Mean LH (IU/L) Controls Mean LH (IU/L)
2.63
0.59
0.83
2.23
1.06
2.39
2.75
2.10
2.50
3.28
2.68
Mean ± SEM 1.47 ± 0.4 Mean ± SEM 2.62 ± 0.16
significantly greater in the controls (p < 0.01) / 
all 6 control subjects having mean values greater than
2 IU/L compared to only 2 of the head injury patients.
(4) Pulse Frequency (Table 3 2A + B)
Pulses were identified by the fixed threshold
f
method and the detect program and the periodicity 
the pulses was determined by time series analysis. All
3 methods of pulse analysis demonstrated that there was 
no significant difference in pulse frequency between 
the head-injured patients and the control subjects. 
Although the detect program could only be used to 
analyse the first 4 hours of results, whereas the fixed 
threshold method could be applied to the full 6 hours 
of results, the detect program consistently identified 
more pulses in both groups of subjects. It can be seen 
that a "pulse frequency" derived from the time series 
analysis method, by dividing the duration of the study 
in mins by the estimated periodicities, would produce 
values inbetween the fixed threshold and detect 
methods.
(5) Pulse Amplitude (Table 3 3 + tig 13)
The pulse amplitude was significantly smaller in 
head-injured patients by both the f:lxed thresh’ 
method (p < 0.001) and the detect method (p < 0.0/) • j 
The time series analysis method was not adapted t 
measure pulse amplitude. The detect program r o c o i . c
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Table 32A PULSE IDENTIFICATION IN PATIENTS
Fixed Detect
Patient Threshold
(Pulses/6hrs) (pulses/4hrs)
Time
Series Analysis 
(periodicity in 
mins)
JF
AW
RM
PW
GM
100
100
100
90
80
Mean 2.6 ± 0.25 5.2 ± 0.2 94 ± 4
Table 32B PULSE IDENTIFICATION IN CONTROL SUBJECTS
Subject Fixed Detect Time Series
Threshold Analysis
1 2 4 90
2 3 6 100
3 4 4 100
4 2 4 80
5 5 4 85
6 4 5 90
Mean 3.3 ± 0.5 4.5 ± 0.3 91 ± 3
Figure 13 LH pulse amplitude in patients and control 
-subjects
Pulse 3Pulse 1 Pulse 2
Control 1
LH
(IU/L)
Patient 1
Pulse 1 Pulse 2 Pulse 3
360240 300120 180
Timeimins.)
60
Table 33 MEAN PULSE AMPLITUDE (IU/L)
PATIENTS CONTROLS
Fixed Detect Fixed Detect
Threshold Threshold
JF 1.32 0.87 1 2.0 0.83
AW 0.29 0.21 2 2.3 1.07
RM 0.37 0.37 3 2.4 0.62
PW 0.80 0.57 4 2.3 1.03
GM 0.70 0.55 5 1.8 1.28
6 1.5 0.66
in±SEM 0 . 7±0 .2 0.51±0 .1 2.05±0.1 0.92-0
pulse amplitudes in both control subjects and patients 
that were smaller than those obtained by the fixed 
threshold method. The detect program revealed that 54 % 
of pulses in the head-injured patients had an amplitude 
less than 0.3 IU/L, compared to only 12 % in the 
control subjects.
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DISCUSSION
STRESS HORMONE SECTION
Three stress hormones were investigated in this 
study; cortisol, growth hormone and prolactin. Each 
hormone is initially discussed separately before a 
comparison is drawn between them.
Cortisol
The mean cortisol level was elevated shortly after 
injury, with the highest level occurring within 24 
hours. Many of the values at this time were just below 
the mean of 1200 nmol/L attained after a few hours 
maximal stimulation with ACTH in normal subjects (Eik- 
Nes et al, 1954; Christy et al, 1955), suggesting that 
the adrenals were almost maximally stimulated. By 7-10 
days the mean value was just within the normal range 
and after 3-6 months it was in the middle of the normal 
range, which is in keeping with previous workers who 
reported that 6-12 days after injury the level is at 
the upper limit of normal (Barton and Passingham, 
1981) , returning to the middle of the normal range by 
2-3 weeks (Frayn et al, 1983) . No sex difference has 
been reported for the cortisol response to injury and 
in this study similar levels were found in male and 
female survivors. Older patients (greater than 8 0 years 
old) have been reported to have a more sustained 
elevation in their serum cortisol concentration (Frayn
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et al, 1983) , although in this study no difference was 
noted at any stage between levels in younger subjects 
and the limited number of older subjects.
An important factor influencing the cortisol level 
is the severity of the injury. Although a positive 
correlation was found between the plasma cortisol 
concentration and injury severity in male survivors 
studied within 24 hours of injury, a significant 
negative correlation had developed by 1-3 days. One 
week later a positive correlation had become re­
established. Thus our study demonstrates that there is 
a transient phase between the first to third day after 
injury when more severely injured patients have 
significantly lower cortisol levels than less severely 
injured. Our study is the only one to have examined the 
relationship between injury severity and cortisol 
levels more than 24 hours after injury in a large group 
of subjects and thus no other authors have observed the 
transient reversal in this relationship.
Most previous studies have observed a positive 
relationship between injury severity and several 
variables, including plasma cortisol concentrations 
(Stoner et al, 1977; Barton et al, 1987) and the 
incidence, magnitude and duration of the cortisol 
response (Steinbok and Thompson, 19 79; Frayn et al, 
19 83). Two studies failed to detect any relationship 
between severity of injury and cortisol levels (King et 
al, 1970; Barton and Passingham, 1981), but in King's 
study lower cortisol levels were reported with less
185
severe injury, although this just failed to achieve 
significance and Barton and Passingham remarked that 
their finding of a lack of relationship with injury 
severity may have been due to the small number of 
patients in their study.
Although no other studies have reported the 
development of a negative correlation between injury 
severity and cortisol levels a few days after injury,
two previous studies (Stoner et al, 1977; Barton et al,
1987) were able to identify a small subgroup of
subjects with more severe injuries in whom there was a 
negative relationship within 24 hours of injury.
Further evidence for lower cortisol levels in the more 
severely injured was reported by Meguid et al (1974) , 
who observed that admission cortisol levels in a major 
trauma group were lower than those in a minor trauma 
group and by Carey et al (1971) who noted that plasma 
cortisol levels were lower than expected in severely 
injured battle casualties. A possible explanation for 
the lower cortisol levels in the more severely injured 
subjects could be reduced arterial perfusion of the 
adrenal cortex due to a fall in blood pressure. In our 
study although some of the more severely injured 
subjects (fatalities) had low cortisol levels, other 
severely injured subjects had high levels within 24 
hours of injury. Thus a negative relationship was not 
detected in our group of most severely injured subjects 
at this early stage.
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As one of the aims of this study was to detect any 
subjects who developed secondary adrenal failure a 
single random cortisol level would have been
insufficient, particularly in follow-up tests several 
months after injury. Therefore, in order to assess the 
integrity of the pituitary-adrenal axis our patients 
had stimulation tests performed with CRH, on admission 
and during subsequent investigations. All but 7 of the 
48 surviving patients had a basal cortisol level of 
greater than 500 nmol/L on admission, which was taken 
to represent the minimum adequate pituitary-adrenal 
stress response. Only 1 of these 7 patients with a low 
basal level also had an impaired cortisol response to 
CRH and he had probably received exogenous steroids. 
The remaining 6 subjects had less severe injuries and 
their admission to our unit was delayed, possibly
permitting time for their cortisol level to fall to 
less than 500 nmol/L. Subsequently 5 of these 6
subjects had normal levels with an adequate response to 
stimulation with CRH. The 6th subject and 1 further 
subject were found to have levels less than 500 nmol/L, 
with an increment less than 150 nmol/L, after 3-6
months. However their cortisol responses to insulin 
hypoglycaemia were normal, indicating that in these 2 
subjects CRH had not provided a sufficient stimulus to 
cortisol secretion. Therefore in the 48 surviving
patients no cases of early or late secondary 
hypoadrenalism were identified.
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At all times after injury there was a highly 
significant negative correlation between the basal 
cortisol level and the increment in response to CRH, a
finding which has previously been reported in healthy 
subjects (Hermus et al, 1984).
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Growth Hormone
The growth hormone (GH) response to injury was 
similar to the cortisol response, with the highest 
levels occurring within 24 hours. However very few 
survivors had levels greater than the upper limit of 
normal and any such elevations were transient and 
minimal, so that the mean basal level was within the 
normal range at all times. Even our subjects with the 
most severe injuries (the fatalities) rarely had 
elevated values and their mean level was similar to the 
survivors. Frayn et al (19 84 b) noted that GH levels 
were elevated above the normal range if samples were 
taken within 1 hour of injury and there was a rapid 
fall in GH following this initial elevation. Thus the 
delay in our initial sampling, even in subjects studied 
within 24 hours of injury, could explain why the mean 
GH levels were within normal limits, although a 
significant fall in GH was still detected in male 
survivors when later tests were compared to the 
admission values. A similar pattern was apparent in the 
female survivors but did not achieve significance.
A correlation between injury severity and the 
extent of the elevation in GH might seem reasonable, 
but the only studies in patients with head injuries 
have found no such relationship (Rudman et al, 1977; 
King et al, 1981) , although both studies had 
methodological faults (a small number of patients and a
189
delay in sampling). In contrast our largest group (male 
survivors) exhibited a strong correlation between 
injury severity and the basal GH level, from admission 
through to 1 week after injury. The relationship was 
different from that observed with cortisol, as there 
was a consistent positive correlation throughout the 
first week, without a reversal in the relationship 
after 1-3 days. In our 2 other groups (female survivors 
and fatalities) no correlation was present and this may 
have been because of the small numbers in each group.
Plasma GH levels after injury reflect the rate of 
GH synthesis and release from the anterior pituitary 
but more direct information on pituitary function can 
be obtained by performing dynamic tests of GH 
secretion. No previous studies have investigated the 
storage pool of GH after injury, although one study did 
report a paradoxical GH response to an intravenous 
glucose load shortly after head injury, suggesting 
abnormalities in the central control of GH secretion 
(King et al, 1981) .
The response to stimulation with GHRH was 
extremely variable, as has been reported in normal 
subjects (Thorner et al, 1983; Grossman et al, 1984), 
with a wide range of peak levels at all times after 
injury. Both groups of survivors had their lowest 
response on admission, with the male subjects having a 
significantly lower response than the females. 
Subsequently there was no sex difference. Two studies 
have reported no sex difference in the GH response to
190
GHRH (Gelato et al, 1984; Hoi et al, 1985), whereas one 
study recently observed a greater response in male 
subjects and suggested this was related to testosterone 
(Smals et al, 1986). On admission our male subjects had 
a poor GH response with a relatively higher 
testosterone concentration when compared to the 
testosterone level one week later, when the GH response 
was greater. This suggests that the testosterone 
concentration bore no relationship to the GH response 
in our study.
In contrast to cortisol, we observed that the GH 
increment in response to stimulation with its 
hypothalamic releasing factor was directly related to 
the basal GH level. However this relationship was only 
present for the first week after injury, during the 
period of maximum stress, and was no longer apparent 
after 3-6 months. Previous studies in which GHRH tests 
have been performed in healthy subjects and growth 
deficient subjects have not reported any correlation 
between the basal GH level and the increment in 
response to GHRH, although one study did report that 
subjects with a basal GH level less than 1 ng/ml had a 
significantly smaller response than those with a basal 
level greater than 1 ng/ml (Smals et al, 1986). In 
acromegalic subjects a strong correlation has been 
reported between the basal and peak GH levels after 
stimulation with GHRH (Smals et al, 1987). The changing 
relationship in our study may have arisen because 
following injury the dominant influence on the control
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of GH synthesis will be stimulation by endogenous GHRH, 
with a reduction in the inhibitory role of 
somatostatin. Thus the higher plasma GH levels will
directly reflect the increased rate of GH synthesis and 
secretion from the pituitary and, because the 
inhibitory mechanisms are switched off, the GH response 
to exogenous GHRH will be correlated to the plasma GH 
level. However after 3-6 months the inhibitory 
mechanisms will be functioning again and the 
relationship between the amount of GH released in 
response to exogenous GHRH and the basal GH level will 
be lost. Thus it appears that the correlation only 
exists when there is increased secretion, which could 
be due to stress or acromegaly.
The relationship between injury severity and the 
peak GH level was also examined and, as one might have 
expected, a significant correlation was found on 
admission, although the correlation coefficient just 
failed to achieve significance 1 week later.
During the period of the highest rate of GH 
synthesis, shortly after injury, when there is a strong 
relationship between the basal GH and its response to 
exogenous GHRH, the GH storage pool must be at its 
smallest, as the response to exogenous stimulation with 
GHRH was reduced during this period in all groups. At 
this stage plasma GH levels are highest and it is 
likely that a greater proportion of the GH storage pool 
is released with each pulse of endogenous GHRH, such 
that the pool becomes reduced in size. Later the plasma
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GH levels fall, possibly because less GH is released in 
response to endogenous GHRH, and the GH pool re- 
accumulates. This would result in a larger GH response 
to the pharmacological dosage of GHRH in the exogenous 
stimulus, when compared to the admission test results. 
This may explain why the peak level in response to GHRH 
was significantly greater by 7-10 days and had 
increased even further after 3-6 months. Similarly the 
females had their smallest response to stimulation 
shortly after injury and their greatest response during 
convalescence. Thus when the basal GH level was highest 
the response to stimulation was least and as the basal 
GH level fell the response to stimulation increased.
Steroids can inhibit the GH response to 
stimulation (Hartog et al, 1964) and our study has 
demonstrated that the subjects cortisol levels were 
highest at the time of their reduced GH response to 
stimulation. However the strong correlation between the 
basal GH level and the amount of GH released from the 
storage pool in response to GHRH suggests that an 
additional explanation for the initial reduced response 
involving cortisol is not required.
After 3-6 months no survivors were considered to 
be GH deficient, although 1 patient continued to have a 
peak level less than 10 mU/L.
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Prolactin
In this study the mean prolactin levels were elevated 
after head injury. Resting and stimulated PRL levels 
are known to be higher in females and in keeping with 
this all mean values after injury were significantly 
greater in the female group. Following injury the 
increase in basal levels was sustained for a 
considerably longer period than GH, with mean levels 
still outside the normal range after 7-10 days in both 
sexes. By 3-6 months the values had returned to within 
the normal limits. The time course suggests that after 
head injury prolactin remains elevated for a longer 
period than after surgery (McFarlane and Rosin, 198 0) 
and is more in keeping with the prolonged rise observed 
after burn injury (Brizio-Molteni et al, 1984) . The 
only study in which PRL was measured in head-injured 
subjects (King et al, 19 81) was inconclusive, probably 
because of the small number of subjects and the short 
duration of the study. PRL was measured for the first 3 
days after injury in 6 male subjects and was elevated 
in 3 of them.
Despite the difference in time-course of the 
elevation compared to GH, the relationship between 
injury severity and PRL was identical to that for GH. A 
strong correlation existed between injury severity and 
the basal PRL level on admission in both groups of 
survivors and was still present in the males (the 
larger group) one week later. As for GH no relationship 
existed several months later when the patients were
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convalescing. Although a correlation between injury 
severity and PRL level has not previously been 
investigated, Noel et al (1972) reported that subjects
undergoing major surgery had higher PRL levels than 
subjects having gastroscopy or proctoscopy. Our most 
severely injured subjects (the fatalities) did not have 
a greater PRL level than the survivors, possibly 
indicating impaired pituitary PRL secretion in the 
fatalities.
Further evidence for abnormalities in PRL 
secretion after injury came from the dynamic studies. 
There have been no previous reports on the prolactin 
response to stimulation in stressed patients. We found 
that females had the greatest response and their peak 
level after stimulation remained virtually constant at 
the various time points after injury. However in male 
survivors the peak level within 24.hours of injury was 
significantly reduced compared to later stages. The 
mechanism for this initial reduction may be the same as 
for GH, with a poor response to TRH because the PRL 
storage pool has already been discharged following 
injury. However as endogenous TRH is not thought to be 
a physiological mediator of PRL synthesis or secretion 
(Delitala et al, 19 87), stimulation tests with TRH may 
be difficult to interpret because exogenous TRH may 
have incomplete access to the PRL storage pool after 
injury. Increased cortisol levels on admission have 
been suggested as a possible mechanism for the reduced 
GH response to GHRH, but the additional presence of a
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reduced PRL response to TRH makes this unlikely, as 
cortisol is not known to have an inhibitory effect on 
PRL.
In survivors there was no relationship between the 
basal PRL level and the size of the increment in 
response to TRH during the first week after injury. 
However by 3-6 months a significant correlation had 
developed in both groups of survivors. Thus despite the 
similarities to GH with regard to injury severity and 
basal hormone level there was a completely different 
relationship during dynamic testing. As mentioned above 
this may have arisen because TRH is not a physiological 
mediator of PRL secretion and thus may have limited 
access to the PRL storage pool after injury. However 
despite these reservations the peak PRL level in 
response to TRH did have a significant relationship to 
injury severity during the first . week after injury, 
with the correlation coefficients even greater than 
those for basal PRL.
In female subjects the clinical associations of an 
elevated PRL level include galactorrhoea and 
amenorrhoea, but as yet there have been few studies of 
PRL after injury which have also examined these 
features. Hyperprolactinaemia has been said to occur 
frequently after injury to the chest wall in female 
subjects (Besser and Thorner, 1976) and there have been 
several reports of galactorrhoea after surgery to the 
chest wall (Salkin and Davis, 1949; Grossman et al, 
1950; Berger et al, 1966). In a further report a
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subject who had burns to the chest wall developed 
amenorrhoea and galactorrhoea and the elevated 
prolactin levels were reduced to normal by 
bromocriptine (Morley et al, 1977). More recent work 
(MacFarlane and Rosin, 1980) has suggested that in 
galactorrhoea induced by chest wall injury, the 
elevation in PRL is short-lived, but is able to 
initiate lactation, which continues despite the 
presence of normal PRL levels.
In our study 3 of the 8 pre-menopausal females who 
were reviewed after 3-6 months were amenorrhoeic and a 
further 3 had experienced a menstrual upset (missed 
period, irregular cycle), although none were found to 
have galactorrhoea. All but 1 of these 8 subjects had a 
PRL level of greater than 700 mU/L after injury and 
they had elevated PRL levels for a longer duration than 
the subjects reported by MacFarlane and Rosin (1980), 
who developed galactorrhoea, following chest wall 
injuries. After 3-6 months only 1 patient continued to 
have a substantial elevation of her PRL level, which 
was probably due to her psychotropic medication, and 
she remained amenorrhoeic. Of the remaining 2 patients 
with amenorrhoea neither had a significant elevation of 
their PRL level after 3-6 months, although both had 
values greater than 1000 mU/L one week after injury. A 
similar pattern was present in 2 of the 3 patients who 
had experienced a transient menstrual upset, with a 
substantial elevation one week after injury but only a 
minimal elevation after 3-6 months. The transient
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increase in PRL concentration during the first week 
after injury may have interfered with gonadotrophin 
regulation at the hypothalamic or pituitary level, 
resulting in a more prolonged menstrual upset (Bouchard 
et al, 1985). However mechanisms other than an 
elevation in PRL could have been responsible, because 
none of the 5 male subjects who were hypogonadal after 
3-6 months had substantial elevations of their PRL 
concentrations at any stage. The only male subject with 
a large elevation after injury was receiving a short 
course of treatment with metoclopramide, which was 
probably responsible for the increase. When reviewed 
after 3-6 months he was no longer receiving this drug 
and his level was within the normal range and he had no 
hypogonadal symptoms.
Summary of the Cortisol, GH and PRL responses to injury
As expected the levels of the three stress
hormones were greatest shortly after injury, at the 
time of maximum stress. Both cortisol and PRL were
raised above the upper limit of normal on admission, 
whereas GH remained within the normal range. The 
increased rate of secretion of each hormone was
maintained for at least 1 week, as their levels at this 
stage remained significantly greater than the 3-6 month 
values. In addition our study has demonstrated that the 
degree of elevation of each hormone on admission was 
significantly correlated to the severity of the head 
injury. However although GH and PRL levels were
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positively correlated to the injury severity throughout 
the first week, cortisol exhibited a temporary reversal 
of this relationship 1-3 days after injury, indicating 
that at this stage more severely injured patients had 
lower cortisol levels.
Within 24 hours of injury the GH and PRL levels 
were significantly correlated, although neither were 
correlated to cortisol. When the cortisol levels fell 
in the more severely injured subjects after 1-3 days 
there was a significant negative relationship between 
the cortisol level and both GH and PRL.
Further differences between the three hormones 
became apparent during dynamic testing. The cortisol 
response to stimulation was negatively correlated to 
the basal cortisol level at all times after injury, 
whereas the GH response was positively correlated to 
its basal level during the first week and the PRL 
response was positively correlated to its basal level 
only after 3-6 months. Thus under conditions of stress 
the normal negative feedback of cortisol on ACTH 
synthesis and release must continue to operate, so that 
in the presence of high cortisol levels there is a 
reduced ACTH and cortisol response to exogenous CRH. In 
contrast during the period of maximum stress shortly 
after injury the stimulation to GH secretion overrides 
any possible negative feedback on its own synthesis and 
a temporary positive relationship is established 
between the basal GH and its response to GHRH. A third 
type of relationship is demonstrated by PRL, with a
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transient loss of the normal positive correlation 
between PRL and its increment in response to TRH 
shortly after injury, possibly because of limited 
access of exogenous TRH to the PRL storage pool at this 
stage. By 3-6 months a positive relationship had become 
re-established. Thus the central control of each stress 
hormone is different after injury. The closest 
relationship appears to be between GH and PRL, although 
they have different responses during dynamic testing.
Despite the various changes in the stress hormone 
secretion described above there were few clinical 
sequelae in the survivors. Although 2 patients had 
subnormal cortisol responses to CRH after 3-6 months, 
they had normal responses to insulin hypoglycaemia and 
thus glucocorticoid deficiency was not apparent in any 
survivors. Whilst a reduced GH response to stimulation 
was frequently present on admission in the survivors, 
no significant abnormalities in GH secretion were noted 
after 3-6 months. The only clinical sequelae related to 
the stress hormones may have been due to 
hyperprolactinaemia, which was frequently found in the 
female survivors, and could have contributed to the 
amenorrhoea and menstrual upset observed in several of 
them.
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THYROIDAL AXIS
Thyroidal hormone levels are known to fall in a 
variety of stressful conditions (Semple, 1986) and thus 
would be expected to decrease following major head 
injury. In our study subnormal T3 levels were observed 
more frequently than subnormal T4 levels and most 
subjects with a subnormal T4 level also had a subnormal 
T3 level. Stress did not disrupt the correlation 
between T3 and T4, which was present at all stages 
after injury. The lowest mean T3 level occurred on 
admission in all 3 groups of subjects and was 
subnormal. The male survivors continued to have a 
subnormal level 1 week later. The degree of the 
reduction in T3 concentration has previously been 
related to the severity of the surgical trauma, as well 
as the prognosis (Delitala et al, 1987) and this 
relationship was confirmed in our study. Combining the 
results from all subjects it was apparent that the T3 
level was inversely related to the injury severity, 
both on admission and 1 week later. Consequently the 
fatalities had the lowest mean level, although it was 
not significantly less than the other 2 groups. A 
similar pattern was apparent for T4, with a 
significantly reduced value on admission, although it 
remained within normal limits. The T4 did not remain 
low for as long as T3 and by 1 week there was a reboijnd 
increase in T4, such that in both groups of survivors 
it was higher than the 3-6 month level (but not 
significantly). This transient increase in T4 was
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associated with a decreased TSH response to TRH one 
week after injury.
The difference in time course between the recovery 
of the T3 and T4 concentrations indicates that the 
suggested impairment in peripheral deiodination of T4 
to T3 after injury takes longer to recover than the 
decreased T4 secretion and binding inhibition of T4, 
which are responsible for the low T4. As for T3 our 
study demonstrated an inverse relationship between T4 
and injury severity on admission and 1 week later. 
Thus, as expected, the fatalities had a lower T4 than 
the 2 groups of survivors.
Most studies of the thyroidal axis after injury 
have reported normal TSH levels (Elliott and Alberti, 
1983) and a recent paper examining TSH levels after 
head injury confirmed that values remained within the 
normal range (King et al, 1981). Although Rudman et al 
(1977) reported "suprahypophyseal hypothyroidism" with 
low TSH levels their results should be interpreted with 
caution as all seven patients received large doses (24 
mg) of dexamethasone daily, a drug which is known to 
suppress the pituitary-thyroid axis. Furthermore during 
their statistical analysis all TSH values less than the 
lower limit of the assay (1 uU/ml) were considered to 
be zero, which resulted in mean values less than the 
lower limit of the assay. However the common feature of 
all these studies was that the TSH level failed to rise 
despite low concentrations of thyroidal hormones,
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indicating central abnormalities in the control of TSH 
secretion.
Accurate -information on TSH levels in non- 
thyroidal illness has only become available with the 
recent development of more sensitive TSH assays. 
Wehmann et al (19 85) and Hamblin et al (1986), 
examining critically ill patients, have reported 
subnormal TSH levels in conjunction with low thyroidal 
hormones. As the TSH levels recovered the thyroidal 
hormones increased back to normal. Our results from the 
male survivors confirm this finding, as a significant 
reduction in TSH with low thyroidal hormone levels was 
observed on admission, with subsequent return of the 
thyroidal hormone levels back to normal as the TSH 
levels recovered. Further evidence that there is a 
central defect in TSH secretion after head injury is 
provided by the inverse relationship observed between 
the peak TSH level on admission and the injury severity 
(a relationship with basal TSH levels could not be 
investigated because of the lack of a lower limit to 
the TSH assay). Thus hypothalamo-pituitary control of 
the thyroid axis is upset by head injury and may be 
responsible for the observed subnormal thyroidal 
hormone concentrations.
Although no relationship was present between the 
basal TSH level and the thyroidal hormone 
concentrations on admission, a significant positive 
correlation had developed with T3 after 1 week and was 
present with both thyroidal hormones after 3-6 months.
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Dynamic stimulation tests of TSH have not 
previously been performed in injured patients, although 
in healthy subjects there is a direct relationship
between the basal TSH level and the increment in
response to TRH (Erfurth et al, 19 84) . In the female 
survivors a strong correlation was present at all times 
after injury and in male survivors after 1 week and 3-6 
months. Examination of individual cases in which the
new, more sensitive TSH assay was used also suggests 
that the normal relationship between TSH and its 
increment appears to have been maintained after injury. 
Three of the 4 patients with subnormal TSH responses to 
TRH shortly after injury had basal TSH levels 
determined by the new assay and their values were 
grossly reduced (all less than 0.2 mU/L) - the fourth
patient had a basal level < 1 mU/L by the old assay.
During subsequent tests although 2 of the patients 
still had subnormal TSH responses when their basal 
levels were just within normal limits (0.6 + 0.7 mU/L), 
all remaining TRH tests returned to normal when the 
basal TSH had risen back into the normal range.
Persistent abnormalities in the thyroidal axis 
were unusual with no survivors developing secondary 
hypothyroidism. One patient was found to have 
undiagnosed primary hypothyroidism and was commenced on 
treatment. An exaggerated TSH response to stimulation, 
suggestive of central hypothyroidism (Faglia et al, 
1973) or subclinical hypothyroidism was observed in 1 
female subject during all 3 of her tests.
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Our study has confirmed that a reduction in 
thyroidal hormone concentrations occurs after injury 
and that the extent of the fall is dependent on the
injury severity. In addition evidence of a reduction in 
TSH levels was presented and it has been suggested that 
central abnormalities may contribute to the fall in 
thyroidal hormone levels after injury.
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GONADAL AXIS
There have been several studies on the effects of 
injury on the gonadal axis in man and in all cases a 
transient fall in total testosterone has been reported 
(Nakashima et al, 1975; Rudman et al, 1977; Wang et al, 
1978 b; Vogel et al, 1985; Woolf et al, 1985; Woolf et 
al, 198 6). We also observed a rapid and substantial 
fall in testosterone after head injury, with the nadir 
occurring between 1-3 days. The mean level remained 
suppressed one week later but it was back in the normal 
range when the convalescent tests were performed after 
3-6 months. However 5 of the male survivors, who had 
made a complete neurological recovery, were found to 
have persistently low gonadal steroid concentrations 
after 3-6 months and they had all developed hypogonadal 
symptoms. They had no significant previous ill-health 
and had not sustained gonadal injury. This long 
duration of symptoms has not previously been reported 
and is in contrast to Rudman et al (1977) who observed 
that testosterone returned towards the normal range 
when consciousness was regained. Although Woolf et al 
(1985) observed that testosterone levels remained low 
beyond the period of coma he found that they returned 
to normal once the patients were ambulatory and he did 
not report any patients with prolonged hypogonadism.
In previous studies attempts have been made to 
relate the fall in testosterone to the severity of the
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injury, with varying results. Woolf et al (1985) 
initially reported no relationship but in a subsequent 
paper (Woolf et al, 19 86 he found that the fall in
testosterone by day 4 was greater in patients with more 
severe injuries. Rudman et al (1977) reported that the 
fall in testosterone was significantly related to the 
depth of coma, although he excluded 2 of his 7 patients 
in this analysis. Our study has demonstrated a 
significant inverse relationship between injury 
severity and the testosterone concentration on 
admission.
In order to confirm that the fall in total 
testosterone concentration was real and not due to 
changes in binding proteins the free testosterone 
concentration was determined in a proportion of 
subjects. It fell to very low levels and was strongly 
correlated to the total testosterone concentration. No 
direct measurements of free testosterone have 
previously been made, although the percentage of 
dialysable (Goussis et al, 19 83) and ultrafilterable 
(Woolf et al, 1985) testosterone were noted to be 
unchanged during the fall in testosterone after injury.
Female patients in our study had a similar pattern 
with a significant fall in oestradiol concentration 
occurring after injury. The lowest mean level, which 
was recorded after 1 week, was in the post-menopausal 
range and 3 of our subjects, who were amenorrhoeic when 
reviewed after 3-6 months, continued to have low 
oestradiol concentrations. Thus our results are at
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variance with Woolf et al (19 85) , who reported that the 
abnormalities only persisted for 7 days in women of 
reproductive age. The fall in oestradiol concentration
was independent of the stage of the menstrual cycle, as 
previously noted by Woolf et al (1985) . In this small 
group of subjects no relationship between the 
oestradiol concentration and injury severity was found. 
Combining the results from male and female survivors, 8 
of the 31 survivors tested . after 3-6 months had 
prolonged hypogonadism.
In order to determine whether abnormalities in 
central control were responsible for the fall in 
gonadal steroid concentration the basal gonadotrophin 
levels were measured. In male survivors a significant 
decrease from the admission values occurred in both FSH 
and LH after 1-3 days and remained low 1 week later, 
with recovery by 3-6 months. At all stages after injury 
the strong correlation between basal FSH and LH was 
maintained. A similar pattern with a significant fall 
in FSH and LH during the first week after injury has 
previously been observed (Rudman et al, 1977? King et 
al, 1981? Woolf et al, 1985? Woolf et al, 1986) . No 
fall in gonadotrophin levels was found in the small 
group of female patients in our study and this may have 
arisen because few members of this group were studied 
within 24 hours of injury. Woolf et al (1985) observed 
a significant fall in pre and postmenopausal women. The 
lack of a compensatory rise in the basal gonadotrophin 
concentration in both groups of survivors during the
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period of low gonadal steroid concentration, confirms 
that there is disturbance of the central control of 
gonadotrophin secretion after head injury.
At the time of the nadir in basal and peak FSH 1 
week after injury, both indices were negatively 
correlated to injury severity. In contrast no 
correlation was found between LH and injury severity at 
this stage, although a significant negative correlation 
between both basal and peak LH and injury severity had 
developed after 3-6 months in the female survivors. 
Such a prolonged effect of injury on hormone 
concentration seems unlikely but menstrual 
irregularities were common, even at this late stage and
as injury severity was correlated to both basal and
peak LH and just failed to achieve significance with 
basal FSH the relationship may be genuine.
Woolf et al (1985) suggested that the first
abnormality to develop was the fall in testosterone 
concentration and this was independent of the
gonadotrophin concentration. Our results support his 
first suggestion, as within 24 hours of injury 7 
subjects had a subnormal testosterone concentration but 
only 3 of them had developed a subnormal LH level. 
However his second suggestion is refuted by this study, 
as a highly significant correlation was found between 
the testosterone and LH levels on admission in the male 
survivors. This indicates that after head injury the 
fall in testosterone concentration must be faster than 
LH, while remaining correlated to it. This could arise
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because of a relatively greater reduction in 
testosterone secretion or a faster metabolic 
degradation rate for testosterone.
Dynamic studies of gonadotrophin secretion were 
performed and a greatly exaggerated LH response to GnRH 
was observed on admission in both male and female 
patients and the peak level remained outside the normal 
range 1 week later in the male subjects. The FSH 
response was also exaggerated within 24 hours of injury 
in the male survivors, although it had returned to 
within the normal range on subsequent testing. In 
contrast to our results Woolf et al (1985) and Rudman 
et al (1977) reported normal gonadotrophin responses to 
GnRH in a small group of patients (9 in total). However 
their patients had been tested several days after 
admission, thereby missing the time when we observed 
the maximal response, and they were receiving 
dexamethasone, which is known to suppress the gonadal 
axis. Four of the 8 subjects (5 male, 3 female) with 
prolonged hypogonadism in our study continued to have 
an exaggerated LH response to stimulation after 3-6 
months.
On admission, during the period of the greatest 
response, a highly significant correlation was present 
between the basal gonadotrophin level and the increment 
in response to GnRH. However in subsequent tests this 
relationship was lost. This pattern is similar to that 
observed with GH and suggests that inhibitory 
influences on FSH and LH secretion are suppressed after
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injury, permitting a direct relationship between the 
basal gonadotrophin levels and their responses to GnRH.
Our observations on head injured patients do not 
agree with any of the recognised hormonal patterns 
occuring in hypogonadism. In primary hypogonadism a low 
testosterone is accompanied by elevated gonadotrophin 
levels and an exaggerated response to GnRH, whereas in 
secondary hypogonadism low testosterone occurs in 
conjunction with low to normal gonadotrophin levels and 
an absent or delayed response to GnRH. Our patients 
differed in that while testosterone levels were low and 
the basal gonadotrophin levels fell there was an 
exaggerated response to GnRH.
In order to provide further information on the 
central abnormalities responsible for this unique 
pattern the pulsatile secretion of LH was investigated 
in 5 male survivors. Three different methods of pulse 
analysis were used and each demonstrated 'that there was 
no difference in LH pulse frequency between the head- 
injured subjects and the controls. Thus, as there is a 
one to one relationship between endogenous GnRH pulses 
and LH pulses (Clarke and Cummins, 1982), the 
hypothalamic pulse generator must be firing at its 
normal frequency. However the 2 methods of pulse 
analysis which were able to measure pulse amplitude 
demonstrated a significant reduction in pulse amplitude 
in the head-injured subjects. This could mean that 
there is a reduced amount of endogenous GnRH in each 
pulse secreted by the hypothalamus, which could be due
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to dysfunction in the hypothalamus or at a higher 
level. Alternatively the hypothalamus and higher 
centres could be functioning normally with endogenous
GnRH secreted in normal amounts at a normal frequency, 
with the defect occurring in the pituitary. A possible 
pituitary defect could be down-regulation of the 
pituitary GnRH receptors. Whatever the mechanism the 
final result appears to be impaired endogenous 
secretion of the gonadotrophins but continued 
synthesis. The defect in secretion would produce a fall 
in both the gonadotrophin and gonadal steroid 
concentrations and the continued synthesis would 
explain the exaggerated gonadotrophin response to 
exogenous GnRH, which at such a high dosage might be 
able to overcome the block to gonadotrophin release.
There are several factors which may have had an 
influence on the development of the central gonadal 
axis dysfunction. Apart from physical damage to the 
hypothalamus or pituitary, alternative explanations for 
deficient gonadotrophin pulsatile secretion may be 
increased activity of the opioidergic system, which is 
an important modulator of the hypothalamic pulse 
generator (Moult et al, 1981; Ellingboe et al, 19 82) 
and increased adrenergic tone which may act directly 
(Woolf et al, 1986) or modulate the opioid influence on 
gonadotrophin release (Kalra and Crowley, 1982) . 
Although hyperprolactinaemia can also result in 
hypogonadism, possibly by diminishing pulsatile GnRH 
release (Bouchard et al, 1985) , our patients
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(particularly the males) had relatively small 
elevations of their serum prolactin levels.
Acute administration of opiate drugs can result in 
a fall of basal LH and testosterone concentrations, 
with the decrease dependent on the potency of the 
opiate (Cicero et al, 1977 a). As many of our patients 
were treated with opiate analgesics this therapy may 
have contributed to the fall in LH and testosterone. 
However our subjects also had a fall in FSH, which has 
not been observed after opiate administration (Mirin et 
al, 1976) and despite the difference in potencies of 
the 2 analgesics used in our study there was no 
significant difference in any of the hormone levels 
between the 2 groups. Furthermore animal experiments 
have shown that the LH response to GnRH (and the 
pituitary content of LH) is not altered by morphine 
administration (Cicero et al, 1977 b). Thiopentone 
anaesthesia produces no change in LH concentration 
although a fall in testosterone has been reported 
(Salo, 1982). As the mean hormone levels in our 
ventilated and unventilated patients were similar, 
thiopentone is unlikely to have had an important 
contribution to the observed changes.
The exaggerated gonadotrophin response is unlikely 
to be due to interaction between the hypothalamic 
releasing factors, as 3 recent studies have reported no 
potentiation of LH release after administration of 
combinations of the releasing factors (Sheldon et al, 
1985? Looij et al, 1986; Sandler et al, 1986) .
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Similarly, it is unlikely to be due to a concurrently 
administered drug, as patients treated with different 
classes of analgesics and antibiotics had an 
exaggerated response.
The finding that a substantial number of patients 
are symptomatically hypogonadal several months after 
severe head injury and that this is confirmed by the 
presence of low gonadal steroid concentrations is of 
practical importance and possibly prognostic 
significance. In our review of post-traumatic 
hypopituitarism it was observed that the symptoms of 
hypogonadism preceded the diagnosis of
panhypopituitarism by months to years (Edwards and 
Clark, 198 6) . Therefore careful review of these
patients has been arranged to determine if the gonadal
< '
axis dysfunction is the forerunner of
panhypopituitarism. Analysis of the endocrine and 
injury data failed to identify any risk factors which 
could predict the subsequent development of prolonged 
hypogonadism.
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FATALITIES
Endocrine Findings, Histopathological Study, Endocrine- 
Histological Comparison and Prognostic Indicators
Endocrine Findings
Cortisol
Major abnormalities in stress hormone secretion 
were found in the group of 12 fatalities. The most 
serious complication was glucocorticoid deficiency, 
which was present in 4 subjects on admission and had 
developed in a further subject 1 week later. Death 
occurred shortly after injury in the 4 subjects with 
glucocorticoid deficiency on admission and the results 
of the releasing factor test were only available pre- 
mortem in 1 of these cases. He was commenced on 
hydrocortisone but was pronounced brain stem dead 2 
hours later. These 4 subjects had such severe brain 
injury that survival was most unlikely even with 
replacement therapy. The fifth subject, who had a 
normal cortisol response on admission, had received a 3 
day course of dexamethasone after his first releasing 
factor test but developed a severe rise in intracranial 
pressure on the 7th day after injury and was pronounced 
brain stem dead shortly after completion of the second 
releasing factor test. Thus again it is unlikely that 
replacement therapy would have affected his outcome.
The results in this subject are completely 
different from a head-injured patient reported by
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Steinbok and Thompson (1979) who was noted to have 
breakthrough of his cortisol levels when dexamethasone 
was reduced to 4 mg/day, a dose which is normally 
suppressive. Our subject may have developed secondary 
hypoadrenalism between his first and second tests and 
was thereby unable to mount such a response. Our 
results also disagree with a report by Carey et al
(1971), who suggested that cortisol levels continue to 
rise in fatally injured subjects until death.
Growth Hormone
On admission GH levels were similar to those in 
the male survivors. Although 4 fatalities had virtually 
no GH response to stimulation, with peak levels < 2
mU/L, this may not have reflected complete destuction 
of the somatotrophes, as several survivors had a 
similar response on admission but a normal response on 
retesting.
Carey et al (1971) also reported a continued 
increase in GH, to very high levels, in two fatally 
injured patients. However only one of our 12 fatalities 
had a substantial elevation of their GH level on 
admission (28 mU/L) and neither of the 2 fatalities who 
were retested 1 week later (shortly before their 
deaths) had elevated levels.
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Prolactin
Although the basal level was similar to that in 
the male survivors, 7 of the fatalities had either no 
PRL response or a subnormal response to stimulation 
with TRH, resulting in a substantially lower peak 
level. Three of these subjects also had a low basal 
level, suggesting that there was destruction of their 
lactotrophes and possibly their anterior pituitary 
glands.
Thyroidal Axis
As expected thyroidal abnormalities were 
particularly common in the fatalities, with 9 subjects 
having a subnormal T3 level and 5 having a subnormal 
T4. In 6 subjects the T3 level was less than the lower 
limit of the T3 assay. Subnormal TSH responses to TRH 
were also frequently found in this group (9 cases). One 
fatality had results compatible with central 
hypothyroidism (Faglia et al, 1973) .
Gonadal Axis
The basal FSH and LH levels were greater than 
those found in the survivors and the LH response to 
stimulation was reduced, indicating that the LH storage 
pool had been diminished while maintaining the higher 
basal level. In contrast to the 3 stress hormones 
measured in this study, the gonadotrophins were found 
to be significantly greater in the fatalities when
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compared to the survivors. Thus with very severe injury 
the stimulus to gonadotrophin secretion must override 
the negative influences observed in less severely 
injured subjects. This may explain why the testosterone 
concentration was significantly greater in the 
fatalities and, unlike the survivors, was not 
negatively correlated to injury severity.
Histopathological Study
Although pituitary and hypothalamic damage have 
long been recognised after fatal head injury and may 
contribute to the fatal outcome (Daniel and Treip, 19 61 
and 1966; Harper et al, 1986), pituitary function has 
never been assessed in such a group. In this study 
pituitary function was assessed in 12 subjects who died 
as a consequence of their head injury, and subsequently 
their endocrine results were related to the 
histological findings in the hypothalamus and 
pituitary.
The histological changes observed in the anterior 
pituitary were similar to those previously reported 
(Daniel et al, 1959 b; Daniel and Treip, 1961; 
Ceballos, 19 66; Kornblum and Fisher, 1969; Harper et 
al, 1986) and included large centrally situated 
infarcts with a small surviving rim of variable 
thickness. The occurrence of large anterior pituitary 
infarctions in 9 of the 10 pituitary glands available 
for histological examination was considerably greater 
than the incidence in the above studies. This
difference may have arisen because our subjects had 
more severe head injuries, as all 12 died within 1 week 
of injury, whereas other studies included less severely 
injured subjects, who died several months after injury.
Hypothalamic damage was also frequently observed 
in our subjects, with petechial haemorrhages or small 
infarcts located in the paraventricular and supraoptic 
nuclei, median eminence and upper stalk, which is 
similar to the findings in previous studies (Treip, 
1970; Crompton, 1971). Only 1 of our subjects had stalk 
section and this is in keeping with the low incidence
reported by Ceballos (1966) and Harper et al (1986).
Anterior pituitary necrosis develops because of an 
interruption of blood flow in the hypothalamo- 
hypophyseal portal vessels in the pituitary stalk. 
Although it was initially suggested by Daniel and Treip 
(1961) that stalk transection was the responsible 
mechanism it is apparent from our study and other 
recent papers that stalk transection is infrequent and 
it is more likely that compression of stalk portal 
vessels on the diaphragma sella due to post-injury 
pituitary swelling and intracerebral oedema is
responsible (Kornblum and Fisher, 19 69; Harper et al, 
1986) . All 12 of our subjects had evidence of gross 
cerebral oedema on their CT scans, with obliteration of 
the lateral ventricles and perimesencephalic cisterns 
and flattening of the cortical sulci, and at
postmortem, their brains were described as swollen and 
oedematous, with cerebellar coning frequently present.
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Thus compression of the stalk vessels seems likely in 
these circumstances.
Harper et al (1986) reported a high incidence of 
fracture of the base of the skull in subjects with 
infarction of the anterior lobe and Daniel and Treip
(1966) stated that a basal fracture was one of the two 
consistent clinical findings in such cases, the other 
being prolonged coma disproportionate to the severity 
of the head injury. However in this study there was no 
relationship between the histological changes and the 
site of skull fracture, as large pituitary infarcts 
were present in subjects with frontal, parietal and 
basal fractures and in 1 subject with no fracture. In 
addition the direction of the injuring force did not 
appear important as similar pituitary damage was 
observed in the 6 subjects whose impact was 
predominantly in the antero-posterior plane when 
compared to the 6 subjects injured by a lateral force.
It has also been suggested that hypotension and 
anoxia after injury may be responsible for the massive 
anterior pituitary infarction (Orthner and Mayer
(1967). However all our subjects were maintained on a 
ventilator with their gas exchange carefully monitored 
and, as many of our fatalities were organ donors, blood 
pressure was carefully controlled.
Thus in our cases massive pituitary infarction was 
not due to hypotension or hypoxia and was independent 
of the direction of the injuring force or the presence 
of a skull fracture. It seems more likely that the
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severity of the injury and the consequent intracerebral 
oedema, by producing stalk compression, are the 
determinants of the resulting pituitary necrosis.
Endocrine-Histological Comparison
Previous histological studies have not been able 
to compare their findings with the premortem endocrine 
results. Our finding of multiple hormone deficiencies 
in 6 of the cases with large pituitary infarcts is not 
surprising, but a further 3 cases had virtually normal 
dynamic tests. This may have arisen because these 3 
subjects survived for 4-5 days after their endocrine 
tests were performed and thus may have developed 
pituitary infarction (possibly with endocrine 
abnormalities) at this late stage, during the period 
when their intracranial pressure was rising. The 
subject with pituitary stalk transection had no hormone 
response to stimulation, presumably because the blood 
supply to the anterior pituitary must have been 
completely severed.
The finding of most clinical relevance was that 5 
subjects were glucocorticoid deficient. This occurred 
in 3 subjects with large pituitary infarcts, the 
subject with stalk transection and one case in which 
the pituitary was unavailable but the hypothalamus had 
infarction of the median eminence. Apart from the case 
with stalk transection similar histology was observed 
in other subjects but was not accompanied by 
glucocorticoid deficiency.
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Immunocytochemical staining for ACTH, GH, PRL and 
TSH was generally positive in all subjects and was not 
reduced in patients with subnormal hormone levels or
impaired hormone responses to releasing factor 
stimulation. However staining for LH was negative in 
virtually all fatalities and clearly different from the 
staining produced in control subjects. • This is in 
keeping with the endocrine results for LH, which 
suggested a reduction in the LH storage pool. A similar 
reduction may have occurred to the GH and PRL storage 
pools, as elevated basal levels on admission were 
associated with a reduced response to stimulation, but 
this was not apparent from the immunocytochemical 
staining.
Prognostic Indicators
Our study has identified several endocrine changes 
associated with a poor prognosis. "'Glucocorticoid 
insufficiency was not demonstrated in any survivors 
during the first week after injury, but occurred in 5 
fatalities. Similarly a deficient PRL response was 
present in 6 fatalities but not observed in any 
survivors.
There were several other endocrine changes 
suggestive of a poor prognosis. A reduced TSH response 
to TRH was the most frequent abnormality in the 
fatalities (9 cases) but was also present in some 
survivors. Analysis of mean levels demonstrated that T4 
was lower in fatalities (T3 just failed to achieve
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significance), whereas FSH, LH and testosterone levels 
were significantly higher in fatalities.
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DIABETES INSIPIDUS
Diabetes insipidus (DI) has long been recognised 
as a complication of head injury (Rowntree, 1924) and 
it is said to be the most common hypothalamic disorder 
following trauma (Porter and Miller, 1948). However 
the two largest studies reported a low incidence, with 
4 cases out of 2500 head injured subjects in Pickles 
(1947) series and 13 cases out of 5000 non-fatal closed 
head injuried in the study by Porter and Miller (1948). 
The incidence in our study in the survivors was 2 out 
of 48 subjects which is 15-25 times greater than the 
previous two studies. This substantial increase may 
have arisen because the 2 large studies were reported 
40 years ago and since then there have been 
considerable advances in intensive care therapy, such 
that severely head-injured subjects, who are more 
likely to develop DI (Porter and Miller, 1948; Verbalis 
et al, 1985) are now surviving and subsequently 
developing it. There may also be better recognition of 
this complication because of an increased awareness. 
There have been no previous studies of DI complicating 
fatal head injury. The high incidence on this study (5 
of 12 cases) confirms the association with severity of 
injury.
It has been suggested that the lesion responsible 
for the develoment of DI is most commonly in the 
pituitary stalk and occurs due to stretching of the 
relatively fixed stalk by the displaced brain at the 
time of injury (Porter and Miller, 1948). Animal
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experiments (Magoun et al, 19 39; Pickford and Ritchie, 
1945) and studies in humans who have had their 
pituitary stalk sectioned (Lispett et al, 1956) have 
demonstrated that the develoment of permanent DI is 
dependent on the number of surviving ADH secreting 
neurons and if less that 10-20% remain viable then 
permanent DI will occur (Verbalis et al, 1985) . Thus 
in our 3 subjects (2 survivors, 1 fatality) with 
transient DI it is likely that more than 20% of the ADH 
secreting cells survived and, once the inflammatory 
oedema had settled, ADH secretion could recommence with 
resolution of the DI.
The direction of the injuring force which is most 
likely to produce the stalk lesion appears to be in the 
antero-posterior plane, as 15 of Porter and Miller*s 18 
subjects and 6 of our 7 cases had frontal or occipital 
injuries.
The onset of DI in our subjects varied between 12 
hours to 5 days after injury, which is similar to 
previous studies. The onset was abrupt in each subject 
arid none had the occasionally reported triphasic 
pattern (Verbalis et al, 1985), in which an initial 
phase of DI is followed by a transient antidiuretic 
phase before the eventual return of DI.
Anterior pituitary dysfunction has been reported 
in association with DI but its frequency is uncertain. 
Barreca et al (1980) reported defective anterior 
pituitary hormone secretion in 8 out of 10 subjects, 
with GH and TSH most commonly involved and Verbalis et
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al (1985) observed deficient TSH and ACTH secretion in 
40% and 36% of subjects respectively. However neither 
study states how the hormone response was deemed to be 
deficient and the number of patients that actually
required replacement therapy is not recorded. In
contrast Porter and Miller (194 8) observed only 1 case
of anterior pituitary insufficiency out of 18 subjects 
with DI and Notman et al (198 0) reported 1 subject with 
hypopituitarism out of 10 cases. Neither of our 
survivors had evidence of anterior pituitary 
dysfunction, although both had an elevated PRL level, 
which occurred shortly after injury and was probably 
due to the stress response rather than hypothalamic 
damage, as their PRL level was subsequently normal. 
However subnormal hormone responses to stimulation were 
found in 4 of the 5 fatalities with DI, which is 
presumably a consequence of their more severe injuries.
Thus DI was a relatively frequent occurrence in 
fatalities but was infrequent in the survivors. In
contrast to previous studies disturbances of anterior 
pituitary function occurred considerably more often 
than the development of DI in both the survivors and 
fatalities.
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S U M M A R Y  O F  R E S U L T S
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Sixty subjects (48 male) were studied, of whom 12 
died. Traffic accidents were responsible for 49 of the 
60 injuries. A skull fracture was present in 32 
subjects and 42 required assisted ventilation.
1. Gonadal Axis
The levels of total and free testosterone, 
oestradiol, basal FSH and basal LH fell significantly 
during the first 3 days after injury, when the LH and 
FSH responses to GnRH achieved their highest peak 
levels. This hormone pattern has not previously been 
reported in the gonadal axis. Persistent biochemical 
hypogonadism was found in 8 of 31 patients retested 
after 3-6 months, all of whom had clinical symptoms of 
hypogonadism. Analysis of the pulsatile release of LH 
shortly after injury demonstrated a reduced pulse 
amplitude with a normal pulse frequency, which may be 
due to either a hypothalamic or pituitary defect.
2. Thyroidal Axis
Basal TSH levels were frequently less than the 
lower limit of the assay within 24 hours of injury, in 
both survivors and fatalities and the TSH response to 
TRH was markedly reduced in fatalities. Thyroxine (T4) 
and tri-iodothyronine (T3) levels were reduced shortly 
after injury and were significantly lower in 
fatalities.
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3. Cortisol Secretion
In the survivors cortisol levels were 
substantially elevated shortly after injury and 
gradually fell back into the normal range. However 5 
fatalities were found to have low cortisol levels after 
injury (less than 400 nmol/L) and were considered to be 
glucocorticoid deficient.
4. Prolactin Secretion
Prolactin levels were elevated during the first 
week after injury. Female subjects had the highest 
basal levels and the greatest prolactin response to 
TRH, whereas fatalities had a significantly reduced 
response to TRH.
5. Growth Hormone Secretion
GH levels were highest on admission but remained 
within normal limits. There was a large variability in 
the GH response to GRH between patients. The response 
on admission was significantly reduced compared to 
later tests.
6. Response to Releasing Factor
At all stages after injury there was a significant 
negative relationship between the basal cortisol level 
and the size of the increment in response to CRH, 
whereas TSH remained positively correlated to its
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increment throughout. During the first week after 
injury GH, FSH and LH were correlated to their 
increment but no relationship was present after 3-6 
months. In contrast PRL was only correlated to its 
increment aftr 3-6 months.
7. Injury Severity and Hormone Concentrations
During the first week after injury the cortisol, 
GH and prolactin levels were positively correlated to 
injury severity (with a transient reversal in the 
cortisol relationship 1-3 days after injury). In 
contrast the testosterone, T3, T4 and the peak TSH 
level in response to TRH were negatively correlated to 
injury severity during this period. FSH levels became 
negatively correlated to injury severity at the end of 
the first week.
8. Histopathological Study
Large anterior pituitary infarcts were present in 
9 of the 10 anterior pituitary glands studied. Damage 
to the hypothalamus was relatively mild, with 
occasional petechial haemorrhages in the
paraventricular and supraoptic nuclei (6 cases), median 
eminence (3 cases) and the stalk (2 cases). Six of the 
9 subjects with large pituitary infarcts had multiple 
hormone deficiences, including low levels of T3, T4 and 
cortisol and impaired pituitary hormone responses 
during the stimulation test.
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9. Diabetes Insipidus
This occurred in 5 of the 12 fatalities but only 2 
of the 48 survivors. The injuring force was in the 
antero-posterior direction in 6 of the 7 subjects with 
diabetes insipidus.
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C O N C L U S I  0 N S
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1. Endocrine function after head injury has not
previously been studied. This project has 
demonstrated biochemical hypogonadism in virtually 
all subjects after injury, which persisted in a 
substantial proportion of subjects 3-6 months 
later. Further investigations demonstrated 
abnormalities in pulsatile LH secretion, 
indicating a central defect (hypothalamus or 
pituitary). Although impotence, loss of libido and 
amenorrhoea have been recognised after head injury 
they have previously been ascribed to
psychological effects of the injury, whereas our 
study provides firm evidence of an endocrine cause
and raises the possibility of therapeutic
intervention.
2. In a review of the reported cases of post-
traumatic hypopituitarism (including > 6 of our own 
cases) we observed that hypogonadism often 
preceded subsequent panhypopituitarism. Thus our 
group of 8 patients with persistent hypogonadism 
may have an increased risk of subsequently 
developing post-traumatic hypopituitarism,
although follow-up tests have not yet detected any 
further endocrine abnormalities.
3. Five of the 12 fatalities were found to be 
glucocorticoid deficient after injury and at post­
mortem had extensive anterior pituitary necrosis,
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stalk transection or hypothalamic infarction. 
Therefore glucocorticoid replacement therapy 
should be considered for patients who are 
considered to have the most severe injuries on 
clinical grounds, before the results of hormone 
investigations are available.
4. The stress hormone response was usually well 
preserved in survivors and the levels of cortisol, 
GH and PRL were positively correlated to the 
injury severity within 24 hours of injury. In 
contrast thyroidal and gonadal hormones were 
negatively correlated to injury severity. A sex 
difference was observed for prolactin, with female 
subjects having a greater release, which may have 
contributed to the oligo/amenorrhoea frequently 
observed in these subjects.
5. During the period of maximal stress positive 
correlations developed between GH, FSH and LH and 
the size of their increments, whereas PRL lost its 
normal positive relationship and the cortisol and 
TSH relationships were unchanged. Thus severe 
stress was able to override the physiological 
central inhibitory influences on GH, FSH and LH 
secretion and also disrupted central control of 
PRL secretion.
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6. Diabetes insipidus was frequently observed in the 
fatalities, requiring treatment in 4 cases, but 
was rare (and temporary) in the survivors.
7. This study has identified a group of hormone
measurements on admission which are indicators of 
a bad prognosis (low cortisol, T3 and T4 levels, 
reduced prolactin and TSH responses to stimulation 
with TRH and a lack of a reduction in FSH, LH and 
testosterone concentrations) . Early identification 
of patients with such hormonal abnormalities may 
alert the clinician to the severity of the injury 
and target patients who require more intensive 
support.
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